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Abstract
The process by which a single fertilized egg develops into a human being with over 200
cell types, each with a distinct gene expression pattern controlling its cellular state, is
poorly understood. An understanding of the transcriptional regulatory networks that
establish and maintain gene expression programs in mammalian cells is fundamental to
understand development and should provide the foundation for improved diagnosis and
treatment of disease. Although it is not yet feasible to map the entirety of these networks
in vertebrate cells, recent work in embryonic stem (ES) cells has demonstrated that core
features of the network can be discovered by focusing on key transcriptional regulators
and their target genes. Here, I describe important insights that have emerged from such
studies and highlight how similar approaches can be used to discover the core networks
of other vertebrate cell types. Knowledge of the regulatory networks controlling gene
expression programs and cell states can guide efforts to reprogram cell states and holds
great promise for both disease therapeutics and regenerative medicine.
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Preamble
In the first chapter of this thesis I discuss relevant background information, key themes
uncovered, and future challenges pertaining to my thesis work on the transcriptional
regulatory network of embryonic stem cells. I first introduce transcriptional regulatory
networks; discussing mechanisms of eukaryotic transcription, their study in vertebrate
cells, and computational insights stemming from studies of networks in model organisms.
I then highlight the importance of discovering the transcriptional regulatory network of
embryonic stem cells. Next I discuss key themes uncovered from my, and others' work,
underscoring their potential implications. Throughout the first chapter I also offer future
challenges, goals and possible approaches that logically follow my thesis work. In the
following chapters and appendices of this thesis I then present more detailed accounts of
the body of work constituting my thesis and discussed in Chapter 1.

Chapter 1
Dissecting Transcriptional Regulatory Networks of Vertebrate Cells
Introduction
With a few exceptions, the diverse array of cell types that constitute the human body have
identical genetic material and it is the regulated expression of this genetic material that
confers unique properties onto different cell types. During development the genetic
material from the initial fertilized egg is methodically passed on to each daughter cell.
However, differences in expression of the genetic material between daughter cells are
induced in order to initiate different cell lineages. In this manner, different cell types are
specified during development by the precise establishment of their unique gene
expression programs.
Complex organisms such as humans, that have to specify over 200 diverse cell
types, must therefore have robust mechanisms to tightly control the unique expression
pattern of each cell. These expression patterns are controlled by transcriptional
regulators, which act in a combinatorial manner to control gene expression. Throughout
development the set of transcriptional regulators expressed is adjusted in order to
establish the proper combination of regulators to specify a given cell type and expression
program.
While proper gene expression directs cell fate during development, abnormal
gene expression can affect cell state to induce disease. Inappropriate gene expression
patterns are the underlying cause of many devastating human diseases including some
cancers, autoimmune diseases, diabetes and cardiovascular disease, and many regulators
that control gene expression patterns within a cell have been linked to these diseases
(Arce et al., 2006; Bennett et al., 2001; Chahrour and Zoghbi, 2007; Couzin, 2008;
Kloosterman and Plasterk, 2006; Ryffel, 2001; Villard, 2004; Vogelstein et al., 2000;
Wang et al., 2007). Either genetic mutation or aberrant expression of these regulators can
cause disease development. Although some disease related expression regulators have
been extensively studied, our understanding of how they act within the cell to induce a
disease state is limited because we cannot place their contribution to gene expression
within the larger context of cellular gene expression control.
The control of expression patterns in vertebrate cells is almost entirely unmapped
due to experimental and conceptual limitations that attend its study. Although initial
maps of transcriptional regulatory networks have been created for several model
organisms (Davidson et al., 2002; Lee et al., 2002; Salgado et al., 2006), it is not yet
possible to create equivalent maps in vertebrate cells due to experimental limitations.
Recently, however, several groups have begun to tackle the challenge of mapping the
control of gene expression patterns in vertebrate cells, particularly embryonic stem (ES)
cells, and have demonstrated that significant insights can be obtained using current
technologies. A paradigm for studying vertebrate regulatory networks, established by
studies in ES cells, together with key themes uncovered from these studies, are described
here and provide a possible guide for future studies.
Elucidation of vertebrate control of gene expression patterns must be aggressively
pursued as it will lead to advances in our understanding of development, control of
cellular state, dysregulation of cell state in disease, as well as our ability to manipulate
cell state for disease treatment and regenerative medicine.
Molecular Mechanisms Controlling Eukaryotic Transcription
The level and types of RNA species produced within a cell determines cellular state and
is a tightly regulated process. In eukaryotes the control of RNA expression includes
inputs from transcription factors, chromatin regulators, signaling pathways and non-
coding RNAs (Figure 1). These components form a complex network, the transcriptional
regulatory network (TRN), which regulates the expression of RNA within a cell. The
mechanisms by which these components affect gene expression are largely understood
and can be used to guide the process of mapping the TRNs of vertebrate cells. Here we
will only briefly discuss the role of various inputs in the control of gene expression. For
more detailed descriptions of eukaryotic transcription and gene expression the reader is
referred to several excellent reviews (Kornberg, 2007; Lee and Young, 2000; Lemon and
Tijan, 2000; Li et al., 2007; Orphanides and Reinberg, 2002).
In a simplified model, eukaryotic transcription can be viewed as a sequence of
events, each step being a regulated process (Figure 2). The initial steps include binding
of transcription factors (also called sequence-specific DNA binding factors) to cis
regulatory DNA elements, acetylation of histones, and recruitment of the transcription
apparatus (Gill, 2001; Santos-Rosa et al., 2002; Struhl, 2005). Serine 5 of the
heptapeptide repeat on the C-Terminal Domain (CTD) of RNA Pol II then becomes
phosphorylated, allowing Pol II to initiate transcription, and leading to methylation of
lysine 4 of histone 3 by a histone methylase of the trithorax family (Hirose and Ohkuma,
2007; Pokholok et al., 2005; Santos-Rosa et al., 2002). The Nelf and DSIF complexes
cause a promoter-proximal pause of transcription that is relieved upon phosphorylation of
PolllI's CTD at serine 2 (Sims et al., 2004). This hyperphosphorylated form of Pol II can
then transcribe through the gene, and during this process a histone methyltransferase
methylates lysine 36 of histone 3 (Bannister et al., 2005; Pokholok et al., 2005).
Methylated H3K36 residues are recognized by histone deacetylases, which deacetylate
histones in the coding region, essentially resetting the chromatin for the next round of
transcription (Lee and Shilatifard, 2007). Various component classes are involved in the
regulation of different steps in the process of gene expression and the manner in which
these components regulate this process affects their role in the transcriptional regulatory
network controlling cellular gene expression.
Transcription factors lie at the heart of transcriptional regulation and anchor
transcriptional regulatory networks. Due to their ability to recognize specific DNA
sequences transcription factors serve as the mechanism whereby the genetic information
encoding instructions for proper gene expression is interpreted. Pol II cannot itself
recognize promoter sequences and instead must be recruited by transcription factors.
Transcription factors are also the single largest protein family encoded in the human
genome, where they account for approximately 10% of protein-coding genes (Babu et al.,
2004; Lander et al., 2001; Levine and Tijan, 2003). They bind to both promoter proximal
and distal (even as far away as 100Kb) regulatory DNA sequences and can both aid or
inhibit recruitment of the transcription apparatus at target genes (Blackwood and
Kadonga, 1998; West and Fraser, 2005).
Chromatin regulators are typically recruited to specific portions of the genome by
DNA-binding transcription factors or the transcription apparatus where they can affect
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Figure 1 Abstract Map of a Transcriptional Regulatory Network.
Diagram depicting the inputs from transcription factors (blue circles), chromatin
modifiers (green circles), signaling pathways, and miRNAs (purple diamonds) to form a
network regulating the expression of target genes (target protein coding genes are
represented by orange rectangles and target non-coding RNAs are represented by purple
diamonds).
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Figure 2 Model of eukaryotic transcription.
(A) Transcription factors (red and purple ovals) bind to DNA motifs and recruit
transcription apparatus (blue complex) and histones H3 and H4 become acetylated.
(B) Transcription is initiated by the phosphorylation (yellow stars) of serine 5 on the
heptapeptide repeat on the C-terminal domain of PolII by TFIIH (green complex), histone
H3 is tri-methylated at lysine 4 by the Trithorax complex and PollI starts transcribing.
(C) Transcription is stalled by NELF (yellow complex)'and DSIF (light green complex).
(D) Stall is released by phosphorylation of serine 2 on the PolII C-terminal domain,
NELF and DSIF by PTEFb (pink complex).
(E) PolII now transcribes through the entire entire gene creating full-length transcript and
leading to methylation of lysine 36 on histone H3.
gene expression and hence act to augment the transcriptional regulatory network. Unlike
many transcription factors, most chromatin regulators function in the same fashion at all
target genes, either repressing or activating their expression. Chromatin regulators often
function by depositing methylation or acetylation marks on histones making it possible to
deduce the role of many chromatin regulators at target genes in the transcriptional
regulatory network by examining a small number of histone modifications. Cells are able
to maintain histone marks and so the affect of chromatin modifiers can be long lasting
and has been proposed as a possible mechanism of cellular memory (Bantignies and
Cavalli, 2005; Hirose, 2007; Turner, 2002).
Signaling pathways connect environmental signals to the transcriptional
regulatory network to effect changes in gene expression and potentially the network
itself. They can transduce extracellular signals through a series of intracellular
components eventually ending with a terminal component capable of affecting cellular
state through a variety of mechanisms. Terminal components are often protein kinases
that activate transcriptional regulators, or are transcriptional regulators themselves such
as transcription factors and chromatin modifiers. In this manner, signaling pathways can
initiate new gene expression programs and can be viewed as the most upstream
components of transcriptional regulatory networks.
Although the mechanisms by which non-coding RNAs (ncRNAs) affect gene
expression are less understood, the need to incorporating their influence into the
transcriptional regulatory network is clear. Non-coding RNAs can affect chromatin state
and transcriptional regulators (Amaral et al., 2008; Barrandon et al., 2008; Goodrich and
Kugel, 2006; Hawkins and Morris, 2008). A large class of ncRNAs, termed micro RNAs
(miRNAs), modify gene expression by inducing degradation of mRNA transcripts
(Ambros and Chen, 2007; McManus and Sharp, 2002; Wu and Belasco, 2008). In this
way ncRNAs can act at multiple stages of transcription regulation, with miRNAs acting
downstream of other component classes in the transcriptional regulatory network.
Through an understanding of the mechanistic control of gene expression by these
component classes, scientists can gain insight into how each type of component controls
the transcriptional regulatory network genome-wide and use this knowledge to guide
studies in this area. Transcription factors, by recognizing genetic information encoded in
DNA, act as the anchor of the network. Chromatin regulators, by modifying chromatin
structure are able to augment the landscape of the network and can also serve to
implement more long-term or stable gene expression regulation. Signaling pathways act
to maintain or initiate changes in the regulatory network in response to environmental or
developmental cues. miRNAs and other ncRNAs may act to fine-tune expression levels
and serve as a rapid means of control or change in the network as they are faster to
produce then protein regulators and can immediately affect protein production by
eliminating existing mRNAs rather than simply eliminating the production of mRNAs.
Given these unique roles it is clear that studies of transcriptional regulatory networks
must begin by examining key transcription factors but that regulators from each
component class should be examined to gain a more thorough understanding of the multi-
level and combinatorial control of vertebrate gene expression.
Core Transcriptional Regulatory Networks
Levine and Tijan proposed that "organismal complexity arises from progressively more
elaborate regulation of gene expression" (Levine and Tijan, 2003). Organismal
complexity does not correlate with genome size but rather with the ratio of transcriptional
regulators to genes (Babu et al., 2004; Levine and Tijan, 2003; Nimwegen, 2003; Tupler
et al., 2001). Given the combinatorial nature of the control of gene expression, a small
increase in the number of transcription factors could lead to a large increase in regulatory
complexity. With the large number of regulators in vertebrates this implies that their
transcriptional regulatory networks will be enormously complex.
Transcription factors alone account for approximately 10% of protein-coding
genes in humans (Babu et al., 2004; Lander et al., 2001; Levine and Tijan, 2003). If one
assumes that 1/3 of protein-coding genes are expressed in each cell type (Brandenberger
et al., 2004; Guenther et al., 2007; Sato et al., 2003; Su et al., 2004), and that a similar
fraction of transcription factor genes are expressed, then roughly 700 transcription factors
are expressed in each cell. Even attempting to map this network, without accounting for
the other types of network components such as chromatin regulators or ncRNAs, is
currently not feasible experimentally.
While each regulator contributes to the proper expression of genes within a cell,
only a small subset of these regulators play key roles in establishment or maintenance of
cell state. Many regulators can be removed without dire consequences for the cell
(Giaever et al., 2002; Kemphues, 2005; Winzeler et al., 1999). This may be a biological
mechanism to protect against mutations and to ensure robust gene expression patterns,
and may be due to the scale-free architecture of biological networks (discussed below).
The small set of regulators that play a vital role in a particular transcriptional regulatory
network are termed here 'key regulators' and are defined by their important role in
maintenance or establishment of the cell state governed by the network.
A simplified version of a transcriptional regulatory network that still captures
many important themes can be deduced by discovering the population of genes that are
controlled by the key regulators for that cell type. We call this simplified network the
'core transcriptional regulatory network'. Given current experimental limitations in
studying complete vertebrate networks, discussed below, more focused studies of core
networks, guided by identification of key regulators, should predominate scientific
efforts. These studies of core networks, though missing many inputs from other
regulators, can nonetheless still elucidate key network themes, as has been shown to be
the case in ES cells.
Transcriptional Regulatory Networks in Vertebrate Cells
Studies of transcriptional regulatory networks in vertebrate cells are of vital importance
to studies of development, disease treatment and regenerative medicine but are hindered
by substantial experimental and conceptual challenges. Recent technological advances
have allowed for high-throughput studies in model organisms such as E. coli and S.
cerevisiae, but due to the increased complexity, the same brute-force approaches cannot
efficiently map the TRNs of vertebrate cells. In order to achieve success in vertebrate
studies it is therefore important to identify a clear set of goals, to understand the
capabilities and limitations of currents technologies and to identify pivotal challenges
faced by vertebrate studies.
Goals
Knowledge of vertebrate TRNs throughout development is essential to understanding this
process as well as being able to manipulate cell fates for medicinal purposes. The overall
goal of mapping the complete transcriptional regulatory network of every cell type and
understanding how these networks are dynamically established during development is a
large challenge that cannot, with current technologies and resources, be solved within a
short timeframe. Given the extreme complexity in deciphering these networks it is
important to establish goals that can guide scientists to choose which portions of the
overall goal to tackle first. Although studies in ES cells did not explicitly lay out a series
of objectives, they have nonetheless established a clear set of goals that can guide future
studies.
As scientists cannot simultaneously tackle all possible cell-types, an initial goal
must be to identify cell-types that will yield the highest rewards. These cell-types should
be selected based on medical relevance and ease of study. Cell-types that hold the most
promise for regenerative medicine or for disease treatment should be prioritized.
However, practical concerns regarding the ease of obtaining high numbers of
homogenous cells should also be taken into account. Although primary tissues would be
ideal, comparable cell lines will often be the best choice due to the experimental benefits
they offer.
As discussed above, it is also of primary importance to assemble an initial map of
the core transcriptional regulatory network using a subset of components that are most
likely to play a key role in the control of gene expression for the particular cell type.
Given the enormous number of transcriptional regulators that are involved in the control
of gene expression, it is vital to identify a manageable number of these components that
could quickly be mapped and that are likely to reveal key themes in the transcriptional
regulatory network. The first components to be studied are likely to be cell type specific
transcription factors, but it will also be important to add inputs from other component
classes.
Another goal should be to identify how cells dynamically manipulate their
transcriptional regulatory networks in response to extracellular cues. These studies will
be quite challenging as capturing dynamic changes in a complex network is
experimentally much more difficult than mapping more static cell states. However, this
understanding is of vital importance because it can guide efforts to manipulate cell state
for medical purposes.
The ultimate goal is for scientists to be able to manipulate cell state, ideally
without the use of recombinant DNA. Knowledge of how cells in vivo direct changes in
the transcriptional regulatory network to affect changes in cell state should be able to
guide efforts by scientists to do the same. This goal is of vital importance as the
controlled manipulation of cell state is a necessary step to being able to harness the
therapeutic potential that modem biology promises.
By prioritizing the order in which scientists tackle the monumental challenge of
mapping the complete vertebrate TRN throughout development it is likely that the
conceptual and medical benefits that stem from this knowledge will be realized more
rapidly.
Current Technologies
Generally two types of experiments are used to study transcriptional regulatory networks
in vertebrates: location analysis and expression studies. Location analysis identifies the
location of proteins along the genome and so can identify potential direct target genes of
transcriptional regulators. Expression studies, such as the measurement of expressional
changes upon loss of a transcriptional regulator, are also used to identify potential direct
or indirect target genes or to examine the functional consequence of regulator binding at
target gene promoters.
The location analysis assay identifies the location of regulatory proteins along the
genome and so can be used to identify the direct target genes of a transcriptional
regulator. The technology behind this assay is quickly evolving to improve both data
quality and high-throughput capabilities. Detailed descriptions of location analysis
assays can be found in several manuscripts and are only briefly described below
(Acevedo et al., 2007; Bulyk, 2006; Gordon et al., 2007; Lee et al., 2006).
The location analysis protocol builds off of the classic pull-down experiment.
Protein-DNA interactions are first immobilized by chemical crosslinking in vivo.
Crosslinked chromatin is then sheared into smaller fragments, typically 100-500bp in
length. Sequences bound by the protein of interest are then enriched by
immunoprecipitation, either of native protein or a tagged protein construct. Enriched
sequences are then identified by DNA microarrays (using non-immunoprecipitated
chromatin as a control) or by direct sequencing.
The experimental ease and cost associated with the detection of bound DNA
sequences by either array or sequencing have been reduced recently, making the use of
these techniques by many labs now possible. The increased resolution offered by
sequencing based technologies makes it likely that this method will predominate in future
studies. In fact, this technology can pinpoint protein binding sites to within 25bp or less
(Marson et al., submitted).
Expression analyses also play a vital role in mapping transcriptional regulatory
networks (Bar-Joseph et al., 2003; Gao et al., 2004; Goutsias and Lee, 2007; Li et al.,
2008). Advances in measurement of transcript levels as well as manipulation of
transcriptional regulators to induce changes in expression have been made recently and
improve the ability of scientists to study transcriptional regulatory networks in vertebrate
cells. Sequencing based technologies now allow for the efficient measurement of small
RNA transcripts in addition to the measurement of mRNA levels (Marson et al.,
submitted). This allows for small non-coding RNAs, such as miRNAs, to be
incorporated into maps of transcriptional regulatory networks. Advances in the
manipulation of transcriptional regulators through RNAi allow for more efficient studies
examining the functional consequences of transcriptional regulators on target gene
expression (Cockrell, 2007; Dann, 2007; Ding and Buchholz, 2006).
Although these genomic technologies continue to improve, there remain
fundamental challenges that have not yet been solved that impede more high-throughput
studies.
Challenges
While maps of the transcriptional regulatory networks of model organisms such as E.
coli, S. cerevisiae and even the multicellular organism sea urchin, are rapidly being
discovered, little is known about the TRNs of vertebrate cells due to enormous
experimental and conceptual challenges associated with studying these networks. A key
aspect of mapping the TRNs of vertebrate cells will likely be the development of
technologies and analyses that will make these studies more feasible. In order to push
forward the development of these technologies it is vital to first clearly establish what the
specific challenges in creating maps of vertebrate TRNs are.
An obvious experimental challenge faced in vertebrates is the shear number of
networks to map. It is estimated that humans have over 200 cell types, each with a
unique regulatory network. Given the difficulty of creating a complete TRN for even a
single vertebrate cell type, the added challenge of performing this task in many cell types
only multiplies the experimental time and expense.
A related experimental challenge is the difficulty in obtaining the necessary purity
and number of cells to perform the requisite experiments. Most chromatin
immunoprecipitation experiments require at least one million relatively pure population
of cells. Obtaining this number and purity of cells can be very difficult, if not nearly
impossible, for certain cell types. It would be particularly challenging to attempt to
obtain relatively homogenous cell populations for cells transitioning from one cell type to
another. Currently, scientists can approximate this process only by attempting to string
together static TRN maps made from cells frozen in different stages of development.
Another immense experimental challenge faced is simply the incredible number
of components to map in vertebrate cells. Even if researchers were to map only the role
of transcription factors, this would require mapping roughly 700 factors. With current
technologies, mapping the regulatory relations for this number of factors would be
infeasible due to both experimental time and expense.
A related experimental challenge is the difficulty in mapping regulatory relations
for many factors. Current assays only map one factor at a time. A major experimental
challenge will be to develop high-throughput techniques that allow scientists to map
many factors in a single experiment.
Another limitation with current location analysis assays is the difficulty in
immunoprecipitating certain factors. These difficulties can be caused by many reasons
such as lack of a strong antibody, obstruction of antigen by other components and
indirect or temporal interaction of the factor with the chromatin. Some labs have avoided
issues associated with antibody performance by instead tagging proteins. However, this
technique is hampered by the difficulty of tagging endogenous proteins and by potential
biological effects due to the tag. Limitations caused by the immunoprecipitation step will
likely be solved in the near future by a combination of better antibody production, more
high-throughput and quality checked tagging strategies, and better techniques for
capturing indirect and transient protein-DNA interactions.
There are also analytical challenges associated with network studies in vertebrate
cells; a major one being the assignment of target genes. Data gathered from location
analysis experiments merely reveals where along the chromosome a regulator binds,
which does not automatically translate into a clear list of target genes. In higher
organisms, regulatory binding sites can be quite far from the transcription start site,
making it difficult to assign binding sites to target genes without further information
(Blackwood and Kadonga, 1998; West and Fraser, 2005). Current studies generally use
simple algorithms to identify target genes based solely on promoter proximal binding
events and so likely miss assignment of many target genes. New technologies, such as
Chromatin Conformation Capture (3C) hold great promise for use in assigning binding
sites to target genes (Dekker et al., 2002).
Another conceptual challenge is to decipher the logic controlling target gene
expression. Current technologies can identify the regulators of a target gene but it is
difficult to determine how they act in combination to determine expression level. The
solution to this question will likely come from a combination of more collected data to
analyze, new analysis techniques and also new types of experiments aimed at deciphering
this logic.
A final, and perhaps most important, conceptual challenge is the useful
interpretation and representation of network maps. Even in bacteria these maps are too
complex to be represented in a figure that can be comprehended. Just as a series of tools
had to be developed in order to allow researchers to easily make use of genome sequence
data, it will also be necessary to develop tools to allow researchers to easily make use of
TRN data. It seems likely that the production of vertebrate network data and the
development of user-friendly tools, will fundamentally change the process of biological
research just as genome sequence data has.

Insights from Model Organisms
The transcriptional regulatory networks of several model organisms have largely been
mapped and analyses of these networks offer important insights that will likely translate
to vertebrate cells. Researchers often represent and analyze these networks as graphs
where nodes represent transcriptional regulators (regulatory proteins or RNAs) and target
genes/transcripts (Figure 3A). Edges connect regulators to target genes and imply
regulation of expression of the target gene by the regulator. In some representations,
edges can also be used to depict the regulation of a factor by another factor, or to depict
the fact that a gene is the transcript encoding a regulator. A few key insights from studies
in model organisms are discussed below and, for more thorough reviews, the reader is
referred to several excellent papers (Alon, 2007; Balaji et al., 2006; Davidson et al.,
2002; Lee et al., 2002; Levine and Davidson, 2005; Salgado et al., 2006; Thieffry et al.
1998).
Scale-free/hub network architecture
Canonical network or graph-theory terms and measures are also used to describe
biological transcriptional regulatory networks. An important measure associated with
every network node is its degree, k, also referred to as its connectivity; the number of
edges connecting the node to other network nodes. The average node degree is equal to
2L/N, where L is the total number of network edges and N is the total number of network
nodes. The degree distribution of a network describes the probability, P(k), that a node
will have k edges. When P(k) follows a Poisson distribution (i.e. edges are distributed
randomly) then the network is termed random whereas when P(k) follows a Power Law
distribution the network is termed scale-free (Figure 3B).
Transcriptional regulatory networks, along with many other types of biological
and real-world networks tend to be scale-free or hub networks (Barabasi and Oltvai,
2004). Unlike random networks, where most nodes have close to the average degree,
scale-free networks have a subset of nodes that have many connections. These nodes act
as network hubs. Scale-free networks also describe protein interaction networks, social
networks and the network of internet web pages (Goh et al., 2002).
A hub network architecture creates network stability in that the removal or
disruption of a large number of nodes at random will not greatly affect the overall
network (Barabasi and Oltvai, 2004). However, these networks are vulnerable to the
directed disruption of key hubs. This type of network architecture would therefore allow
cells to maintain proper gene expression even with mutations in several genes. However,
when a set of key regulators are disrupted, as is often the case in cancer and disease, then
the network becomes unstable and could lead to improper gene expression and a change
in cell state.
Network Motifs
The determination of a large amount of the TRNs for several model organisms has
allowed computational analyses of these networks to identify general network motifs. A
network motif is a pattern in the connection between nodes that occurs in the network at a
higher than random frequency. Several important network motifs have been identified in
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Figure 3 Network diagrams and motifs.
(A) Graph representation of a transcriptional regulatory network where nodes represent
transcriptional regulators (blue circles) or target genes (orange rectangles). Regulation of
a target gene by a transcriptional regulator is depicted by a black line.
(B) Depictions of random and scale-free/hub networks, each with 11 regulators (circles)
and 11 edges (black lines). Hub nodes are colored red.
(C) Depictions of network motifs. Regulators are represented as blue circles, target
genes as orange rectangles, positive regulation is represented by arrows and negative
regulation by t-bars.
model organism TRNs and are depicted in Figure 3C (Alon et al., 2007; Balaji et al.,
2007; Lee et al., 2002).
Autoregulation is the simplest possible network motif and involves a regulator
regulating its own transcript, either positively or negatively. Autoregulation can be used
to affect response time and variation (Alon et al., 2007). Negative autoregulation
decreases the amount of time it takes for a regulator to reach its stable expression level
upon induction and leads to tight control of expression level. Alternatively, positive
autoregulation increases the amount of time it takes for a regulator to reach its stable
expression level and causes higher variation in expression level and potentially even a
bimodal distribution of expression in a population of cells. Autoregulation can therefore
be used by cells to control the stability and dynamics of key regulators' expression levels.
Feedforward loops are another common network motif found in the TRNs of
model organisms. There are 8 possible feedforward motifs involving 3 nodes, but 2 of
these motifs occur at a high frequency (Alon et al., 2007). A common motif is a coherent
feedforward motif where regulator A positively regulates the transcripts of B and C and
regulator B additionally positively regulates the transcript of C. Another common motif
is an incoherent feedforward motif where regulator A positively regulates the transcripts
of B and C but regulator B negatively regulates the transcript of C. Coherent feedforward
motifs can be used by cells to control the response time to both addition and removal of
signal and incoherent feedforward motifs can be used to create a pulse of expression.
Other important network motifs are the single-input and multi-input motifs (Balaji
et al., 2007; Lee et al., 2002). Single-input motifs involve a single transcriptional
regulator node connecting to many target gene nodes that are not controlled by other
regulators. This motif allows a cell to turn on a set of related target genes simply by
turning on a single regulator. This motif is useful for the control of genes with simple
expression patterns where their expression is reliant on a single condition/cell type.
Conversely, multi-input motifs involve regulation of target genes by a combination of
regulators and allow the cell to integrate multiple signals to control complex expression
profiles.
Combinatorial Control of Gene Expression
In order for organisms to establish complex patterns of gene expression using a limited
number of transcriptional regulators these regulators must act in various combinations to
produce differing expression patterns. Complex patterns of gene expression are of
obvious importance for multicellular organisms that must establish many different cell
fates. However, even unicellular organisms rely on the combinatorial control of gene
expression to allow them to adjust their expression pattern in response to varying
environmental conditions.
Analysis of the S. cerevisiae transcriptional regulatory network revealed the large
extent of combinatorial control of gene expression in eukaryotic cells (Balaji et al. 2006).
The network analyzed included 157 transcription factors, 4410 target genes and a total of
12873 interactions. The average gene was controlled by 2.9 regulators, with 45 genes
being regulated by 15 or more regulators. Further analysis uncovered the extent to which
pairs of regulators controlled significantly overlapping target gene sets. They found that
a surprising number of regulators controlled overlapping gene sets, forming multi-input
motifs. These analyses demonstrate the large extent to which transcriptional regulators
act in combination at target genes, even in relatively simple organisms, to create complex
patterns of gene expression and it is postulated that higher organisms will display even
more complex and combinatorial regulation of gene expression.
ES Cells Provide an Initial Transcriptional Regulatory Network
An important first goal stated above is to map the transcriptional regulatory networks of
developmentally and medically important cells types. Embryonic stem cells are perhaps
the most developmentally and medically relevant cell type as they are capable of
differentiating into all other cell types within the vertebrate body. They nearly mark the
starting point for the dynamic map of regulatory networks throughout development and
are currently the earliest experimentally feasible cell type that can be studied, as
relatively pure populations can be grown in culture. For these reasons, embryonic stem
cells are a natural choice for initial efforts dissecting vertebrate TRNs. In fact, several
labs have already made great advances in mapping this network and their work sets a
precedent for how future studies of vertebrate networks could be successfully conducted.
ES cells are defined by two properties; the ability to self-renew and the ability to
differentiate into many cell types (plutipotency). ES cells are derived from the inner cell
mass of the developing blastocyst and can be propagated in culture under appropriate
conditions. In culture these cells can be induced to undergo differentiation towards
various cell states and, to some extent, can be directed down specific lineages, although
our current understanding and ability to manipulate this process is limited. Better
understanding the transcriptional regulatory network of ES cells and how it is
dynamically altered during development will not only aid our understanding of this
process, but will likely also aid our ability to manipulate this process in order to create
therapeutically relevant cell types.
With the recent advance in the ability to induce pluripotent stem cells from
somatic cells, the use of ES cells in human regenerative medicine is now even more of a
possibility that must be aggressively explored. The ability to derive ES cells from a
patient and to then manipulate these cells into medically relevant cell types holds great
promise for many diseases. However, realization of this potential requires an
understanding of the network controlling ES cells and how it is manipulated by external
signals to differentiate down various pathways.
Studies in both human and mouse ES cells have begun to assemble a map of their
transcriptional regulatory network. Although more work must to be done to further fill in
this initial network diagram, already many important insights into the control of the
pluripotent state as well as general insights into vertebrate TRNs have been discovered.
This review will outline studies of the TRN of ES cells in order to highlight important
insights into vertebrate networks and to offer a paradigm for how further studies in
vertebrate cells can be efficiently and effectively conducted.
Selection of Key Regulators
A crucial aspect of the approach used to study networks in ES cells is careful
identification of key transcriptional regulators that must be mapped. This has allowed
for the elucidation of fundamental themes found within this network even though only a
small fraction of the regulatory relations have been mapped. Key transcriptional
regulators play a vital role in establishing or maintaining a cell state, acting to define the
specific network needed for a particular cell type. Given the importance of identifying
key regulators to map, it is essential to define criteria that can be used to guide this
process. Studies in ES cells suggest that several lines of evidence prove useful for
identification of key regulators, including genetic phenotypes, expression profiles and
knowledge of molecular characteristics.
Genetic Phenotypes
Genetic perturbation of key network components often results in a phenotype that
highlights their vital role in a particular cell type. There are generally three types of
genetic evidence that one can use to identify potential key regulators; genetic perturbation
in the cell type of interest, genetic perturbation in a whole animal model, and ectopic
expression of the component in a different cell type. One can draw upon the array of
knowledge gained from these three types of studies in model organisms to identify
potential key regulators of a particular network.
Improper levels of key component expression within the cell type(s) they control
can lead to loss of cellular identity or function. In ES cells either loss or overexpression
of the key regulator Oct4 leads to inappropriate differentiation (Niwa et al. 2000).
Animals lacking a key regulator are often unable to properly produce or maintain
that particular cell type. For example, mice with mutations in the Pax-6 gene, a master
regulator of sensory organs display the small eye phenotype and mutations in Pax-6 are
also associated with the human eye disease aniridia (Callaerts et al. 1997). Similarly,
mice missing Oct4 are unable to develop a normal inner cell mass (Nichols et al., 1998).
Certain components are so key that their improper expression can transform one
cell type to another. A classic example of this phenomenon is the ability of MyoD to
transform fibroblasts into muscle cells (Weintraub et al. 1989). Recent studies have also
demonstrated the ability of several key ES cell regulators to transform somatic cells into
ES cells (Jaenisch and Young, 2008; Okita et al., 2007; Park et al., 2008; Takahashi and
Yamanaka, 2006; Takahashi et al., 2007; Wernig et al., 2007; Yu et al., 2007).
Expression Profiles
Key components that act to establish or maintain a cells' transcriptional regulatory
network are often uniquely expressed in that particular cell type. Expression of these
components in other cell types could transform these networks and so their expression is
highly specific to a single or small subset of cell types. The large number of expression
datasets publicly available can therefore be used to identify potential key components of
transcriptional regulatory networks.
Simple clustering of expression data can often identify regulators that are
uniquely expressed in a cell type. For example, the transcriptional regulator NeuroD I is
uniquely expressed in neural cells and pancreatic islet cells and has been shown to be
capable of reprogramming hepatocytes to pancreatic like cells (Kojima et al., 2003).
Work from the Yamanaka lab leveraged this type of analysis to identify a small number
of potential key regulators of ES cells for reprogramming purposes (Takahashi and
Yamanaka, 2006).
Molecular Knowledge
Knowledge of molecule relations and interactions can also aid the identification of key
components. There are many published experimental and computational studies that
offer a wealth of information to scientists regarding the relationships and interactions
between proteins. This information can easily be exploited to identify new key
components through their relation to other known key components
Regulators within certain gene families often share important roles in the
regulation of transcription and development. For example, proteins in the homeodomain
family have been shown to be key regulators of cell fate specification (Hombria and
Lovegrove, 2003). The fact that the ES cell regulators Oct4 and Nanog are
homeodomain proteins further implicated a key role for these factors in maintaining the
ES cell state.
Regulators often act in complexes to exert their influence on gene expression and
the knowledge of a key role of one coregulator can imply an equally important role for
the other. For example, the fact that Sox2 forms a heterodimer with the key ES cell
regulator Oct4 highly suggested that Sox2 is also a key regulator of ES cells (Ambrosetti
et al., 1997). A recent study in ES cells has further exploited this concept by identifying
proteins that interact with the ES cell key regulator Nanog in an attempt to identify other
key ES cell regulators (Wang et al., 2006).
Transcription Factors
Initial studies of transcription factors in the ES cell transcriptional regulatory network
focused on the key regulators Oct4, Sox2 and Nanog. Knowledge of genetic
phenotypes, expression profiles and molecular relations were all leveraged to identify
these factors as potential key components of the ES cell network. Genetic studies
demonstrated functional consequences in ES cells of inappropriate expression of these
factors, the expression of Oct4 and Nanog was found to be specific to pluripotent cells,
and Sox2 was known to form a heterodimer with Oct4 (Ambrosetti et al., 1997; Avilion
et al., 2003; Chambers et al., 2003; Hart et al., 2003; Lee et al., 2004; Mitsui et al., 2003;
Nichols et al., 1998; Scholer et al., 1990). Due to the overwhelming evidence suggesting
a key role for these regulators in the ES cell network, two groups mapped their target
genes in ES cells and uncovered several important network themes (Boyer et al., 2005;
Loh et al., 2006).
The genomic binding sites for these three factors were identified in ES cells using
location analysis and revealed a striking co-regulation of target genes. Although Oct4
and Sox2 were expected to bind the same target genes, as they form a heterodimer,
researchers were surprised to find that Nanog also occupied a large percentage of Oct4-
Sox2 bound genes. More recent studies that map additional transcription factors in ES
cells have found that these factors also follow the theme of target gene co-occupancy
(Cole et al., 2008; Kim et al., 2008).
These studies suggest that the multi-input motif may be a powerful network motif
utilized in vertebrate cells. While the average target gene in E. coli is regulated by
roughly 2 transcription factors, and the average gene in S. cerevisiae is regulated by
roughly 3 transcription factors, these early studies in ES cells suggest that this number
will be significantly higher for vertebrate cells. This finding supports the hypothesis put
forth by Levine and Tijan that increased organism complexity is due in large part to
increased complexity of gene expression patterns (Levine and Tijan, 2003).
The large extent of co-regulation of vertebrate genes also implies complex logic
controlling genes' expression patterns that may allow cells to delicately adjust their
expression programs. Although a correlation between the number of transcription factors
regulating a gene and its expression level has been noted, it seems clear that future work,
both experimental and computational, will need to be performed in order to tease apart
the clearly complex logic controlling vertebrate gene expression (Kim et al., 2008). A
potential advantage offered cells by a high level of co-regulation of target genes is that
gene expression may be more robust to changes in single transcription factors or
sequence motifs. This co-regulation may also help explain why genetic perturbation of
regulators or perturbation of motifs in promoter sequences does not always result in large
expression changes for many target genes.
Studies using advanced sequencing technologies further reveal that Oct4, Sox2
and Nanog often bind to DNA regions in extremely close proximity, within a region of
roughly 25 base pairs (Marson et al., submitted). This proximity provokes the hypotheses
that these, and perhaps other factors may be forming complexes on DNA to coordinately
affect transcription, or that they may be competing for binding to DNA sequences with
the data representing a population of cells' binding events rather than co-binding within
individual cells. More studies into the biochemical nature of these binding events are
needed in order to test these possibilities.
Initial studies also revealed that the key regulators Oct4, Sox2 and Nanog form a
fully connected (complete) interconnected autoregulatory loop (Figure 4A). A motif such
as this could act to stabilize the core ES cell transcriptional regulatory network while also
allowing for its rapid change upon the correct set of differentiation signals. For example,
Chickarmane et al. demonstrate how the circuit formed by Oct4, Sox2 and Nanog could
act as a bistable switch controlling ES cell maintenance versus differentiation
(Chickarmane et al., 2006). The connection of key regulators to each other could be a
general network mechanism permitting the integration of multiple signals to produce a
coordinated response in gene expression.
Another important theme uncovered through these studies was the control of other
transcriptional regulators by key components. The target genes of Oct4, Sox2 and Nanog
were significantly enriched for transcription factors and developmental regulators (Boyer
et al., 2005). The control of these secondary regulators allows key transcription factors to
indirectly affect a much larger set of genes. This hierarchical network structure has been
described in model organisms and may likely prove to be a common vertebrate network
architecture (Martinez-Antonio and Collado-Vidas, 2003). This network structure may
allow for greater genome sequence variability as genes could be regulated by
transcription factors other than the key regulators, with a diversity of binding motifs.
This network structure would also allow for rapid large-scale changes in transcription
program in response to signals that may only directly target a handful of key regulators.
Closer analysis of the transcriptional regulators bound by Oct4, Sox2 and Nanog
revealed that they bound to both active transcription factors and repressed developmental
regulators. This observation demonstrated the importance of regulation of silent
developmental regulators in ES cells as well as other cell types. Inappropriate expression
of these regulators could initiate transcriptional regulatory networks for other cell types,
so it is vital to maintain these key regulators of other cell types in the repressed state.
This repression by key regulators in ES cells, would therefore act to maintain the ES cell
state and ensure that improper differentiation did not occur. This network structure
stabilizes cell state and is likely an architecture employed by many vertebrate cell types.
Chromatin Regulators
Several groups have studied important chromatin regulators and marks in ES cells and
their combined work reveals important insights into developmental networks (Lee et al.,
2006; Guenther et al., 2007; Boyer et al., 2006; Bernstein et al., 2006). These studies
focused on general chromatin marks associated with transcription as well as Polycomb
and Trithorax Group (PcG and trxG) proteins. These regulators were identified as key
regulators of the ES cell network due to an abundance of genetic evidence demonstrating
an essential role for these regulators in early development (Breiling et al., 2007; Faust et
al., 1998; O'Carroll et al., 2001; Pasini et al., 2004). Studies of their role in the ES cell
network have revealed important insights that translate to general themes of vertebrate
transcriptional regulatory networks.
Studies of repressive Polycomb and activating Trithorax complexes in ES cells
revealed a crucial role for these chromatin modifiers in the ES cell transcriptional
regulatory network. The set of silent developmental regulators bound by key
transcription factors in ES cells were found to also be targets of both Polycomb and
Trithorax complexes. These developmental regulators were therefore described as being
bivalently marked by both activating and repressive marks.
Further chromatin studies revealed that the transcription apparatus was recruited
to the promoters of these bivalently marked developmental regulators but that full-length
transcript was not produced. This implies that while Pol II is recruited and transcription
initiated, that transcription elongation is stalled and therefore no transcript is produced.
This stalled transcription suggests that developmental regulators are perhaps poised to be
expressed and that their expression is much more dynamic than previously believed.
This feature of developmental regulators may offer several benefits to ES cells.
First, it seems to maintain the silence of these regulators so as not to allow induction of
transcriptional networks of other cell types governed by them. Second, by maintaining
poised Pol II at the promoters of these genes, it allows for the rapid expression and
establishment of a new network upon induction of differentiation and removal of
repressive Polycomb at a subset of these developmental regulators (Figure 4B). Finally,
it may even function to mark these regulators within the cell, serving to especially protect
them against mutations or improper expression without permanently shutting down their
transcriptional capability. This last hypothesis is supported by the observation that
Polycomb binding at these developmental regulators differs from its binding at other
target genes by binding to the entire gene region, rather than a punctate binding site
within a gene's promoter.
As Polycomb repression of developmental regulators has an important role in
maintaining cell state the key question of what directs Polycomb to these regulators
emerges. There seem to be two hypotheses that could explain the targeting of Polycomb
Group Complexes. The first is that sequence specific transcription factors bind motifs
within these genes and recruit PcG. The second is that non-coding RNA transcripts
direct the binding of PcG. A role for non-coding RNAs in directing PcG mediated
repression is supported by the work of the Chang lab (Rinn et al., 2007). It seems likely
that PcG recruitment to developmental regulators may be mediated by a distinct
mechanism from its recruitment to other target genes given its unique binding profile at
these regulators. An equally pressing question that must be addressed is what selectively
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Figure 4 Diagrams of network themes/concepts.
(A) Interconnected autoregulatory loop. Genes (orange rectangles) encoding
transcriptional regulators (blue circles) are themselves controlled by the transcriptional
regulators, forming an interconnected autoregulatory loop.
(B) Diagram of the transcriptional regulatory network in ES cells and induction of a new
network upon differentiation. Key transcription factors (blue circles) regulate active
genes (orange rectangles) and along with Polycomb chromatin modifier (green circle)
regulate silent developmental regulators (green rectangles) in ES cells. Upon induction
of differentiation, a subset of developmental regulators become activated and produce
transcriptional regulators (purple circles), which control target genes (purple rectangles)
of the transcriptional regulatory network for the new cell type.
removes polycomb from a subset of developmental regulators upon differentiation. A
better understanding of this process will likely aid our ability to direct differentiation for
therapeutic purposes.
Along with the discovery of paused Pol II at developmental regulators scientists
also found that regulation of transcript elongation is a pervasive regulatory mechanism in
ES and other cells at a wide set of genes. Data from Guenther et al. 2007 estimates that
approximately 30% of genes in ES and other cells have transcription initiation without
elongation. Regulation of transcription elongation rather than initiation would allow cells
to respond more quickly to environmental stimuli to produce full-length transcripts. The
pervasiveness of this level of regulation suggests that the decrease in response time is of
great benefit to cells. These discoveries in ES cells also call for further examination of
the detailed mechanism of this type of regulation.
Signaling Pathways
A recent pioneering study of the role of a signaling pathway in the ES cell regulatory
network has revealed the importance of pathway components in the network and the
necessity for their further study (Cole et al., 2008). Genetic evidence demonstrates a
clear role for the Wnt signaling pathway throughout development and in ES cells (Logan
and Nusse, 2004; Reya and Clevers, 2005). A terminal component of this pathway, Tcf3,
was identified as a likely key regulator in ES cells due to its genetic and expression
phenotypes (Korinek et al., 1998; Merrill et al., 2004; Pereira et al., 2006). The
incorporation of Tcf3 in the ES cell network map reveals a potential means for
environmental signals to affect changes in the network for differentiation in vivo or for
reprogramming in culture.
Tcf3 was discovered to co-occupy the genome with the key transcriptional
regulators Oct4, Sox2, and Nanog. Genomic analyses suggested that these four
regulators largely bind to the same promoter regions and even that they bind in extremely
close proximity within promoter regions. This co-occupancy of target genes suggests
that the Wnt signaling pathway, through Tcf3, intimately connects to the core regulatory
network of ES cells and is, in fact, part of this core network. The direct connection of
signaling pathways to key target genes throughout the genome offers the cellular benefit
of decreased response time to developmental cues. It is likely that this finding will apply
to many other key signaling pathways and other cell types but further studies are needed
to explore this possibility.
In addition to joining the key transcription factors Oct4, Sox2 and Nanog at target
genes, Tcf3 also joins these regulators in the interconnected autoregulatory loop formed
by them. Tcf3 both regulates and is regulated by these key transcription factors. In this
manner, cells can respond to Wnt signaling through a feedforward loop where the key ES
cell regulators as well as their targets are immediately targeted by Tcf3. This network
structure would allow for both rapid and stable response to environmental stimuli.
Expression analyses of both Tcf3 and Wnt pathway perturbation revealed that
Tcf3 mainly functions to repress target genes under standard conditions in ES cells but
that it can activate these genes upon Wnt stimulation. This dynamic positive and
negative regulation by Tcf3 allows Wnt signals to quickly adjust the gene expression
program of and influence the delicate balance between pluripotency and differentiation in
ES cells. The direct connection of factors whose influence on gene expression can be
dynamically regulated by environmental signals to the transcriptional regulatory network
suggests mechanisms whereby cells undergo changes in gene expression programs and
cell state as well as mechanisms whereby scientists may be able to manipulate networks
to reprogram cell states.
Non-coding RNAs
Several recent studies have revealed an important role for the miRNA class of non-
coding RNAs in ES cells. Genetic studies of the miRNA machinery revealed an
important role for this pathway in ES cells and expression studies have identified several
miRNAs with ES cell specific expression (Bernstein et al., 2003; Houbaviy et al., 2003;
Houbaviy et al., 2005; Kanellopoulou et al., 2005; Mineno et al., 2006; Murchison et al.,
2005; Suh et al., 2004; Wang et al., 2007). This evidence argues that miRNAs also play a
key role in the regulatory network of ES cells. Studies examining their role are beginning
to highlight some important insights.
The miRNA machinery has been shown to be essential for the proper down-
regulation upon differentiation of the key ES cell transcription factor Oct4 (Stadler and
Ruohola-Baker, 2008). This regulation has been linked to chromatin modifications
(Sinkkonen et al., 2008). These studies therefore suggest that miRNAs directly or
indirectly regulate both key transcription factors and chromatin modifiers. An important
implication of these results is that miRNAs may play a key role in down-regulating key
regulators upon induction of a new cell fate in order to allow establishment of a new
transcriptional regulatory network. The possibility of miRNAs shutting down key
network components upon signals to differentiate suggests that they may also be able to
aid reprogramming of cell state in culture.
Work examining the regulation of miRNA genes by other network components
has revealed that they are largely regulated in a manner similar to that of protein-coding
genes (Marson et al., submitted). A major aspect of this work was the systematic
identification of miRNA promoters, which had previously been unmapped. This
demonstrated that miRNA promoters can largely be identified by markers of transcription
initiation such as the presence of Pol II and transcription-associated chromatin marks.
miRNA genes, like protein-coding genes, were also found to be targets of key
transcription factors and chromatin modifiers. A subset of silent miRNA genes were also
found to be bivalently marked in ES cells, presumably due to their key role in other cell
types.
These findings suggest that miRNA genes can and should be incorporated into
maps of transcriptional regulatory networks. A key aspect to mapping their role in this
network, however, will be the accurate mapping of miRNA target genes either
computationally or experimentally. The relatively recent addition of miRNA genes to the
ES cell transcriptional regulatory network map highlights both their key role in the
network and also the great need for more studies in this area in order to uncover further
themes.

Using ES Cell Studies to Guide Future Efforts
The body of work performed in ES cells can be used to guide future efforts to uncover
transcriptional regulatory networks. Studies in ES cells have led to great advances in our
understanding of these cells and their control. The importance of the themes uncovered
highlights the necessity to continue further studies of transcriptional regulatory networks.
Network themes discovered in one cell type often apply to others and so can guide
studies in other cell types. Several themes uncovered in the ES cell transcriptional
regulatory network also apply to other cell types. For example, the themes of regulatory
loops of key regulators, co-occupancy of target genes and silencing of developmental
regulators are found in multiple cell-types (Bracken et al., 2006; Kim et al., 2008; Lynn
et al., 2007; Odom et al., 2004; Olson, 2006; Rajasekhar and Begemann, 2007).
Therefore, a theme uncovered in one network could be examined to determine whether it
is found in other networks as well. This could greatly increase the efficiency of mapping
key network themes in various cell types.
While only a handful of network components have been mapped in ES cells many
important themes have been uncovered and our understanding of the network and its
structure has drastically improved with each new component mapped. Initial network
maps in ES cells involving only 3 transcription factors identified several fundamental
network themes including autoregulation, co-regulation of target genes and regulation of
developmental regulators. The universality of these themes suggests that initial studies in
other vertebrate cell types that map only a few key transcriptional regulators will also
identify important network themes.
The success of studies in ES cells is largely due to the careful selection of
network components to map. In order to uncover as much of the core circuitry as
possible with each new factor mapped it is critical to select components that are most
likely to play key roles in the network. Studies in ES cells have demonstrated that key
components can be identified using information from genetic phenotypes, expression
profiles and molecular knowledge. Given current experimental limitations, the directed
selection of components to map initially in various cell types will be essential.
Studies in ES cells have also demonstrated the importance of incorporating
different types of inputs into network diagrams. The addition to the ES cell network map
of inputs from chromatin modifiers, signaling pathways, and non-coding RNAs added
additional layers of regulation to the map that both deepened and expanded our
understanding of it. The addition of chromatin modifiers for example elucidated the
transcriptional state of target genes and suggested a mechanism whereby networks could
quickly initiate changes to induce differentiation down specific lineages. This work
highlights the importance of incorporating a diversity of components into maps of
regulatory networks.
Studies in ES cells have also demonstrated the importance of utilizing
standardized experimental techniques in order to facilitate the incorporation of different
components into a single network map. All experimental techniques have their own
biases and noise associated with them. In genomic studies such as the mapping of
transcriptional regulatory networks where new data must be layered on top of existing
data, it is especially critical to minimize additional noise created by experimental
variation in order to fully interpret the results. The maintenance of uniform data
collection when switching to new technologies should be upheld for future network
studies.
Concluding Remarks
Although the genome-wide study of transcriptional regulatory networks in vertebrate
cells is a young field its importance and application to developmental biology and disease
treatment is already evident. As scientists have begun to manipulate regulatory networks
to induce certain cell states, a better understanding of these networks and their
manipulation is critical. Although the experimental and conceptual tools to allow
scientists to efficiently map transcriptional regulatory networks throughout human
development and disease do not yet exist, important advances within this field can
nonetheless be made with directed studies. It will be important to both continue
dissecting piece-by-piece vertebrate transcriptional regulatory networks and to advance
technologies to allow for more high-throughput studies. The ultimate goal being to
improve our manipulation and modeling of these networks as well as to fit them into the
larger context of systems biology which encompasses all cellular components and
interactions.
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working closely with fellow computational labmate Stuart Levine. We tweaked the error
model for use with genome-wide human binding data and designed the gene-calling
parameters to use with this new type of data. I also worked with Sarah Johnstone to
construct most of the manuscript figures. I also made significant contributions to the
conceptual content of the manuscript by uncovering the high overlap between target gene
sets and the core interconnected autoregulatory loop.
Summary
The transcription factors OCT4, SOX2, and NANOG have essential roles in early
development and are required for the propagation of undifferentiated embryonic stem
(ES) cells in culture. To gain insights into transcriptional regulation of human ES cells,
we have identified OCT4, SOX2, and NANOG target genes using genome-scale location
analysis. We found, surprisingly, that OCT4, SOX2, and NANOG co-occupy a
substantial portion of their target genes. These target genes frequently encode
transcription factors, many of which are developmentally important homeodomain
proteins. Our data also indicate that OCT4, SOX2, and NANOG collaborate to form
regulatory circuitry consisting of autoregulatory and feedforward loops. These results
provide new insights into the transcriptional regulation of stem cells and reveal how
OCT4, SOX2, and NANOG contribute to pluripotency and self-renewal.
Introduction
Mammalian development requires the specification of over 200 unique cell types from a
single totipotent cell. Embryonic stem (ES) cells are derived from the inner cell mass
(ICM) of the developing blastocyst and can be propagated in culture in an
undifferentiated state while maintaining the capacity to generate any cell type in the
body. The recent derivation of human ES cells provides a unique opportunity to study
early development and is thought to hold great promise for regenerative medicine (Pera
and Trounson, 2004; Reubinoff et al., 2000; Thomson et al., 1998). An understanding of
the transcriptional regulatory circuitry that is responsible for pluripotency and self-
renewal in human ES cells is fundamental to understanding human development and
realizing the therapeutic potential of these cells.
Homeodomain transcription factors are evolutionarily conserved and play key
roles in cell-fate specification in many organisms (Hombria and Lovegrove, 2003). Two
such factors, OCT4/POU5F1 and NANOG, are essential regulators of early development
and ES cell identity (Chambers et al., 2003; Hay et al., 2004; Matin et al., 2004; Mitsui et
al., 2003; Nichols et al., 1998; Zaehres et al., 2005). Several genetic studies in mouse
suggest that these regulators have distinct roles but may function in related pathways to
maintain the developmental potential of these cells (Chambers, 2004). For example,
disruption of OCT4 or NANOG results in the inappropriate differentiation of ICM and ES
cells to trophectoderm and extra-embryonic endoderm, respectively (Chambers et al.,
2003; Mitsui et al., 2003; Nichols et al., 1998). However, overexpression of OCT4 in ES
cells leads to a phenotype that is similar to loss of NANOG function (Chambers et al.,
2003; Mitsui et al., 2003; Nichols et al., 1998; Niwa et al., 2000). Knowledge of the set of
genes regulated by these two transcription factors might reveal why manipulation of
OCT4 and NANOG results in these phenotypic consequences.
OCT4 is known to interact with other transcription factors to activate and repress
gene expression in mouse ES cells (Pesce and Sch6ler, 2001). For example, OCT4, a
member of the POU (PIT/OCT/UNC) class of homeodomain proteins, can
heterodimerize with the HMG-box transcription factor, SOX2, to affect the expression of
several genes in mouse ES cells (Botquin et al., 1998; Nishimoto et al., 1999; Yuan et al.,
1995). The cooperative interaction of POU homeodomain and HMG factors is thought to
be a fundamental mechanism for the developmental control of gene expression (Dailey
and Basilico, 2001). The extent to which ES cell gene regulation is accomplished by
OCT4 through an OCT4/SOX2 complex and whether NANOG has a role in this process
are unknown.
OCT4, SOX2, and NANOG are thought to be central to the transcriptional
regulatory hierarchy that specifies ES cell identity because of their unique expression
patterns and their essential roles during early development (Avilion et al., 2003;
Chambers et al., 2003; Hart et al., 2004; Lee et al., 2004; Mitsui et al., 2003; Nichols et
al., 1998; Sch6ler et al., 1990). Studies in a broad range of eukaryotes have shown that
transcriptional regulators that have key roles in cellular processes frequently regulate
other regulators associated with that process (Guenther et al., 2005; Lee et al., 2002;
Odom et al., 2004). It is likely that the key stem cell regulators bind and regulate genes
encoding other transcriptional regulators, which in turn determine the developmental
potential of these cells, but we currently lack substantial knowledge of the regulatory
circuitry of ES cells and other vertebrate cells.
To further our understanding of the means by which OCT4, SOX2, and NANOG
control the pluripotency and self-renewal of human ES cells, we have used genomescale
location analysis (chromatin immunoprecipitation coupled with DNA microarrays) to
identify the target genes of all three regulators in vivo. The results reveal that OCT4,
SOX2, and NANOG co-occupy the promoters of a large population of genes, that many
of these target genes encode developmentally important homeodomain transcription
factors, and that these regulators contribute to specialized regulatory circuits in ES cells.
Results and Discussion
OCT4 Promoter Occupancy in Human ES Cells
DNA sequences occupied by OCT4 in human H9 ES cells (NIH code WA09;
Supplemental Data) were identified in a replicate set of experiments using chromatin
immunoprecipitation (ChIP) combined with DNA microarrays (Figure 1A and
Supplemental Data). For this purpose, DNA microarrays were designed that contain 60-
mer oligonucleotide probes covering the region from -8 kb to +2 kb relative to the
transcript start sites for 17,917 annotated human genes. Although some transcription
factors are known to regulate genes from distances greater than 8 kb, 98% of known
binding sites for human transcription factors occur within 8 kb of target genes (Figure
SI). The sites occupied by OCT4 were identified as peaks of ChIP-enriched DNA that
span closely neighboring probes (Figure 1B). OCT4 was associated with 623 (3%) of the
promoter regions for known protein-coding genes and 5 (3%) of the promoters for known
miRNA genes in human ES cells (Table S2).
Two lines of evidence suggested that this protein- DNA interaction dataset is of
high quality. First, the genes occupied by OCT4 in our analysis included many previously
identified or supposed target genes in mouse ES cells or genes whose transcripts are
highly enriched in ES cells, including OCT4, SOX2, NANOG, LEFTY2I EBAF, CDX2,
HAND], DPPA4, GJAIICONNEXIN43, FOXOIA, CRIPTO/TDGFJ, and ZIC3 (Abeyta
et al., 2004; Brandenberger et al., 2004; Catena et al., 2004; Kuroda et al., 2005; Niwa,
2001; Okumura-Nakanishi et al., 2005; Rodda et al., 2005; Sato et al., 2003; Wei et al.,
2005) (Table S2). Second, we have used improved protocols and DNA microarray
technology in these experiments (Supplemental Data) that should reduce false positive
rates relative to those obtained in previous genome-scale experiments (Odom et al.,
2004). By using this new technology with yeast transcription factors, where considerable
prior knowledge of transcription factor binding sites has been established, we estimated
that this platform has a false positive rate of <1% and a false negative rate of 20%
(Supplemental Data).
OCT4, SOX2, and NANOG Co-Occupy Many Target Genes
We next identified, with location analysis, protein-coding and miRNA genes targeted by
the stem cell regulators SOX2 and NANOG. SOX2 and NANOG were found
associated with 1271 (7%) and 1687 (9%), respectively, of the promoter regions for
known protein-coding genes in human ES cells (Tables S2-S4). It was immediately
evident that many of the target genes were shared by OCT4, SOX2, and NANOG (Figure
2A). Examples of protein-coding genes that are co-occupied by the three regulators are
shown in Figure 2B (Table S5). Control experiments showed that the set of promoters
bound by the cell-cycle transcription factor E2F4 in these human ES cells did not overlap
substantially with those bound by the three stem cell regulators (Tables S2 and S6). We
found that OCT4, SOX2, and NANOG together occupy at least 353 genes in human ES
cells.
Previous studies in murine ES cells have shown that SOX2 and OCT4 can interact
to synergistically activate transcription of target genes and that this activity is dependent
upon the juxtaposition of OCT4 and SOX2 binding sites (Ambrosetti et al., 1997;
Remenyi et al., 2004). Our results revealed that approximately half of the promoter
regions occupied by OCT4 were also bound by SOX2 in human ES cells (Figure 2A;
Table S2). It was surprising, however, to find that >90% of promoter regions bound by
both OCT4 and SOX2 were also occupied by NANOG. Furthermore, we found that
OCT4, SOX2, and NANOG binding sites occurred in close proximity at nearly all of the
genes that they cooccupied (Figure 2C). These data suggest that OCT4, SOX2, and
NANOG function together to regulate a significant proportion of their target genes in
human ES cells.
A class of small noncoding RNAs known as micro- RNAs (miRNA) play vital
roles in gene regulation, and recent studies indicate that more than a third of mammalian
protein-coding genes are conserved miRNA targets (Bartel, 2004; Lewis et al., 2005). ES
cells lacking the machinery that processes miRNA transcripts are unable to differentiate
(Kanellopoulou et al., 2005). Moreover, recent evidence indicates that microRNAs play
an important role in organismal development through regulation of gene expression
(Pasquinelli et al., 2005). OCT4, SOX2, and NANOG were found associated with 14
miRNA genes and co-occupied the promoters of at least two miRNA genes, mir-137 and
mir-301 (Table 1). Our results suggest that miRNA genes are likely regulated by OCT4,
SOX2, and NANOG in human ES cells and are important components of the
transcriptional regulatory circuitry in these cells.
ES Cell Transcription Factors Occupy Active and Inactive Genes
OCT4 and SOX2 are known to be involved in both gene activation and repression in vivo
(Botquin et al., 1998; Nishimoto et al., 1999; Yuan et al., 1995), so we sought to identify
the transcriptional state of genes occupied by the stem cell regulators. To this end, the set
of genes bound by OCT4, SOX2, and NANOG were compared to gene expression
datasets generated from multiple ES cell lines (Abeyta et al., 2004; Brandenberger et al.,
2004; Sato et al., 2003; Wei et al., 2005) to identify transcriptionally active and inactive
genes (Table S2). The results showed that one or more of the stem cell transcription
factors occupied 1303 actively transcribed genes and 957 inactive genes.
The importance of OCT4, SOX2, and NANOG for early development and ES cell
identity led us to focus additional analyses on the set of 353 genes that are cooccupied
by these regulators in human ES cells (Table S5). We first identified transcriptionally
active genes. Transcripts were consistently detected in ES cells for approximately half of
the genes co-bound by OCT4, SOX2, and NANOG. Among these active genes, several
encoding transcription factors (e.g., OCT4, SOX2, NANOG, STAT3, ZIC3) and
components of the Tgf-P (e.g., TDGF1, LEFTY2/EBAF) and Wnt (e.g., DKKI, FRAT2)
signaling pathways were notable targets. Recent studies have shown that Tgf-P3 and Wnt
signaling play a role in pluripotency and self-renewal in both mouse and human ES cells
(James et al., 2005; Sato et al., 2004). These observations suggest that OCT4, SOX2, and
NANOG promote pluripotency and selfrenewal through positive regulation of their own
genes and genes encoding components of these key signaling pathways.
Among transcriptionally inactive genes co-occupied by OCT4, SOX2, and
NANOG, we noted a striking enrichment for transcription factor genes (p < 10-18; Table
S7), many of which have been implicated in developmental processes. These included
genes that specify transcription factors important for differentiation into extra-embryonic,
endodermal, mesodermal, and ectodermal lineages (e.g., ESX11, HOXB1, MEIS], PAX6,
LHX5, LBX1, MYF5, ONECUT1) (Table S5). Moreover, nearly half of the transcription
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Figure 1. Genome-Wide Location Analysis in Human Embryonic Stem Cells
(A) DNA segments bound by transcriptional regulators were identified using chromatin
immunoprecipitation (ChIP) and identified with DNA microarrays containing 60-mer
oligonucleotide probes covering the region from -8 kb to +2 kb for 17,917 annotated
transcription start sites for human genes. ES cell growth and quality control, ChIP
protocol, DNA microarray probe design, and data analysis methods are described in
detail in Experimental Procedures and Supplemental Data.
(B) Examples of OCT4 bound regions. Plots display unprocessed ChIP-enrichment ratios
for all probes within a genomic region. Genes are shown to scale below plots (exons and
introns are represented by thick vertical and horizontal lines, respectively), and the
genomic region represented is indicated beneath the plot. The transcription start site and
transcript direction are denoted by arrows.
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Figure 2. OCT4, SOX2, and NANOG Target Genes in Human ES Cells
(A) Venn diagram representing the overlap of OCT4, SOX2, and NANOG promoter
bound regions.
(B) Representative examples of protein-coding genes co-occupied by OCT4, SOX2, and
NANOG. Plots display unprocessed ChlPenrichment ratios for all probes within a
genomic region. Genes are shown to scale relative to their chromosomal position. Exons
and introns are represented by thick vertical and horizontal lines, respectively. The start
and direction of transcription are denoted by arrows. Green, red, and purple lines
represent NANOG, SOX2, and OCT4 bound regions, respectively.
(C) OCT4, SOX2, and NANOG bind in close proximity. The distances between the
midpoint of bound regions for pairs of transcription factors was calculated for the 353
regions bound by all three transcription factors. Negative and positive values indicate
whether the first factor is upstream or downstream of the second factor in relation to the
gene. The frequency of different distances between the bound regions is plotted as a
histogram.
Table 1. mlRNA Loci near OCT4, SOX2, and NANOG Bound
Regions
Transcription Factor
mlRNA OCT4 SOX2 NANOG
mlr-7-1 +
mlr-10a +
mlr-22 + +
mlr-32 + +
mlr- 128a +
mir-135b + +
mlr-137 + + +
mir-196a-1 +
ml r- 196b +
mlr-204 + +
mlr-205 + +
mlr-301 + + +
mlr-361 +
mlr-448 +
Proximal binding of OCT4, SOX2, and NANOG to mlRNAs from the
RFAM database. flanscriptlon factors bound are Indicated by a
66 +
factor genes that were bound by the three regulators and transcriptionally inactive
encoded developmentally important homeodomain proteins (Table 2). These results
demonstrate that OCT4, SOX2, and NANOG occupy a set of repressed genes that are key
to developmental processes.
To determine which of the OCT4, SOX2, and NANOG bound genes were
preferentially expressed in ES cells, we compared expression datasets (Abeyta et al.,
2004; Sato et al., 2003) from ES cells and a compendium of differentiated tissues and cell
types (Su et al., 2004) (Figure 3; Supplemental Data). It was notable that DPPA4,
TDGF1, OCT4, NANOG, and LEFTY2 were at the top of the rank order list of genes that
are bound and preferentially expressed in ES cells (Figure 3A). All five of these genes
have been implicated in pluripotency (James et al., 2005; Mitsui et al., 2003; Chambers et
al., 2003; Nichols et al., 1998; Bortvin et al., 2003). Moreover, several genes that encode
developmentally important homeodomain proteins such as DLX5, HOXB1, LHX5, TITFI,
LBX1, and HOP were at the bottom of this list, indicating that they are preferentially
repressed in ES cells.
The observation that OCT4, SOX2, and NANOG bound to transcriptionally active
genes that have roles in pluripotency and transcriptionally inactive genes that promote
development suggests that these binding events are regulatory. Two additional lines of
evidence indicated that many of the binding events identified in this study contribute to
regulation of their target genes. First, some of the genes identified here (e.g., OCT4,
SOX2, and NANOG) were previously shown to be regulated by OCT4 and SOX2 in
mouse ES cells (Catena et al., 2004; Kuroda et al., 2005, Okumura-Nakanishi et al.,
2005; Rodda et al., 2005). Second, we further explored the hypothesis that bound genes
are regulated by these transcription factors by taking advantage of the fact that OCT4 and
NANOG are expressed in ES cells, but their expression is rapidly downregulated upon
differentiation. We compared the expression of OCT4, SOX2, and NANOG occupied
genes in human ES cells with expression patterns in 79 differentiated cell types (Su et al.,
2004) (Supplemental Data) and focused the analysis on transcription factor genes because
these were the dominant functional class targeted by the ES cell regulators (Figure 3B).
We expected that for any set of genes, there would be a characteristic change in
expression levels between ES cells and differentiated cells. If OCT4, SOX2, and
NANOG do not regulate the genes they occupy, then these genes should have the same
general expression profile as the control population. We found, however, a significant
shift in the distribution of expression changes for genes occupied by OCT4, SOX2, and
NANOG (p value < 0.001). Taken together, these data support the model that OCT4,
SOX2, and NANOG functionally regulate the genes they occupy and suggest that loss of
these regulators upon differentiation results in increased expression of genes necessary
for development and reduced expression of a set of genes required for the maintenance of
stem cell identity.
Our results suggest that OCT4, SOX2, and NANOG contribute to pluripotency
and self-renewal by activating their own genes and genes encoding components of key
signaling pathways and by repressing genes that are key to developmental processes. It is
presently unclear how the three key regulators can activate some genes and repress
others. It is likely that the activity of these key transcription factors is further controlled
by additional cofactors, by the precise levels of OCT4, SOX2, and NANOG, and by
posttranslational modifications.
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Figure 3. Expression of OCT4, SOX2, and NANOG Co-Occupied Genes
(A) Affymetrix expression data for ES cells were compared to a compendium of
expression data from 158 experiments representing 79 other differentiated tissues and cell
types (Supplemental data). Ratios were generated by comparing gene expression in ES
cells to the median level of gene expression across all datasets for each individual gene.
Genes were ordered by relative expression in ES cells, and the results were clustered by
expression experiment using hierarchical clustering. Each gene is represented as a
separate row and individual expression experiments are in separate columns. Red
indicates higher expression in ES cells relative to differentiated cells. Green indicates
lower expression in ES cells relative to differentiated cells. Examples of bound genes that
are at the top and bottom of the rank order list are shown.
(B) Relative levels of gene expression in H9 ES cells compared to differentiated cells
were generated and converted to log2 ratios. The distribution of these fold changes was
calculated to derive a profile for different sets of genes. Data are shown for the
distribution of expression changes between H9 ES cells and differentiated tissues for
transcription factor genes that are not occupied by OCT4, SOX2, and NANOG (solid
black line) and transcription factor genes occupied by all three (dotted line). The change
in relative expression is indicated on the x axis, and the numbers of genes in each bin are
indicated on the y axes (left axis for unoccupied genes, right axis for occupied genes).
The shift in distribution of expression changes for genes occupied by OCT4, SOX2, and
NANOG is significant (p value < 0.001 using a two-sampled Kolmogorov-Smirnov test),
consistent with the model that OCT4, SOX2, and NANOG are contributing to the
regulation of these genes.
Table 2
Table 2. Examples of Inactive Homeodomaln Genes Co-occupied by OCT4, 80X2, and NANOG
Gene Symbol Entrez Gene ID Gene Name
ATBFI 463 AT binding transcription factor 1
DLXI 1745 distal-less homeobox 1
DLX4 1748 distal-less homeobox 4
DLX5 1749 distal-less homeobox 5
ENI 2019 engraled homolog 1
ESX1L 80712 extraenmbryonic, spermatogenesis, homeobox 1-like
GBX2 2637 gastrulation brain homeobox 2
GSC 145258 goosecold
HOP 84525 homeodomaln-only protein
HOXB1 3211 homeobox B1
HOXB3 3213 homeobox B3
HOXC4 3221 homeobox C4
IPF2 3651 Insulin promoter factor 2
ISL1 3670 ISL1 transcription factor, LIM/homeodomain (Islet-1)
LBX1 10660 transcription factor similar to D. melanogaster homeodomaln protein lady bird late
LHX2 9355 LM homeobox 2
LHX5 64211 LIM homeobox 5
MEISI 4211 myelold ecotroplc viral Integration site 1 homolog (mouse)
NKX2-2 4821 NK2 transcription factor related, locus 2 (Drosophila)
NKX2-3 159296 NK2 transcription factor related, locus 3 (Drosophila)
ONECUTI 3175 one cut domain, family member 1
OTP 23440 orthopedia homolog (Drosophlla)
OTX1 5013 orthodenticle homolog 1 (Drosophila)
PAX6 5080 paired box gene 6
717F1 7080 thyroId transcription factor 1
Core Transcriptional Regulatory Circuitry in ES Cells
In order to identify regulatory network motifs associated with OCT4, SOX2, and
NANOG, we assumed that regulator binding to a gene implies regulatory control and
used algorithms that were previously devised to discover such regulatory circuits in yeast
(Lee et al., 2002). The simplest units of commonly used transcriptional regulatory
network architecture, or network motifs, provide specific regulatory capacities such as
positive and negative feedback loops to control the levels of their components (Lee et al.,
2002; Milo et al., 2002; Shen-Orr et al., 2002).
Our data indicated that OCT4, SOX2, and NANOG form feedforward loops that
involve at least 353 protein coding and 2 miRNA genes (Figure 4A). Feedforwardloop
motifs contain a regulator that controls a second regulator and have the additional feature
that both regulators bind a set of common target genes. The feedforward loop has
multiple regulatory capacities that may be especially useful for stem cells. When both
regulators are positive, the feedforward loop can provide consistent activity that is
relatively insensitive to transient changes in input (Mangan et al., 2003; Shen-Orr et al.,
2002). If the regulators have positive and negative functions, the feedforward loop can
act as a switch that enables a rapid response to inputs by providing a timesensitive delay
where the downstream regulator acts to counter the effects of the upstream regulator in a
delayed fashion (Mangan and Alon, 2003; Mangan et al., 2003). In ES cells, both
regulatory capacities could be useful for maintaining the pluripotent state while retaining
the ability to react appropriately to differentiation signals. Previous studies have shown
that feedforwardloop architecture has been highly favored during the evolution of
transcriptional regulatory networks in less complex eukaryotes (Lee et al., 2002; Ma et
al., 2004; Milo et al., 2002; Resendis-Antonio et al., 2005; Shen-Orr et al., 2002). Our
data suggest that feedforward regulation is an important feature of human ES cells as
well.
Our results also showed that OCT4, SOX2, and NANOG together bound to the
promoters of their own genes, forming interconnected autoregulatory loops (Figure 4B;
see also Figure S2). Transcriptional regulation of OCT4, SOX2, and NANOG by the
OCT4-SOX2 complex was recently described in murine ES cells (Catena et al., 2004;
Kuroda et al., 2005; Okumura-Nakanishi et al., 2005; Rodda et al., 2005). Our data
indicate that this autoregulatory loop is conserved in human ES cells and, more
importantly, that NANOG is a component of the regulatory apparatus at these genes.
Thus, it is likely that the expression and function of these three key stem cell factors are
inextricably linked to one another. Autoregulation is thought to provide several
advantages, including reduced response time to environmental stimuli and increased
stability of gene expression (McAdams and Arkin, 1997; Rosenfeld et al., 2002; Shen-
Orr et al., 2002; Thieffry et al., 1998).
The autoregulatory and feedforward circuitry described here may provide
regulatory mechanisms by which stem cell identity can be robustly maintained yet permit
cells to respond appropriately to developmental cues. Modifying OCT4 and NANOG
levels and function can change the developmental potential of murine ES cells (Chambers
et al., 2003; Mitsui et al., 2003; Nichols et al., 1998; Niwa et al., 2000), and this might be
interpreted as being a consequence of perturbing independent regulatory pathways under
the control of these two regulators. Our results argue that the levels and functions of these
key stem cell regulators are tightly linked at both target genes and at their own promoters
and thus provide an additional framework for interpreting the genetic studies. Changes in
the relative stoichiometry of these factors would disturb the autoregulatory and
feedforward circuitry, producing changes in global gene regulation and thus cell fate.
Expanded Transcriptional Regulatory Circuitry
An initial model for ES cell transcriptional regulatory circuitry was constructed by
identifying OCT4, SOX2, and NANOG target genes that encode transcription factors and
chromatin regulators and integrating knowledge of the functions of these downstream
regulators in both human and mouse based on the available expression studies and
literature (Figure 5). The model includes a subset of active and a subset of repressed
target genes based on the extensive expression characterization of the 353 co-bound
genes as described earlier. The active targets include genes encoding components of
chromatin remodeling and histone-modifying complexes (e.g., SMARCADI, MYST3, and
SET), which may have general roles in transcriptional regulation, and genes encoding
transcription factors (e.g., REST, SKIL, HESX1, and STAT3), which themselves are
known to regulate specific genes. For instance, REST has recently been shown to be
highly abundant in ES cells and functions in part to repress neuronal specific genes
(Ballas et al., 2005). Previous studies have proposed that NANOG may function through
the Tgf-P3 pathway in ES cells (Chambers, 2004). Our model suggests that this occurs
through direct regulation of key components of this pathway (e.g., TDFG1,
LEFTY2/EBAF) and through regulation of at least one transcription factor, SKIL, which
controls the activity of downstream components of this pathway (SMAD2, SMAD4) (He
et al., 2003). Our data also reveal that OCT4, SOX2, and NANOG co-occupy STAT3, a
key regulator of selfrenewal in mouse ES cells (Chambers, 2004), suggesting that STAT3
may also play a role in human ES cells.
The model described in Figure 5 also depicts a subset of the genes bound by
OCT4, SOX2, and NANOG that are inactive and that encode transcription factors that
have key roles in differentiation and development. These include regulators with
demonstrated roles in development of all embryonic lineages. This initial model for ES
cell transcriptional regulatory circuitry is consistent with previous genetic studies in mice
that suggest that OCT4 and NANOG maintain pluripotency through repression of
differentiation programs (Chambers et al., 2003; Mitsui et al., 2003; Niwa et al., 2000).
This model also provides a mechanistic framework for understanding how this is
accomplished through regulation of specific sets of genes that control cell-fate
specification.
Concluding Remarks
Discovering how gene expression programs are controlled in living cells promises to
improve our understanding of cell biology, development, and human health. Identifying
the target genes for key transcriptional regulators of human stem cells is a first critical
step in the process of understanding these transcriptional regulatory networks and
learning how they control cell identity. Mapping OCT4, SOX2, and NANOG to their
binding sites within known promoters has revealed that these regulators collaborate to
form in ES cells regulatory circuitry consisting of specialized autoregulatory and
feedforward loops. Continued advances in our ability to culture and genetically
manipulate human ES cells will allow us to test and manipulate this circuitry.
Identification of the targets of additional transcription factors and chromatin regulators
using the approaches described here should allow investigators to produce a more
comprehensive map of transcriptional regulatory circuitry in these cells. Connecting
signaling pathways to this circuit map may reveal how these pluripotent cells can be
stimulated to differentiate into different cell types or how to reprogram differentiated
cells back to a pluripotent state.
Figure 4
Figure 4. Transcriptional Regulatory Motifs in Human ES Cells
(A) An example of feedforward transcriptional regulatory circuitry in human ES cells.
Regulators are represented by blue circles; gene promoters are represented by red
rectangles. Binding of a regulator to a promoter is indicated by a solid arrow. Genes
encoding regulators are linked to their respective regulators by dashed arrows.
(B) The interconnected autoregulatory loop formed by OCT4, SOX2, and NANOG.
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Figure 5. Core Transcriptional Regulatory Network in Human ES Cells
A model for the core transcriptional regulatory network was constructed by identifying
OCT4, SOX2, and NANOG target genes that encode transcription factors and chromatin
regulators and integrating knowledge of the functions of these downstream regulators
based on comparison to multiple expression datasets (Supplemental Data) and to the
literature. A subset of active and inactive genes co-occupied by the three factors in
human ES cells is shown here. Regulators are represented by blue circles; gene promoters
are represented by red rectangles; gray boxes represent putative downstream target genes.
Positive regulation was assumed if the target gene was expressed whereas negative
regulation was assumed if the target gene was not transcribed.
Experimental Procedures
Growth Conditions for Human Embryonic Stem Cells
Human embryonic stem (ES) cells were obtained from WiCell (Madison, Wisconsin;
NIH Code WA09). Detailed protocol information on human ES cell growth conditions
and culture reagents are available at http://www.mcb.harvard.edu/melton/hues. Briefly,
passage 34 cells were grown in KO-DMEM medium supplemented with serum
replacement, basic fibroblast growth factor (bFGF), recombinant human leukemia
inhibitory factor (LIF), and a human plasma protein fraction. In order to minimize any
MEF contribution in our analysis, H9 cells were cultured on a low density of irradiated
murine embryonic fibroblasts (ICR MEFs) resulting in a ratio of approximately >8:1 H9
cell to MEF. The culture of H9 on low-density MEFs had no adverse effects on cell
morphology, growth rate, or undifferentiated status as compared to cells grown under
typical conditions. In addition, immunohistochemistry for pluripotency markers (e.g.,
OCT4, SSEA-3) indicated that H9 cells grown on a minimal feeder layer maintained the
ability to generate derivates of ectoderm, mesoderm, and endoderm upon differentiation
(Figures S3 and S4).
Antibodies
The NANOG (AF1997) and SOX2 (AF2018) antibodies used in this study were
immunoaffinity purified against the human proteins and shown to recognize their target
proteins in Western blots and by immunocytochemistry (R&D Systems Minneapolis,
Minnesota). Multiple OCT4 antibodies directed against different portions of the protein
(AF1759 R&D Systems, sc-8628 Santa Cruz, sc-9081 Santa Cruz), some of which were
immunoaffinity purified, were used in this study and have been shown to recognize their
target protein in Western blots and by immunocytochemistry. The E2F4 antibody used in
this study was obtained from Santa Cruz (sc-1082) and has been shown to recognize
E2F4-responsive genes identified in previous ChIP studies (Table S2) (Ren et al., 2002;
Weinmann et al., 2002).
Chromatin Immunoprecipitation
Protocols describing all materials and methods can be downloaded from
http://jura.wi.mit.edu/young/hESRegulation/.
Human embryonic stem cells were grown to a final count of 5 x 107- 1 x 108 cells
for each location analysis reaction. Cells were chemically crosslinked by the addition of
one-tenth volume of fresh 11% formaldehyde solution for 15 min at room temperature.
Cells were rinsed twice with lx PBS and harvested using a silicon scraper and flash
frozen in liquid nitrogen and stored at -800 C prior to use. Cells were resuspended, lysed
in lysis buffers, and sonicated to solubilize and shear crosslinked DNA. Sonication
conditions vary depending on cells, culture conditions, crosslinking, and equipment. We
used a Misonix Sonicator 3000 and sonicated at power 7 for 10 x 30 s pulses (90 s pause
between pulses) at 40C while samples were immersed in an ice bath. The resulting
wholecell extract was incubated overnight at 4°C with 100 ul of Dynal Protein G
magnetic beads that had been preincubated with 10 ug of the appropriate antibody.
Beads were washed five times with RIPA buffer and one time with TE containing 50 mM
NaCl. Bound complexes were eluted from the beads by heating at 650C with occasional
vortexing, and crosslinking was reversed by overnight incubation at 65°C. Whole-cell
extract DNA (reserved from the sonicationstep) was also treated for crosslink reversal.
Immunoprecipitated DNA and whole-cell extract DNA were then purified by treatment
with RNaseA, proteinase K, and multiple phenol:chloroform: isoamyl alcohol
extractions. Purified DNA was blunted and ligated to linker and amplified using a two-
stage PCR protocol. Amplified DNA was labeled and purified using Invitrogen Bioprime
random primer labeling kits (immunoenriched DNA was labeled with Cy5 fluorophore,
whole-cell extract DNA was labeled with Cy3 fluorophore). Labeled DNA was combined
(5-6 ug each of immunoenriched and whole-cell extract DNA) and hybridized to arrays
in Agilent hybridization chambers for 40 hr at 400 C. Arrays were then washed and
scanned (Supplemental Data).
Array Design and Data Extraction
The design of the 10-slide oligo-based promoter arrays used in this study and data
extraction methods are described in detail in Supplemental Data. Arrays were
manufactured by Agilent Technologies (http://www.agilent.com).
Supplemental Data
Supplemental Data include seven figures, seven tables, and Supplemental text and can be
found with this article online at http:// www.cell.com/cgi/content/full/122/6/947/DCI/.
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Summary
Polycomb group proteins are essential for early development in metazoans, but their
contributions to human development are not well understood. We have mapped the
Polycomb Repressive Complex 2 (PRC2) subunit SUZ12 across the entire non-repeat
portion of the genome in human embryonic stem (ES) cells. We found that SUZ 12 is
distributed across large portions of over two hundred genes encoding key developmental
regulators. These genes are occupied by nucleosomes trimethylated at histone H3K27,
are transcriptionally repressed, and contain some of the most highly conserved non-
coding elements in the genome. We found that PRC2 target genes are preferentially
activated during ES cell differentiation and that the ES cell regulators OCT4, SOX2, and
NANOG co-occupy a significant subset of these genes. These results indicate that PRC2
occupies a special set of developmental genes in ES cells that must be repressed to
maintain pluripotency and that are poised for activation during ES cell differentiation.
Introduction
Embryonic stem (ES) cells are a unique self-renewing cell type that can give rise to the
ectodermal, endodermal, and mesodermal germ layers during embryogenesis. Human ES
cells, which can be propagated in culture in an undifferentiated state but selectively
induced to differentiate into many specialized cell types, are thought to hold great
promise for regenerative medicine (Thomson et al., 1998; Reubinoff et al., 2000; Mayhall
et al., 2004; Pera and Trounson, 2004). The gene expression program of ES cells must
allow these cells to maintain a pluripotent state but also allow for differentiation into
more specialized states when signaled to do so. Learning how this is accomplished may
be key to realizing the therapeutic potential of ES cells and further understanding early
development.
Among regulators of development, the Polycomb group proteins (PcG) are of
special interest. These regulators were first described in Drosophila, where they repress
the homeotic genes controlling segment identity in the developing embryo (Lewis, 1978;
Denell and Frederick, 1983; Simon et al., 1992; Orlando and Paro, 1995; Pirrotta, 1998;
Kennison, 2004). The initial repression of these genes is carried out by DNA binding
transcriptional repressors, and PcG proteins modify chromatin to maintain these genes in
a repressed state (Duncan, 1986; Bender et al., 1987; Strutt et al., 1997; Horard et al.,
2000; Hodgson et al., 2001; Mulholland et al., 2003).
The PcG proteins form multiple Polycomb Repressive Complexes (PRCs), the
components of which are conserved from Drosophila to humans (Franke et al., 1992;
Shao et al., 1999; Birve et al., 2001; Tie et al., 2001; Cao et al., 2002; Czermin et al.,
2002; Kuzmichev et al., 2002; Levine et al., 2002). The PRCs are brought to the site of
initial repression and act through epigenetic modification of chromatin structure to
promote gene silencing (Pirrotta, 1998; Levine et al., 2004; Lund and van Lohuizen,
2004; Ringrose and Paro, 2004). PRC2 catalyzes histone H3 lysine-27 (H3K27)
methylation, and this enzymatic activity is required for PRC2-mediated gene silencing
(Cao et al., 2002; Czermin et al., 2002; Kuzmichev et al., 2002; Muller et al., 2002;
Kirmizis et al., 2004). H3K27 methylation is thought to provide a binding surface for
PRC1, which facilitates oligomerization, condensation of chromatin structure, and
inhibition of chromatin remodeling activity in order to maintain silencing (Shao et al.,
1999; Francis et al., 2001; Cao et al., 2002; Czermin et al., 2002).
Components of PRC2 are essential for the earliest stages of vertebrate
development (Faust et al., 1998; O'Carroll et al., 2001; Pasini et al., 2004). PRC2 and its
related complexes, PRC3 and PRC4, contain the core components EZH2, SUZ12, and
EED (Kuzmichev et al., 2004; Kuzmichev et al., 2005). EZH2 is a H3K27
methyltransferase, and SUZ12 (Suppressor of zeste 12) is required for this activity (Cao
and Zhang, 2004; Pasini et al., 2004). ES cell lines cannot be established from Ezh2-
deficient blastocysts (O'Carroll et al., 2001), suggesting that PRC2 is involved in
regulating pluripotency and self-renewal. Although the PRCs are known to repress
individual HOX genes (van der Lugt et al., 1996; Akasaka et al., 2001; Wang et al., 2002;
Cao and Zhang, 2004), it is not clear how these important PcG regulators contribute to
early development in vertebrates.
Because the nature of PRC2 target genes in ES cells might reveal why PRC2 is
essential for early embryonic development, pluripotency, and self-renewal, we have
mapped the sites occupied by the SUZ12 subunit throughout the genome in human ES
cells. This genome- wide map reveals that PRC2 is associated with a remarkable cadre of
genes encoding key regulators of developmental processes that are repressed in ES cells.
The genes occupied by PRC2 contain nucleosomes that are trimethylated at histone H3
lysine-27 (H3K27me3), a modification catalyzed by PRC2 and associated with the
repressed chromatin state. Both PRC2 and nucleosomes with histone H3K27me3 occupy
surprisingly large genomic domains around these developmental regulators and are
frequently associated with highly conserved noncoding sequence elements previously
identified by comparative genomic methods. The transcription factors OCT4, SOX2, and
NANOG, which are also key regulators of ES cell pluripotency and self-renewal, occupy
a significant subset of these genes. Thus, the model of epigenetic regulation of homeotic
genes extends to a large set of developmental regulators whose repression in ES cells
appears to be key to pluripotency. We suggest that PRC2 functions in ES cells to repress
developmental genes that are preferentially activated during differentiation.
Results and Discussion
Mapping Genome Occupancy in ES Cells
We mapped the location of both RNA polymerase II and the SUZ12 subunit of PRC2
genome-wide in human ES cells (Figure 1). The initiating form of RNA polymerase II
was mapped to test the accuracy of the method and provide a reference for comparison
with sites occupied by PRC2. The SUZ12 subunit of PRC2 is critical for the function of
the complex and was selected for these genomewide experiments. Human ES cells (H9,
NIH code WA09) were analyzed by immunohistochemistry for characteristic stem cell
markers, tested for their ability to generate cell types from all three germ layers upon
differentiation into embryoid bodies, and shown to form teratomas in
immunocompromised mice (Supplemental Data; Figures S1-S3).
DNA sequences bound by RNA polymerase II were identified in replicate
chromatin-immunoprecipitation (ChIP) experiments using DNA microarrays that contain
over 4.6 million unique 60-mer oligonucleotide probes spanning the entire nonrepeat
portion of the human genome (Figure 1 and Supplemental Data). To obtain a probabilistic
assessment of binding events, an algorithm was implemented that incorporates
information from multiple probes representing contiguous regions of the genome, and
threshold criteria were established to identify a dataset with minimal false positives and
false negatives. RNA polymerase II was associated with the promoters of 7,106 of the
approximately 22,500 annotated human genes, indicating that one-third of protein-coding
genes are prepared to be transcribed in ES cells. Three lines of evidence suggest this
dataset is of high quality. Most of the RNA polymerase II sites (87%) occurred at
promoters of known or predicted genes. Transcripts were detected for 88% of the genes
bound by RNA polymerase II in previous expression experiments in ES cells. Finally,
independent analysis using gene-specific PCR (Supplemental Data) indicated that the
frequency of false positives was approximately 4% and the frequency of false negatives
was approximately 30% in this dataset. A detailed analysis of the RNA polymerase II
dataset, including binding to miRNA genes, can be found in Supplemental Data (Tables
S 1-S6 and Figures S4 and S5).
The sites occupied by SUZ12 were then mapped throughout the entire nonrepeat
genome in H9 ES cells using the same approach described for RNA polymerase II
(Figure IC). SUZ12 was associated with the promoters of 1,893 of the approximately
22,500 annotated human genes, indicating that 8% of protein-coding genes are occupied
by SUZ12 in ES cells (Supplemental Data; Tables S7 and S8). Independent site-specific
analysis indicated that the frequency of false positives was approximately 3% and the
frequency of false negatives was approximately 27% in this dataset.
Comparison of the genes occupied by SUZ12 with those occupied by RNA
polymerase II revealed that the two sets were largely exclusive (Figure ID; Supplemental
Data; Table S8). There were, however, genes where SUZ 12 and RNA polymerase II
cooccupied promoters. At these genes, PRC complexes may fail to block assembly of the
preinitiation complex (Dellino et al., 2004), consistent with the observation that
Polycomb group proteins can associate with components of the general transcription
apparatus (Breiling et al., 2001; Saurin et al., 2001). The vast majority of SUZ12 bound
sites were found at gene promoters (Figure 1E). Ninety-five percent of the SUZ12 bound
regions were found within 1 kb of known or predicted transcription start sites
(Supplemental Data and Table S7). This suggests that SUZ12 functions in human ES
cells primarily at promoters rather than at distal regulatory elements. It is interesting that
40% of all SUZ12 bound regions are within 1 Kb of CpG islands (Table S7), given the
recent discovery of a mechanistic link between PcG proteins and DNA
methyltransferoses (Vire et al., 2006).
Global Transcriptional Repression by PRC2
PRC2 is composed of three core subunits, SUZ12, EED, and EZH2, and has been shown
to mediate histone H3K27 methylation at specific genes in vivo. To confirm that SUZ 12
is associated with active PRC2 at target genes, we used chromatin immunoprecipitation
with antibodies against EED and the histone H3K27me3 mark and analyzed the results
with promoter microarrays. We found that EED and the histone H3K27me3 mark
cooccurred with SUZ12 at most genes using a high-confidence binding threshold (Figure
2). The false negative rates of thresholded data can lead to an underestimate of the
similarity between different datasets. Plotting raw enrichment ratios for genes associated
with SUZ12, EED, or H3K27me3 demonstrates that SUZ12 binding represents PRC2
binding at almost all target genes (Figure S6).
Genetic and biochemical studies at selected genes indicate that PRC2-mediated
H3K27 methylation represses gene expression, but it has not been established if it acts as
a repressor genome-wide. If genes occupied by SUZ12 are repressed by PRC2, then
transcripts from these genes should generally be present at lower levels in ES cells than
in differentiated cell types. To test this prediction, we compared the expression levels of
PRC2-occupied genes in four different ES cell lines with the expression level of these
genes in 79 differentiated human cell and tissue types (Sato et al., 2003; Abeyta et al.,
2004; Su et al., 2004). We found that PRC2 occupied genes were generally
underexpressed in ES cells relative to other cell types (Figure 2C). A small fraction of the
genes occupied by PRC2 were relatively overexpressed in ES cells (Figure 2C); these
tended to show less extensive SUZ12 occupancy and were more likely to be cooccupied
by RNA polymerase II (Supplemental Data). These results are consistent with the model
that PRC2-mediated histone H3K27 methylation promotes gene silencing at the majority
of its target genes throughout the genome in ES cells.
Key Developmental Regulators Are Targets of PRC2
Examination of the targets of SUZ12 revealed that they were remarkably enriched for
genes that control development and transcription (Figure 3) and that SUZ12 tended to
occupy large domains at these genes (Figure 4). Although only 8% of all annotated genes
were occupied by SUZ12, 50% of those encoding transcription factors associated with
developmental processes were occupied by SUZ12. By comparison, RNA polymerase II
preferentially occupied genes involved in a broad spectrum of cell proliferation functions
such as nucleic acid metabolism, protein synthesis, and cell cycle (Figure 3A and
examples in Figure IB; Supplemental Data; Table S 10).
It was striking that SUZI2 occupied many families of genes that control
development and transcription (Figures 3B and S7 and Table S 11). These included 39 of
40 of the homeotic genes found in the HOX clusters and the majority of homeodomain
genes. SUZ12 bound homeodomain genes included almost all members of the DLX,
IRX, LHX, and PAX gene families, which regulate early developmental steps in
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Figure 1. Genome-Wide ChIP-Chip in Human Embryonic Stem Cells
(A) DNA segments bound by the initiation form of RNA polymerase II or SUZ12 were
isolated using chromatin-immunoprecipitation (ChIP) and identified with DNA
microarrays containing over 4.6 million unique 60-mer oligonucleotide probes spanning
the entire nonrepeat portion of the human genome. ES cell growth and quality control, the
antibodies, ChIP protocol, DNA microarray probe design, and data analysis methods are
described in detail in Supplemental Data.
(B) Examples of RNA polymerase II ChIP signals from genome-wide ChIP-Chip. The
plots show unprocessed enrichment ratios (blue) for all probes within a genomic region
(ChIP versus whole genomic DNA). Chromosomal positions are from NCBI build 35 of
the human genome. Genes are shown to scale below plots (exons are represented by
vertical bars). The start and direction of transcription are noted by arrows.
(C) Examples of SUZ12 ChIP signals from genome-wide ChIP-Chip. The plots show
unprocessed enrichment ratios (green) for all probes within a genomic region (ChIP
versus whole genomic DNA). Chromosomal positions, genes, and notations are as
described in (B).
(D) Chart showing percentage of all annotated genes bound by RNA polymerase II
(blue), SUZ12 (green), both (yellow), or neither (gray).
(E) Distribution of the distance between bound probes and the closest transcription start
sites from RefSeq, Ensembl, MGC, UCSC Known Genes and H-Inv databases for SUZ12
(green line), and RNA polymerase II (blue line). The number of bound probes is given as
the percentage of total probes and is calculated for 400 bp intervals from the start site.
The null-distribution of the distance between all probes and the closest transcription are
shown as a black line.
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Figure 2. SUZ12 Is Associated with EED, histone H3K27me3 Modification, and
Transcriptional Repression in ES Cells
(A) Venn diagram showing the overlap of genes bound by SUZl2 at high-confidence,
genes bound by EED at high-confidence, and genes trimethylated at H3K27 at
highconfidence. The data are from promoter microarrays that contain probes tiling 8 kb
and +2 kb around transcription start. 72% of the genes bound by SUZ12 at high-
confidence are also bound by EED at high-confidence; others are bound by EED at lower
confidence (Figure S6).
(B) SUZ12 (top), EED (middle), and H3K27me3 (bottom) occupancy at NEUROD1. The
plots show unprocessed enrichment ratios for all probes within this genomic region
(SUZ12 ChIP versus whole genomic DNA, EED ChIP versus whole genomic DNA, and
H3K27me3 ChIP versus total H3 ChIP). Chromosomal positions are from NCBI build 35
of the human genome. NEURODlis shown to scale below plots (exons are represented
by vertical bars). The start and direction of transcription are noted by arrows.
(C) Relative expression levels of 604 genes occupied by PRC2 and trimethylated at
H3K27 in ES cells. Comparisons were made across four ES cell lines and 79
differentiated cell types. Each row corresponds to a single gene that is bound by SUZ 12,
associated with EED and H3K27me3, and for which Affymetrix expression data are
available. Each column corresponds to a single expression microarray. ES cells are in the
following order: HI, H9, HSF6, HSF1. For each gene, expression is shown relative to the
average expression level of that gene across all samples, with shades of red indicating
higher than average expression and green lower than average expression according to the
scale on the right. Cell types are grouped by tissue or organ function, and genes are
ranked according the significance of their relative level of gene expression in ES cells.
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Figure 3. Cellular Functions of Genes Occupied by SUZ 12
(A) Genes bound by SUZ12 or RNA polymerase II were compared to biological process
gene ontology categories; highly represented categories are shown. Ontology terms are
shown on the y axis; p-values for the significance of enrichment are graphed along the x
axis (SUZ12 in green, RNA polymerase II in blue).
(B) Selected examples of developmental transcription factor families bound by SUZ 12.
SUZ 12 is represented by the green oval; individual transcription factors are represented
by circles and grouped by family as indicated. Examples of transcription factors with
defined roles in development are labeled. Transcription factor families include homeobox
protein (HOX), basic helix-loop-helix domain containing, class B (BHLHB), HOX
cofactors (MEIS/EVX), distal-less homeobox (DLX), Forkhead box (FOX), NEUROD,
GATA binding protein (GATA), runt related transcription factor (RUNX), paired box
and paired-like (PAX), LIM homeobox (LHX), sine oculis homeobox homolog (SIX),
NK transcription factor related (NKX), SRY box (SOX), POU domain containing, classes
3 and 4 (POU), early B-cell factor (EBF), atonal homolog (ATOH), hairy and enhancer
of split protein (HES), myogenic basic domain (MYO), T-box (TBX), caudal type
homeobox (CDX), and iroquois homeobox protein (IRX).
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Figure 4. SUZ12 Occupies Large Portions of Genes Encoding Transcription Factors with
Roles in Development
(A) The fraction of SUZ12 target genes associated with different sizes of binding
domains. Genes are grouped into four categories according to their function: Signaling,
Adhesion/ migration, Transcription, and Other.
(B) Examples of SUZ12 (green) and RNA polymerase II (blue) binding at the genes
encoding developmental regulators TBX5 and PAX6. The plots show unprocessed
enrichment ratios for all probes within a genomic region (ChIP versus whole genomic
DNA). Genes are shown to scale below plots (exons are represented by vertical bars).
The start and direction of transcription are noted by arrows.
(C) Binding profiles of SUZ12 (green) and RNA polymerase II (blue) across 500 kb
regions encompassing HOX clusters A-D. Unprocessed enrichment ratios for all probes
within a genomic region are shown (ChIP versus whole genomic DNA). Approximate
HOX cluster region sizes are indicated within black bars.
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neurogenesis, hematopoiesis, axial patterning, tissue patterning, organogenesis, and
cellfate specification. SUZ12 also occupied promoters for large subsets of the FOX,
SOX, and TBX gene families. The forkhead family of FOX genes is involved in axial
patterning and tissue development from all three germ layers (Lehmann et al., 2003).
Mutations in members of the SOX gene family alter cell-fate specification and
differentiation and are linked to several developmental diseases (Schepers et al., 2002).
The TBX family of genes regulates a wide variety of developmental processes such as
gastrulation, early pattern formation, organogenesis, and limb formation (Showell et al.,
2004). Thus, the genes preferentially bound by SUZ12 have functions that, when
expressed, promote differentiation. This is likely to explain, at least in part, why PRC2 is
essential for early development and ES cell pluripotency.
A remarkable feature of PRC2 binding at most genes encoding developmental
regulators was the extensive span over which the regulator occupied the locus (Figures 4,
S8, and S9). For the majority (72%) of bound sites across the genome, SUZ12 occupied a
small region of the promoter similar in size to regions bound by RNA polymerase II
(Figure 1). For the remaining bound regions, SUZ12 occupancy encompassed large
domains spanning 2-35 kb and extending from the promoter into the gene. A large
portion of genes encoding developmental regulators (72%) exhibited these extended
regions of SUZ12 binding. In some cases, binding encompassed multiple contiguous
genes. For instance, SUZ12 binding extended 100 kb across the entire HOXA, HOXB,
HOXC, and HOXD clusters but did not bind to adjacent genomic sequences, yielding a
highly defined spatial pattern (Figure 4B). In contrast, clusters of unrelated genes, such as
the interleukin 1-b cluster, were not similarly bound by SUZ12. Thus, genes encoding
developmental regulators showed an unusual tendency to be occupied by PRC2 over
much or all of their transcribed regions.
PRC2 and Highly Conserved Elements
Previous studies have noted that many highly conserved noncoding elements of
vertebrate genomes are associated with genes encoding developmental regulators
(Bejerano et al., 2004; Siepel et al., 2005; Woolfe et al., 2005). Given SUZ12's strong
association with this class of genes, we investigated the possibility that SUZ12 bound
regions are associated with these highly conserved elements. Inspection of individual
genes suggested that SUZ12 occupancy was associated with regions of sequence
conservation (Figure 5A). Eight percent of the approximately 1,400 highly conserved
noncoding DNA elements described by Woolfe and colleagues (Woolfe et al., 2005) were
found to be associated with the SUZ12 bound developmental regulators (p-value 10 14).
Using entries from the PhastCons database of conserved elements (Siepel et al., 2005),
we found that SUZ 12 occupancy of highly conserved elements was highly significant
(using highly conserved elements with a LoD conservation score of 100 or better, the p-
value for significances was less than 10-5). Since PRC2 has not been shown to directly
bind DNA sequences, we expect that specific DNA binding proteins occupy the highly
conserved DNA sequences and may associate with PRC2, which spreads and occupies
adjacent chromatin. Thus, the peaks of SUZ12 occupancy might not be expected to
precisely collocate with the highly conserved elements, even if these elements are
associated with PRC2 recruitment.
Remarkably, the degree of the association between SUZ12 binding and conserved
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sequences increases when considering sequences with an increasing degree of
conservation (Figure 5B). By comparison, RNA polymerase II showed no such
enrichment. These results suggest that the subset of highly conserved noncoding elements
at genes encoding developmental regulators may be associated with PcG-mediated
silencing of these regulators.
Signaling Genes Are among PRC2 Targets
The targets of SUZ12 were also enriched for genes that encode components of signaling
pathways (Figure 3A and Table S 12). There is evidence that transforming growth factor-
b (TGFb), bone morphogenic protein (BMP), wingless-type MMTV integration site
(Wnt), and fibroblast growth factor (FGF) signaling pathways, which are required for
gastrulation and lineage differentiation in the embryo, are also essential for self-renewal
and differentiation of ES cells in culture (Loebel et al., 2003; Molofsky et al., 2004).
SUZ12 generally occupied the promoters of multiple components of these pathways, but
it occupied larger domains within a group of signaling genes that contained highly
conserved elements. This group contained members of the Wnt family (WNTI, WNT2,
WNT6) as well as components of the TGFb superfamily (BMP2, GDF6). Recent studies
have shown that Wnt signaling plays a role in pluripotency and self-renewal in both
mouse and human ES cells (Sato et al., 2004), and our results suggest that it is important
to maintain specific family members in a repressed state in ES cells.
Activation of PRC2 Target Genes during Differentiation
PRC2 is associated with an important set of developmental regulators that must be silent
in ES cells but activated during differentiation. This observation suggests that PRC2
ultimately functions to repress occupied genes in ES cells and that these genes may be
especially poised for transcriptional activation during ES cell differentiation. We
reasoned that if this model is correct, genes bound by SUZ12 should be preferentially
activated upon ES cell differentiation or in cells that lack SUZ12. Furthermore, in
differentiated cells, SUZ12 might continue to be observed at silent genes but must be
removed from genes whose expression is essential for that cell type.
We first examined gene expression in ES cells stimulated to undergo
differentiation (Sato et al., 2003). We found that genes occupied by SUZ12 were more
likely to be activated during ES cell differentiation than genes that were not occupied by
SUZ12 (Figure 6A; Supplemental Data; Table S13), indicating that SUZ12-occupied
genes show preferential activation during differentiation under these conditions. Thirty-
six percent of genes bound by SUZ 12 showed greater than 2-fold increases in expression
during ES cell differentiation, whereas only 16% of genes not bound by SUZ12 showed
such an increase. This effect was particularly striking at the set of developmental
regulators (Figure 6B). SUZ12 occupied most (83%) of the developmental regulators that
were induced more than 10-fold during ES cell differentiation.
We next examined the expression of SUZ12 target genes in Suzl2-deficient cell
lines derived from homozygous mutant blastocysts (Supplemental Data). We reasoned
that genes bound by SUZ12 in human ES cells have orthologs in mice that should be
upregulated in SuzI 2-deficient mouse cells, although we expected the overlap in these
sets of genes to be imperfect because of potential differences between human and mouse
ES cells, the possible repression of PRC2 target genes by additional mechanisms, and
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Figure 5. SUZ12 Binding Is Associated with Highly Conserved Regions
(A) SUZ12 occupancy (green) and conserved elements are shown at NKX2-2 and
adjacent genomic regions. The plots show unprocessed enrichment ratios for all probes
within this genomic region (SUZ12 ChIP versus whole genomic DNA). Conserved
elements (red) with LoD scores > 160 derived from the PhastCons program (Siepel et al.,
2005) are shown to scale above the plot. Genes are shown to scale below plots (exons are
represented by vertical bars). A higher resolution view is also shown below.
(B) Enrichment of conserved noncoding elements within SUZ12 (green) and RNA
polymerase II (blue) bound regions. The maximum nonexonic PhastCons conservation
score was determined for each bound region. For comparison, the same parameter was
determined using a randomized set of genomic regions with the same size distribution.
The graph displays the ratio of the number of bound regions with that score versus the
number of randomized genomic regions with that score.
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Figure 6. Preferential Activation of PRC2 Target Genes during ES Cell Differentiation
(A) Fold enrichment in the number of genes induced or repressed during ES cell
differentiation. The change in gene expression is given as the log(2) transformed ratio of
the signals in differentiated H1 cells versus pluripotent HI cells and is binned into six
groups. The upper limit of each bin is indicated on the x axis. The two lines show genes
transcriptionally inactive in ES cells (absence of RNA polymerase II) and bound by
SUZ12 (green) and genes transcriptionally inactive in ES cells and repressed by other
means (blue). In both cases, fold enrichment is calculated against the total population of
genes and normalized for the number of genes present in each group.
(B) Expression changes of genes encoding developmental regulators during ES cell
differentiation. Expression ratio (differentiated/pluripotent) is represented by color, with
shades of red indicating upregulation and shades of green downregulation according to
the scale shown above. Genes are ordered according to change in gene expression, with
genes exhibiting higher expression in pluripotent ES cells to the left and genes exhibiting
higher expression in differentiated cells to the right. Genes bound by SUZ12 in
undifferentiated ES cells are indicated by blue lines in the lower panel.
(C) Fold enrichment in the number of genes induced or repressed in SUZI 2-deficient
mouse cells. The change in gene expression is given as the log(2) transformed ratio of the
signals in Suzl2-deficient cells versus wild-type ES cells. The two lines show genes
transcriptionally inactive in human ES cells (absence of RNA polymerase II) and bound
by SUZ12 (green) and genes transcriptionally inactive in human ES cells and repressed
by other means (blue). In both cases, fold enrichment is calculated against the total
population of genes.
(D) Gene expression ratios (log base 2) of Suzl2 target genes in differentiated human HI
ES cells relative to pluripotent H1 ES cells (x axis) and in Suzl2-deficient mouse cells
relative to wild-type mouse ES cells (y axis). Upper right quadrant: genes upregulated
during human ES cell differentiation and in Suzl2-deficient mouse cells; lower right:
genes upregulated during ES cell differentiation and downregulated in Suzl 2-deficient
cells; lower left: genes downregulated during ES cell differentiation and in Suzl 2-
deficient cells; upper left: genes downregulated during ES cell differentiation and
upregulated in Suzl2-deficient cells.
(E) SUZ12 binding profiles across the gene encoding muscle regulator MYOD1 in H9
human ES cells (green) and primary human skeletal myotubes (gray). The plots show
unprocessed enrichment ratios for all probes within a genomic region (ChIP versus whole
genomic DNA). Genes are shown to scale below plots (exons are represented by vertical
bars). The start and direction of transcription are noted by arrows.
(F) Suzl2 binding profiles across the gene encoding LHX9 in H9 human ES cells (green)
and primary human skeletal myotubes (gray). The plots show unprocessed enrichment
ratios for all probes within a genomic region (ChIP versus whole genomic DNA). Genes
are shown to scale below plots (exons are represented by vertical bars). The start and
direction of transcription are noted by arrows.
107
pleiotropic effects of the Suzl2 knockout on genes downstream of Suzl2-target genes.
Differences in gene expression between Suzl 2 homozygous mutant cells and wild-type
ES cells were measured using gene expression microarrays and the human SUZ12
binding data mapped to orthologous mouse genes using HomoloGene
(www.ncbi.nlm.nih.gov/HomoloGene). We found that a significant portion of mouse
genes whose counterparts were bound by SUZ12 in human ES cells were upregulated in
Suzl2-deficient mouse cells (70 of 346 genes, p = 6 10 4); these genes are listed in
Table S14. Orthologs of genes occupied by SUZ12 in human ES cells were more likely to
be activated and less likely to be repressed in Suzl2-deficient mouse cells than orthologs
of genes not occupied by SUZ12 (Figure 6C). Furthermore, we found that orthologs of
Suzl2 target genes that were induced upon human ES cell differentiation were generally
also induced upon loss of Suzl2 in mouse cells (Figure 6D). Genes that were activated
during ES cell differentiation and in Suzl 2-deficient cells included those encoding
transcriptional regulators (GATA2, GATA3, GATA6, HANDI, MEIS2, and SOX17)
signaling proteins (WNT5A, DKKI, DKK2, EFNA1, EFNB 1, EPHA4, and EPHB3) and
the cell-cycle inhibitor CDKN1A. These data indicate that Suzl 2 is necessary to fully
repress the genes that are occupied by PRC2 in wild-type ES cells and have since been
confirmed with binding data and knockout studies of a second PRC subunit in mouse
(Boyer et al., 2006).
If PRC2 functions to repress genes in ES cells that are activated during
differentiation, then in differentiated tissues SUZ12 occupancy should be diminished at
genes encoding developmental regulators that have a role in specifying the identity of
that tissue, similar to results seen with Ezh2 at specific genes in mouse (Caretti et al.,
2004). To test this, we designed an array focused on the promoters of developmental
regulators and used ChIP-Chip to investigate SUZ12 occupancy at these promoters in
primary differentiated muscle cells. The results demonstrated that genes encoding key
regulators of muscle differentiation, including MYOD1, displayed greatly diminished
SUZ12 occupancy when compared to ES cells (Figure 6E). MYOD is a master regulator
for muscle differentiation (Tapscott, 2005), and the gene encoding this transcription
factor displayed no significant SUZ12 occupancy when compared to the levels of SUZ12
occupancy observed in ES cells. Genes encoding other transcriptional regulators that play
a central role in muscle development, such as PAX3 and PAX7 (Brand- Saberi, 2005),
showed reduced levels of SUZ12 occupancy in muscle cells relative to ES cells
(Supplemental Data and Figure S 11). In contrast, other developmental regulators
important for differentiation of nonmuscle tissues remained occupied by SUZ12 in
differentiated muscle cells (Figure 6F and Table S15). These data support a model where
PRC2 binding in ES cells represses key developmental regulators that are later expressed
during differentiation.
Targets of PRC2 Are Shared with Key ES Cell Regulators
The transcription factors OCT4, SOX2, and NANOG have essential roles in early
development and are required for the propagation of undifferentiated ES cells in culture
(Nichols et al., 1998; Avilion et al., 2003; Chambers et al., 2003; Mitsui et al., 2003). We
recently reported that these transcription factors occupied promoters for
many important developmental regulators in human ES cells (Boyer et al., 2005). This
led us to compare the set of genes encoding developmental regulators and occupied by
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OCT4, SOX2, and NANOG with those occupied by PRC2 (Figure 7 and Supplemental
Data). We found that each of the three DNA binding transcription factors occupied
approximately one-third of the PRC2-occupied genes that encode developmental
transcription factors (Figure 7A; Supplemental Data; Table S11). Remarkably, we found
that the subset of genes encoding developmental regulators that were occupied by OCT4,
SOX2, and NANOG and repressed in the regulatory circuitry highlighted in Boyer et al.
were almost all occupied by PRC2 (Figure 7B). These included genes for transcription
factors known to be important for differentiation into extraembryonic, endodermal,
mesodermal, and ectodermal lineages (e.g., ESX1L, ONECUT1, HAND1, HOXB 1). As
expected, active genes encoding ES cell transcription factors (e.g., ZIC3, STAT3, OCT4,
NANOG) were occupied by OCT4, SOX2, NANOG, and RNA polymerase II but not by
PRC2 (Figure 7B).
The observation that OCT4, SOX2, and NANOG are bound to a significant subset
of developmental genes occupied by PRC2 supports a link between repression of
developmental regulators and stem cell pluripotency. Like PRC2, OCT4 and NANOG
have been shown to be important for early development and ES cell identity. It is
possible, therefore, that inappropriate regulation of developmental regulators that are
common targets of OCT4, NANOG, and PRC2 contributes to the inability to establish ES
cell lines in OCT4, NANOG, and EZH2 mutants (Nichols et al., 1998; O'Carroll et al.,
2001; Chambers et al., 2003; Mitsui et al., 2003).
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Figure 7. SUZ12 Is Localized to Genes also Bound by ES Cell Transcriptional Regulators
(A) Transcriptional regulatory network model of developmental regulators governed by
OCT4, SOX2, NANOG, RNA polymerase II, and SUZ12 in human ES cells. The ES cell
transcription factors each bound to approximately one-third of the PRC2-occupied,
developmental transcription factor genes. Developmental regulators were selected based
on gene ontology. Regulators are represented by dark blue circles; RNA polymerase II is
represented by a light blue circle; SUZ12 is represented by a green circle; gene promoters
for developmental regulators are represented by small red circles.
(B) SUZ12 occupies a set of repressed developmental regulators also bound by OCT4,
SOX2, and NANOG in human ES cells. Genes annotated as bound by OCT4, SOX2, and
NANOG previously and identified as active or repressed based on expression data (Boyer
et al., 2005) were tested to see if they were bound by SUZ 12 or RNA polymerase II. Ten
of eleven previously identified active genes were found to be bound by RNA polymerase
II at known promoters, while eleven of twelve previously identified repressed genes were
bound by SUZ12. Regulators are represented by dark blue circles, RNA polymerase II by
a light blue circle, and SUZ 12 by a green circle. Gene promoters are represented by red
rectangles.
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Concluding Remarks
We have mapped the sites occupied by SUZ12 throughout the genome to gain insights
into how PRC2 contributes to pluripotency in human embryonic stem cells. ES cells
proliferate in an undifferentiated state yet remain poised to respond to development cues.
Genes encoding the transcriptional regulators that promote differentiation must therefore
be repressed in ES cells but activated upon receiving signals to differentiate. We found
that PRC2 occupies large domains at genes encoding a key set of repressed
developmental regulators that are preferentially activated upon cellular differentiation,
thus implicating this complex directly in the maintenance of the pluripotent state.
Transcription factors and chromatin regulators contribute to the transcriptional
regulatory circuitry responsible for pluripotency and self-renewal in human ES cells.
Understanding this circuitry is fundamental to understanding human development and
realizing the therapeutic potential of these cells. In this context, we find it exciting that
the outlines of the core transcriptional regulatory circuitry of human ES cells are
emerging. The transcription factors OCT4, SOX2, and NANOG are associated with
actively transcribed genes that contribute to growth and self-renewal (Boyer et al., 2005).
These factors also occupy genes encoding key developmental regulators that are
transcriptionally repressed, due at least in part to their association with PRC2 and
nucleosomes modified at histone H3K27me3. Further study of transcription factors and
chromatin regulators genome-wide will allow investigators to produce a more
comprehensive map of transcriptional regulatory circuitry in ES cells and to test models
that emerge from the circuitry. This information may provide insights into approaches by
which pluripotent cells can be stimulated to differentiate into different cell types.
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Experimental Procedures
Cells and Cell Culture
Human H9 ES cells (WiCell, Madison, WI) were cultured as described (Boyer et al.,
2005). Primary human skeletal muscle cells were obtained from Cell Applications (San
Diego, CA) and expanded and differentiated into myotubes according to the supplier's
protocols. Suzl2 / mouse cell lines were derived from blastocysts from crosses between
heterozygous Suzl2 mutant animals, as described in Supplemental Data.
Chromatin Immunoprecipitation and DNA Microarray Analysis
ChIP was combined with DNA microarray analysis as described (Boyer et al., 2005). The
antibodies used here were specific for hypophosphorylated RNA polymerase II (8WG16)
(Thompson et al., 1989), SUZ12 (Upstate, 07-379), EED (Hamer et al., 2002),
H3K27me3 (Abcam, AB6002), and total histone H3 (Abcam, AB1791). The design of
the oligo-based arrays, which were manufactured by Agilent Technologies, is described
in detail in Supplemental Data. A whole-chip error model was used to calculate
confidence values from the enrichment ratio and the signal intensity of each probe (probe
p-value) and of each set of three neighboring probes (probe-set p-value). Probe-sets with
significant probe-set p-values (p < 0.001) and significant individual probe p-values were
judged to be bound (see Supplemental Data for additional information). Bound regions
were assigned to genes if they were within I kb of the transcription start site from one of
five genomic databases; RefSeq, MGC, Ensembl, UCSC Known Gene, or H-Inv. All
microarray data is available at ArrayExpress under the accession designation E-WMIT-7.
Gene Expression Analysis
Gene expression data were collated from H1 ES cells (Sato et al., 2003), H9, HSF1, and
HSF6 ES cells (Abeyta et al., 2004), and 79 differentiated human cell and tissue types
(Su et al., 2004) and analyzed as described in detail in Supplemental Data. Replicate gene
expression data was obtained for wild-type mouse ES cells and Suzl2- deficient cells
using Agilent Mouse Development arrays and were analyzed as described in
Supplemental Data.
Supplemental Data
Supplemental Data include fifteen figures, fifteen tables, Experimental Procedures, and
References and can be found with this article online at
http://www.cell.com/cgi/content/full/125/2/301/DCI/.
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My contribution to this project
I initiated the effort within the Young Lab to study signaling pathways in embryonic stem
cells, identifying key pathways to study and general experimental designs to be used.
Along with labmates Sarah Johnstone and Jamie Newman, we led the study of Tcf3 and
the Wnt pathway in embryonic stem cells. We additionally spearheaded the
establishment of embryonic stem cell tissue culture within the Young Lab, including the
foundation of a new tissue culture facility for the lab. I helped work out tissue culture
conditions, performed all the ChIP-chip experiments and did the bulk of the
computational analyses for this project. I also led the conceptual and experimental
approaches taken for this work.
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Abstract
Embryonic stem cells have a unique regulatory circuitry, largely controlled by the
transcription factors Oct4, Sox2 and Nanog, which generates a gene expression program
necessary for pluripotency and self-renewal (Boyer et al. 2005; Loh et al. 2006;
Chambers et al. 2003; Mitsui et al. 2003; Nichols et al. 1998). How external signals
connect to this regulatory circuitry to influence embryonic stem cell fate is not known.
We report here that a terminal component of the canonical Wnt pathway in embryonic
stem cells, the transcription factor Tcf3, co-occupies promoters throughout the genome in
association with the pluripotency regulators Oct4 and Nanog. Thus Tcf3 is an integral
component of the core regulatory circuitry of ES cells, which includes an autoregulatory
loop involving the pluripotency regulators. Both Tcf3 depletion and Wnt pathway
activation cause increased expression of Oct4, Nanog and other pluripotency factors and
produce ES cells that are refractory to differentiation. Our results suggest that the Wnt
pathway, through Tcf3, brings developmental signals directly to the core regulatory
circuitry of ES cells to influence the balance between pluripotency and differentiation.
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Introduction
Embryonic stem (ES) cells provide a unique opportunity to study early development and
hold great promise for regenerative medicine (Thomson et al. 1998; Reubinoff et al.
2000; Pera and Trounson 2004). ES cells are derived from the inner cell mass of the
developing blastocyst and can be propagated in culture in an undifferentiated state while
maintaining the capacity to generate any cell type in the body. Discovering how signaling
pathways and transcriptional regulatory circuitry contribute to self-renewal and
pluripotency is essential for understanding early development and realizing the
therapeutic potential of ES cells.
A model for the core transcriptional regulatory circuitry of ES cells has emerged
from studying the target genes of the ES cell transcription factors Oct4, Sox2 and Nanog
(Boyer et al. 2005; Loh et al. 2006). These master regulators occupy the promoters of
active genes encoding transcription factors, signal transduction components and
chromatin modifying enzymes that promote ES cell selfrenewal. They also occupy the
promoters of a large set of developmental transcription factors that are silent in ES cells,
but whose expression is associated with lineage commitment and cellular differentiation.
Polycomb Repressive Complexes co-occupy the genes encoding these developmental
transcription factors to help maintain a silent transcriptional state in ES cells (Boyer et al.
2006; Lee et al. 2006; Wilkinson et al. 2006; Rajaskhar and Begemann 2007; Stock et al.
2007).
External signals can promote ES cell pluripotency or cause these cells to
differentiate, but precisely how these pathways are connected to the ES cell regulatory
network has not been determined. These signals are produced by the stem cell niche in
the developing blastocyst or, for cultured ES cells, can be produced by added factors or
serum to maintain stem cell identity or promote differentiation. Recent studies have
demonstrated the importance of several signaling pathways in maintaining or modifying
ES cell state, including the Activin/Nodal, Notch, BMP4 and Wnt pathways (Rao et al.
2004; Kristensen et al. 2005; Friel et al. 2005; Boiani and Scholer 2005; Valdimarsdottir
and Mummery 2005; Dreesen and Brivanlou 2007; Pan and Thomson 2007). By
understanding how these signaling pathways influence the gene expression program of
ES cells, it should be possible to discover how they contribute to embryonic stem cell
identity or promote specific differentiation programs.
The Wnt/3-catenin signaling pathway has multiple roles in embryonic stem cell
biology, development and disease (Logan and Nusse 2004; Reya and Clevers 2005;
Clevers 2006). Several studies have shown that activation of the Wnt pathway can cause
ES cells to remain pluripotent under conditions that induce differentiation (Kielman et al.
2002; Sato et al. 2004; Singla et al. 2006; Hao et al. 2006; Ogawa et al. 2006; Miyabashi
et al. 2007; Takao et al. 2007), while other studies have shown that the Wnt pathway has
an important role in directing differentiation of ES cells (Otero et al. 2004; Lindsley et al.
2006). Recent studies have shown that T Cell Factor-3 (Tcf3), a terminal component of
the Wnt pathway, acts to repress the Nanog gene in ES cells (Pereira et al. 2006),
providing an important clue for at least one mechanism by which the Wnt pathway
regulates stem cell state. Nonetheless, we have an incomplete understanding of how the
pathway exerts its effects, in part because few target genes have been identified for its
terminal components in ES cells.
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Stimulation of the canonical Wnt signaling pathway causes the transcriptional co-
activator P-catenin to translocate to the nucleus, where it interacts with constitutively
DNA-bound Tcf/Lef proteins to activate target genes (Behrens et al. 1996; Brantjes et al.
2001; Cadigan 2002). Tcf3, a member of the Tcf/Lef family, is highly expressed in
murine embryonic stem (mES) cells and is critical for early embryonic development
(Korinek et al. 1998; Merrill et al. 2004; Pereira et al. 2006). To determine how the Wnt
pathway is connected to the gene expression program of ES cells, we have determined
the genome-wide binding profile of Tcf3 and examined how perturbations of the pathway
affect the gene expression program. Remarkably, the genome-wide data reveal that Tcf3
co-occupies the ES cell genome with the pluripotency transcription factors Oct4 and
Nanog. These and other results reveal that the Wnt pathway brings developmental signals
directly to the core regulatory circuitry of ES cells, which consists of the pluripotency
transcription factors and Tcf3, together with their mutual target genes.
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Results
Identification of Tcf3 Binding Sites Genome-wide
To determine how the Wnt pathway regulates the gene expression program of murine
embryonic stem cells, we first identified genes occupied by Tcf3. Murine embryonic stem
cells were grown under standard conditions (Supplemental Fig. S1) and DNA sequences
occupied by Tcf3 were identified using chromatin immunoprecipitation (ChIP) combined
with DNA microarrays (ChIP-Chip). For this purpose, DNA microarrays were designed
with 60-mer oligonucleotide probes tiling the entire non-repeat portion of the mouse
genome. The results revealed that Tcf3 occupies over 1000 murine promoters
(Supplemental Table S1), including those of the known Wnt targets Axin2 and Myc (Fig.
1A)(He et al. 1998; Yan et al. 2001; Jho et al. 2002).
Tcf3 Co-occupies the Genome with ES Cell Master Regulators
Inspection of the genes occupied by Tcf3 revealed a large set that were previously shown
to be bound by the homeodomain transcription factor Oct4 (Boyer et al. 2005; Loh et al.
2006), which is an essential regulator of early development and ES cell identity (Nichols
et al. 1998; Hay et al. 2004). To examine the overlap of gene targets more precisely, we
carried out ChIP-Chip experiments with antibodies directed against Oct4 in mES cells
and used the same genome-wide microarray platform employed in the Tcf3 experiment.
Remarkably, the binding profiles of Tcf3 and Oct4 revealed that they bind the same
genomic regions and display identical spatial distribution patterns with regards to
transcription start sites (Fig. IB; Supplemental Fig. S2). These results identified a set of
1224 genes that are co-occupied by Tcf3 and Oct4 at high confidence (Supplemental
Table S1) and suggested that the Wnt pathway connects directly to genes regulated by
Oct4 through Tcf3.
Previous studies in human embryonic stem cells have shown that Oct4 shares
target genes with the transcription factors Nanog and Sox2 (Boyer et al. 2005),
suggesting that Tcf3-occupied genes in murine ES cells should also be occupied by
Nanog and Sox2. Additional genome-wide ChIP-Chip experiments with antibodies
directed against Nanog revealed that it does indeed bind the same sites occupied by Oct4
and Tcf3 (Fig. 1B,C and 2, Supplemental Fig. S2). The fact that Oct4 and Sox2 form
heterodimers in ES cells (Dailey and Bascilico 2001; Okumura-Nakanishi et al. 2005)
and frequently co-occupy promoters in human ES cells (Boyer et al. 2005) makes it likely
that Tcf3 co-occupies much of the genome with Oct4, Nanog and Sox2.
The observation that Tcf3 co-occupies much of the genome with the ES cell
pluripotency transcription factors has a number of implications for the regulatory
circuitry of these cells. Tcf3 binds its own promoter as well as the promoters of genes
encoding Oct4, Sox2 and Nanog (Fig. 2). Thus Tcf3 is an integral component of an
interconnected autoregulatory loop, where all four transcription factors together occupy
each of their own promoters (Fig. 3A). This feature of ES cell regulatory circuitry was
previously described for Oct4, Sox2 and Nanog alone (Boyer et al. 2005) and has been
postulated to be a common regulatory motif for master regulators of cell state (Chambers
et al. 2003; Okumura- Nakanishi et al. 2005; Rodda et al. 2005; Odom et al. 2004; Odom
et al. 2006). Autoregulation is thought to provide several advantages to the control of
cell state, including reduced response time to environmental stimuli and increased
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stability of gene expression (McAdams et al. 1997; Rosenfeld et al. 2002; Shenn- Orr et
al. 2002; Thieffry et al. 1998). It is also notable that Tcf3 and the pluripotency
transcription factors together occupy genes encoding many Wnt pathway components
(Supplemental Fig. S3), suggesting that this transcription factor regulates much of its own
signaling pathway apparatus together with the pluripotency factors.
A model for the core regulatory circuitry of ES cells has been proposed in which
the genes bound by the master regulators Oct4, Sox2 and Nanog fall into two classes:
transcriptionally active genes encoding transcription factors, signaling components and
other products that support the stem cell state, and transcriptionally inactive genes,
consisting mostly of developmental regulators, where Polycomb is bound and RNA
polymerase II is recruited, but transcription is stalled (Boyer et al. 2005; Boyer et al.
2006; Lee et al. 2006; Guenther et al. 2007; Stock et al. 2007; Zeitlinger et al. 2007). Our
results reveal that Tcf3, together with the pluripotency regulators, is associated with both
classes of genes, and thus provide a modified model of the core regulatory circuitry of ES
cells (Fig. 3B). The association of Tcf3 with the set of genes encoding key transcription
factors, signaling pathway components, and developmental regulators suggests that the
Wnt signaling pathway contributes to the regulation of these genes, thereby impacting
embryonic stem cell pluripotency and selfrenewal.
Expression Analysis of Tcf3 Knockdown in mES Cells
Genes bound by Tcf/Lef proteins are thought to be repressed in the absence of Wnt/3-
catenin signaling and to be activated upon Wnt pathway stimulation (Behrens et al. 1996;
Brantjes et al. 2001; Miyabayashi et al. 2007; Daniels et al. 2005; Cavallo et al. 1998).
Murine ES cells have low endogenous Wnt activity in standard culture conditions and the
Wnt pathway can be further stimulated in culture (Dravid et al. 2005; Yamaguchi et al.
2005; Lindsley et al. 2006; Ogawa K et al. 2006; Anton et al. 2007; Takao et al. 2007)
(Supplemental Fig. S4). Thus it is unclear whether Tcf3-occupied genes are being
repressed or activated at the low level of Wnt activity characteristic of standard ES cell
culture conditions. To investigate whether the effect of Tcf3 occupancy is to repress or to
activate genes, RNAi constructs were used to deplete Tcf3 mRNA in mES cells in two
independent experiments (Supplemental Fig. S5) and changes in global mRNA levels
were assayed with DNA microarrays (Fig. 4A). The -3.5% of mouse genes whose
mRNA levels changed by at least two-fold were significantly enriched for Tcf3 targets
relative to genes whose expression was unaltered by the Tcf3 knockdown (p value < 2 x
10-10; Supplemental Fig. S6; Supplemental Table S2). The genes whose expression
increased upon loss of Tcf3 included those encoding the master regulators Oct4, Sox2 and
Nanog, other genes involved in pluripotency such as Lefty2 and Nodal, and the Wnt
pathway component Dkkl (Fig. 4A). The fact that upregulated genes are strongly
enriched for Tcf3 binding suggests that Tcf3 mainly acts to repress genes. Upon loss of
Tcf3, target genes are no longer repressed and can now be activated by other factors (such
as Oct4, Sox2 and Nanog) present at their promoters.
While expression of Tcf3 target genes was often up-regulated upon loss of Tcf3,
the expression of a substantial number of Tcf3-bound genes remained unchanged, and a
relatively small number of Tcf3-bound genes showed reduced expression (Fig. 4A).
Nearly half of the genes occupied by Tcf3, Oct4 and Nanog are co-occupied by
Polycomb Repressive Complexes (Boyer et al. 2006; Lee et al. 2006; Wilkinson et al.
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Figure 1. Tcf3, Oct4, and Nanog co-occupy the genome in mouse ES cells.
(A) Tcf3 binds to known target genes. Examples of previously known Tcf3-bound
regions are displayed as unprocessed ChIP-enrichment ratios for all probes within the
chromosomal region indicated below the plot. The gene is depicted below the plot, and
the TSS and direction are denoted by an arrow.
(B) Tcf3, Oct4, and Nanog display nearly identical binding profiles. Analysis of ChIP-
chip data from genes bound by Tcf3, Oct4, or Nanog reveals that the three factors bind to
similar genomic regions at all promoters. Regions from -8 kb to +2 kb around each TSS
were divided into bins of 250 bp. The raw enrichment ratio for the probe closest to the
center of the bin was used. If there was no probe within 250 bp of the bin center then no
value was assigned. For genes with multiple promoters, each promoter was used for
analysis. The analysis was performed on 3764 genes, which represents 4086 promoters.
Promoters are organized according to the distance between the maximum Tcf3-binding
ratio and the TSS.
(C) Tcf3, Oct4, and Nanog bind in close proximity at target genes. Plots display
unprocessed ChIP-enrichment ratios for all probes within the chromosomal region
indicated below the plot. The gene is depicted below the plot, and the TSS and direction
are denoted by an arrow.
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Figure 2. Tcf3, Oct4, and Nanog bind the promoters of Tcf3, Oct4, Sox2, and Nanog.
Plots display unprocessed ChIP-enrichment ratios for all probes within the chromosomal
region indicated below the plot. The gene is depicted below the plot, and the TSS and
direction are denoted by an arrow.
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Figure 3. Tcf3 is an integral component of the core regulatory circuitry of ES cells.
(A) Tcf3 forms an interconnected autoregulatory loop with Oct4, Sox2, and Nanog.
Proteins are represented by ovals and genes are indicated by rectangles.
(B) Model showing a key portion of the regulatory circuitry of mES cells where Oct4,
Sox2, Nanog, and Tcf3 occupy both active and silent genes. The evidence that Oct4,
Nanog, and Tcf3 occupy these genes is described here; Sox2 occupancy is inferred from
previous studies in human ES cells (Boyer et al. 2005). Evidence that the
transcriptionally silent genes are occupied by Polycomb Repressive Complexes is from
Boyer et al. (2006), and unpublished data and that these genes have stalled RNA
polymerases is from Guenther et al. (2007) and Stock et al. (2007). Proteins are
represented by ovals and genes are indicated by rectangles.
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Figure 4. Knockdown of Tcf3 and activation of the Wnt pathway in mES cells reveal a
role for Tcf3 in repression of target genes and a role in regulating pluripotency.
(A) Tcf3 knockdown results in up-regulation of target genes. The effect of Tcf3
knockdown on gene expression was measured by hybridization of labeled RNA prepared
from Tcf3 knockdown cells against RNA prepared from cells infected with nonsilencing
control lentivirus at 48 h post-infection. A heat map of biological replicate data sets of
expression changes was generated where genes are ordered according to average
expression change. Tcf3 target genes have a higher average expression change than the
average for all genes upon knockdown of Tcf3.
(B) Wnt CM results in up-regulation of Tcf3 target genes. The effect of Wnt activation on
gene expression was measured by hybridization of labeled RNA prepared from mES cells
grown in Wnt CM against RNA prepared from cells grown in mock CM. A heat map of
biological replicate data sets of expression change upon addition of Wnt CM where genes
are ordered according to average expression change of replicates. Tcf3 target genes have
a higher average expression change than the average for all genes upon addition of Wnt
CM.
(C) Tcf3 knockdown results in increased expression of Oct4, Sox2, and Nanog. Real-time
PCR demonstrates that Oct4, Sox, and Nanog have increased expression upon
knockdown of Tcf3. Values are normalized to Gapdh transcript levels, and fold change is
relative to cells transfected with a nonsilencing hairpin.
(D) Tcf3 knockdown results in increased staining for Oct4 and Nanog.
Immunofluorecence was performed on mES cells grown one passage off of feeders that
were either infected with Tcf3 knockdown lentivirus or infected with nonsilencing control
lentivirus. Cells were fixed with 4% paraformaldehyde 96 h post-infection. Cells were
stained with Oct4, Nanog, and DAPI. Images for Oct4 and Nanog staining were taken at
400 - magnification and an exposure time of 300 msec. Tcf3 KD 1 and KD 2 represent
different knockdown hairpin constructs. Tcf3 KD 2 is the virus also used in A, C, E, and
F.
(E) Tcf3 knockdown results in a significant increase of Oct4 staining. Quantification of
Oct4 staining was performed in cells infected with Tcf3 or Gfp knockdown virus.
(F) Tcf3 knockdown cells proliferate over more passages in the absence of LIF. Relative
cell numbers of ES cells transfected with Tcf3 or control virus through multiple passages
off of feeders in the presence or absence of LIF. Identical cell numbers were initially
plated, and cells were split 1:12 every 2-3 d. Cells were counted at each passage and
values for cells grown in the absence of LIF were normalized to cells grown in the
presence of LIF.
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2006; Rajaskhar and Begemann 2007), and their transcriptional state would not be
expected to change as Polycomb would prevent elongation of transcripts at these genes
(Stock et al. 2007). Indeed, we find that expression of genes occupied by Tcf3 and
Polycomb do not show a significant expression change upon loss of Tcf3 (p value > 0.4).
There were some Tcf3 target genes whose expression was down-regulated upon loss of
Tcf3; because mES cells have a low level of Wnt pathway activation, it is possible that
sufficient P-catenin enters the nucleus in order to associate with and activate this subset
of genes. Indeed, we find that some amount of 0-catenin does associate with Tcf3 and
Oct4 as P-catenin can be detected in crosslinked chromatin extracts immunoprecipitated
for either Tcf3 or Oct4 (Supplemental Fig. S7). It is also possible that the loss of
expression of this set of Tcf3 target genes is a secondary consequence of the knockdown.
The repressive activity of Tcf3 appears to be its dominant function for most genes under
these conditions, as the set of Tcf3 bound genes were found to have a significantly higher
increase in expression upon knockdown compared to all genes (Fig. 4A; p value < 7 x 10-
Expression Analysis of Wnt Pathway Activation in mES Cells
We next studied the effect of increased stimulation of the Wnt pathway on Tcf3 target
genes in murine ES cells. Cells were treated with Wnt3a conditioned media in two
independent experiments, and changes in global mRNA levels were assayed with DNA
microarrays (Fig. 4B). The <1% of mouse genes whose mRNA levels changed by at least
two-fold in the Wnt treated cells were significantly enriched for Tcf3 targets relative to
genes whose expression was unaltered by the addition of Wnt (p value < 1.5 x 10-5;
Supplemental Fig. S8; Supplemental Table S3). The genes whose expression most
increased encode the pluripotency factors Oct4 and Nanog, Wnt pathway components
such as Wnt8a and Dkkl, and known Wnt targets such as Brachury (Fig. 4B). These
results are consistent with a model where Tcf3 acts to partially repress many of its target
genes under standard mES cell culture conditions, yet contributes to increased expression
of its target genes under conditions of increased Wnt stimulation. We would therefore
expect a correlation between genes upregulated upon loss of Tcf3 and genes up-regulated
upon Wnt stimulation. Indeed, we do find these gene sets to be significantly correlated (p
value < 1 x 10-8; Supplemental Fig. S9). Although a significant portion of Tcf3 target
genes undergo expression changes upon Wnt stimulation, it is possible that a second class
of Tcf3 target genes are regulated independently of Wnt signaling and therefore are
uninfluenced by changes in pathway activation (Yi and Merrill 2007). In fact, several
studies have shown a 3-catenin independent role for Tcf3 (Kim et al. 2000; Merrill et al.
2001; Roel et al. 2002). It should also be noted that ES cells express other mammalian
Tcf/Lef proteins and that these factors may also mediate the functional consequences of
Wnt signaling (Pereira et al., 2006).
Influence of Tcf3 and Wnt on Pluripotency Regulators and ES Cell State
Evidence that Tcf3 is an integral component of the core transcriptional circuitry of ES
cells that functions to partially repress transcription of pluripotency genes led us to
examine whether Tcf3 knockdown enhances features of ES cells associated with
pluripotency and self-renewal. Quantitative real-time PCR analysis demonstrated that
Tcf3 knockdown in mES cells results in higher transcript levels for the pluripotency
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genes Oct4, Sox2 and Nanog (Fig. 4C). Upregulation of Nanog upon Tcf3 depletion
confirms a previous report that Tcf3 acts to repress this gene under normal ES cell
growth conditions (Pereira et al. 2006). Thus the results of the Tcf3 knockdown
experiment indicate that under normal conditions Tcf3 functions to reduce expression of
the three pluripotency regulators.
We next measured the levels of Oct4 and Nanog proteins in ES cells subjected to
Tcf3 knockdown. The results of immunofluorescence experiments show that there are
substantial increases in the levels of Oct4 and Nanog transcription factors in the nucleus
of such cells (Fig. 4D). There is a significant increase of Oct4 in Tcf3 knockdown cells
compared to control cells based on quantitative measurements of staining intensity using
Cellomics software (Fig. 4E). Remarkably, Tcf3 knockdown mES cells display enhanced
proliferation and Oct4 staining in the absence of feeders and LIF compared to control
cells, supporting previous results (Fig. 4F; Supplemental Fig. S 10)(Pereira et al. 2006).
Previous studies have demonstrated that activation of the Wnt/p-catenin pathway can
have similar effects on ES cell pluripotency (Sato et al. 2003; Singla et al. 2006; Hao et
al. 2006) and we also find that cells treated with Wnt conditioned media show increased
staining of Oct4 (Supplemental Fig. S11). The observation that Tcf3 knockdown and Wnt
stimulation have similar functional consequences is consistent with the expression data
described above for ES cells subjected to Tcf3 knockdown and ES cells treated with
Wnt3a CM. These studies demonstrate the functional importance of Tcf3 occupancy and
Wnt pathway activation for a subset of target genes that includes the pluripotency
regulators.
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Discussion
It is fundamentally important to determine how signaling pathways control ES cell
pluripotency and differentiation and how these pathways connect to discrete sets of target
genes to affect such states. We have found that a terminal component of the Wnt
signaling pathway, the transcription factor Tcf3, is physically associated with the same
genomic sites as the pluripotency regulators Oct4 and Nanog in murine embryonic stem
cells. This result reveals that the Wnt pathway is physically connected to the core
regulatory circuitry of these cells. This core circuitry consists of two key features: an
interconnected autoregulatory loop and the set of target genes that are mutually bound by
the pluripotency transcription factors and Tcf3.
The genome-wide datasets we report here enhance our knowledge of the targets of
Oct4, Nanog and Tcf3. These new datasets were generated using the same protocols and
genome-wide tiling microarrays in ES cells grown under identical conditions, allowing
more reliable conclusions about the overlap of these factors throughout the genome;
previous datasets for these factors came from different murine ES cells grown in different
settings, using different chromatin IP analysis platforms, and these data were not always
genome-wide (Boyer et al. 2005; Boyer et al. 2006; Loh et al. 2006). The new data
reveal, for example, the remarkable extent to which Oct4 and Nanog binding overlap
throughout the ES cell genome and the striking association of Tcf3 with those sites (Fig.
I B). The new data also provide a revised model for the core regulatory circuitry of
murine ES cells, which incorporates Tcf3 and high confidence target genes of key ES cell
regulators (Fig. 3).
The revised model of core regulatory circuitry extends our knowledge of how
extracellular signals from the Wnt pathway contribute to stem cell state. Pereira et al.
(2006) demonstrated that Tcf3 binds the Nanog promoter and represses its mRNA
expression in mES cells. Our data confirm Tcf3 binding and function at Nanog and
extend our knowledge of Tcf3 targets to the other well-characterized pluripotency
regulators Oct4 and Sox2, as well as most of their target genes. Pereira et al. (2006)
proposed a model wherein Tcf3-mediated control of Nanog levels allows stem cells to
balance the creation of lineage-committed and undifferentiated cells. Our results also
support this model, but argue that Tcf3 contributes to the balance through its functions in
the core regulatory circuitry described here.
Our results suggest that the Wnt pathway, through Tcf3, influences the balance
between pluripotency and differentiation in ES cells, as modeled in Figure 5. Under
standard culture conditions, where there is a low-level of Wnt activation, ES cells are
poised between the pluripotent state and any of a number of differentiated states. It is
well established that Oct4, Sox2 and Nanog act to promote the pluripotent state, as
depicted in the model where the influence of these factors is shown by an arrow. Under
standard culture conditions, Tcf3 may exist in an activating or repressive complex, but is
predominantly in a repressive complex promoting differentiation. The loss of Tcf3 in
Tcf3 knockdown cells, would, in this model, favor pluripotency. Wnt stimulation
converts the repressive complex to an activating complex and thus promotes
pluripotency. Our results suggest that the Wnt pathway, through Tcf3, influences the
balance between pluripotency and differentiation by bringing developmental signals
directly to the core regulatory circuitry of ES cells. The observation that the Wnt pathway
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can be manipulated to affect the balance between pluripotency and differentiation
suggests that perturbation of this pathway may impact the efficiency of reprogramming
somatic cells into pluripotent stem cells.
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Figure 5
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Figure 5. Model depicting the influence of Wnt pathway components on pluripotency and
differentiation in ES cells.
ES cells are poised between the pluripotent state and any of a number of differentiated
states. Oct4, Sox2, and Nanog act to promote the pluripotent state (depicted by an arrow).
Tcf3 can exist in an activating complex with -catenin or a repressive complex with
Groucho (Reya and Clevers 2005). Under standard growth conditions, the Wnt pathway
is only active at low levels (Supplemental Fig. S4; Dravid et al. 2005; Yamaguchi et al.
2005; Lindsley et al. 2006; Ogawa et al. 2006; Anton et al. 2007; Takao et al. 2007).
Therefore, Tcf3 is mainly in a repressive complex promoting differentiation (depicted by
a thick arrow), although some Tcf3 associates with -catenin to activate target genes and
promote pluripotency (depicted by a thin arrow). In Tcf3 knockdown cells, there is no
influence from Tcf3 on cell state. Thus, the balance is tipped toward maintaining
pluripotency. Upon Wnt stimulation, the balance again tips toward maintaining
pluripotency as more Tcf3 associates with -catenin in an activating complex (depicted by
a thick arrow). This model is not meant to imply that Wnt or Tcf3 are themselves
pluripotency factors, but rather that they can influence cell state in the presence of other
pluripotency factors, such as Oct4, Sox2, and Nanog.
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Materials and methods
Mouse embryonic stem cell culture conditions
V6.5 murine ES cells were grown on irradiated murine embryonic fibroblasts (MEFs)
unless otherwise stated. Cells were grown under mES cell conditions as previously
described in Boyer et al. (2005). Briefly, cells were grown on 0.2% gelatinized tissue
culture plates in DMEM-KO (Invitrogen 10829-018) supplemented with 15 % fetal
bovine serum (Hyclone, Characterized SH3007103), 1000 Units/mL leukemia inhibitory
factor (LIF) (ESGRO ESG1106), 100pM nonessential amino acids (Invitrogen 11140-
050 ), 2mM L-glutamine (Invitrogen 25030-081 ),100 Units/mL pennicillin and 100
gg/mL streptomycin (Invitrogen 15140-122), and 8 nL/ml 2-mercaptoethanol (Sigma
M7522).
Genome-wide location analysis
Chromatin immunoprecipitation protocol
Protocols describing ChIP methods were downloaded from
http://jura.wi.mit.edu/young_public/hESregulation/ChlP.html with slight modifications.
Briefly, 108 mES cells were grown for one passage off of feeders and then crosslinked
using formaldehyde. Cells were resuspended, lysed in lysis buffer and sonicated to
solubilize and sheer crosslinked DNA. Triton X-100 and SDS were added to the lysate
after sonication to final concentrations of 1% and 0.1% respectively. The resulting whole
cell extract was incubated at 40C overnight with 100 uL of Dynal Protein G magnetic
beads that had been preincubated with 10 ug of the appropriate antibody overnight. After
16-18 hours, beads were washed with the following 4 buffers for 4 minutes per buffer:
low salt buffer (20mM Tris pH 8.1, 150mM NaC1, 2mM EDTA, 1% Triton X- 100, 0.1%
SDS), high salt buffer (20mM Tris pH 8.1, 500mM NaCl, 2mM EDTA, 1% Triton X-
100, 0.1% SDS), LiCl buffer (10mM Tris pH 8.1, 250mM LiCl, ImM EDTA, 1%
deoxycholate, 1% NP-40), and TE+ 50mM NaCl. Bound complexes were eluted from the
beads in elution buffer by heating at 65 0 C with occasional vortexing, and crosslinks were
reversed by overnight incubation at 65 0 C.
ChIP Antibodies
Cell extracts were immunoprecipitated using antibodies against Tcf3 (Santa Cruz sc-
8635), Oct4 (Santa Cruz sc-8628) or Nanog (Bethyl Labs b11662).
Array Design
The murine 244k whole genome array was purchased from Agilent Technology
(www.agilent.com). The array consists of 25 slides each containing -244,000 60mer
oligos (slide ID 15310-3, 15317, 15319-21, 15323, 15325, 15327-30, 15332-7, 15339-41,
15343-44) covering the entire non-repeat portion of the mouse genome at a density of
about 1 oligo per 250bp.
Data Normalization and Analysis
Data normalization and analyses were performed as previously described in Boyer et al.
(2005).
Tcf3 Knockdown
Lentiviral Production
Lentivirus was produced according to Open Biosystems Trans-lentiviralTM shRNA
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Packaging System (TLP4614). The shRNA constructs targeting murine Tcf3 were
designed using an siRNA rules based algorithm consisting of sequence, specificity and
position scoring for optimal hairpins that consist of a 21 base stem and a 6 base loop
(RMM4534-NM-009332). Five hairpin constructs were used to produce virus targeting
Tcf3. A negative control virus was made from the pLKO. 1 empty vector (RHS4080).
Lentiviral Infection of mES Cells
Murine V6.5 ES cells were plated at approximately 30% confluence on the day of
infection. Cells were seeded in 2x mES media with 6 ug/ml of polybrene (Sigma H9268-
10G) and Tcf3 knockdown or control (pLKO. 1) virus was immediately added. After 24
hours, infection media was removed and replaced with mES media with 2 ug/ml of
Puromycin (Sigma P8833). RNA was harvested at 48 hours after infection.
Knockdown Efficiency
Knockdown efficiency was measured using real-time PCR to measure levels of Tcf3
mRNA (Supplemental Fig. S5).
RNA Isolation, Real-time PCR and Analysis of Transcript Levels
To determine transcript levels by RT-PCR, RNA was isolated from approximately
106 - 107 mES cells using TRIzol reagent following the protocol for cells grown in
monolayer (Invitrogen 15596-026). Samples were treated with Dnase I (Invitrogen
18068-015) and cDNA was prepared using SuperScript III reverse transcriptase kit
(Invitrogen 180808-051) using oligo dT primed first strand synthesis. Real-time PCR was
carried out on the 7000 ABI Detection System using Taqman probes for the
housekeeping gene Gapdh (Applied Biosystems Mm99999915_g1) as a control and
genes of interest (Applied Biosystems; Tcf3 Mm00493456_ml, Oct4 Mm00658129_gH,
Sox2 Mm00488369_s 1, Nanog Mm02384862_gl).
Expression Arrays
Genomic expression analysis was measured using Agilent Whole Mouse Genome
Microarrays (Agilent G4122F). 2 ug of RNA was labeled for each sample using the Two-
color Low RNA Input Linear Amplification Kit PLUS (Agilent 5188-5340). RNA from
the treated sample (either Tcf3 KD cells or cells treated with Wnt3a conditioned media)
were labeled with Cy5 and RNA from control cells (infected with empty-vector virus or a
mock conditioned media control, respectively) were labeled with Cy3. Labeled cRNA
was hybridized overnight at 650 C. Slides were washed according to the Agilent protocol
and scanned on an Agilent DNA microarray scanner BA. Data was analyzed using
Agilent Feature Extraction Version 9.5.3 with default settings recommended by Agilent.
Flagged and low-intensity spots were then removed and spots representing a single gene
were averaged.
Wnt Pathway Activation
Wnt pathway activity in mES cells was stimulated using Wnt3a conditioned media
(ATCC CRL-2647) and mock conditioned media (ATCC CRL-2648) was used as a
control. Preparation of conditioned medias was performed as per protocol provided with
the cells. Conditioned media was diluted with mES media at a ratio of 1:1.
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Immunohistochemical Analysis
Mouse ES cells were crosslinked for 10 minutes at room temperature with 4%
paraformaldehyde. Cells were permeabilized with 0.2% Triton X-100 for 10 minutes and
stained for Oct4 (Santa Cruz, sc-5279; 1:200 dilution), Nanog (Abcam, ab1603; 1:250
dilution), and DAPI Nucleic Acid Stain (Invitrogen D1306; 1:10000 dilution) overnight
at 4°C. After several washes cells were incubated for 2 hours at room temperature with
goat-anti mouse conjugated Alexa Fluor 488 (Invitrogen 1:200 dilution) or goat-anti
rabbit conjugated Alexa Fluor 568 (Invitrogen 1:200 dilution).
Quantitative Image Acquisition and Data Analysis
Image acquisition and data analysis was performed essentially as described in Moffat et
al. (2006). Five days post infection cells were fixed and stained with Oct4 and Hoechst
33342 (1:1000 dilution). Stained cells were imaged on an Arrayscan HCS Reader
(Cellomics) using the standard acquisition camera mode (10x objective, 9 fields).
Hoechst was used as the focus channel and intra-well focusing was done every 3 fields.
The Apotome feature was applied to acquire all images. Objects selected for analysis
were identified based on the Hoechst staining intensity using the Target Activation
Protocol and the Isodata Threshold method. Parameters were established requiring that
individual objects pass an intensity and size threshold. The Object Segmentation Assay
Parameter was adjusted for maximal resolution. Following object selection the average
Oct4 intensity was determined and then a mean value for each well was calculated. All
wells used for subsequent analysis contained at least 5000 selected objects.
Supplemental Data
Supplemental Data include nine figures, three tables, and Supplemental text and can be
found with this article online at http://www.genesdev.org/cgi/content/full/22/6/746/DC1.
Accession Numbers
All microarray data from this study are available at ArrayExpress at the EBI
(http://www.ebi.ac.uklarrayexpress) under the accession designation E-TABM-
409.
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Summary
MicroRNAs (miRNAs) are crucial for normal embryonic stem (ES) cell self-renewal and
cellular differentiation, but how miRNA gene expression is controlled by the key
transcriptional regulators of ES cells has not been established. We describe here a new
map of the transcriptional regulatory circuitry of ES cells that incorporates both protein-
coding and miRNA genes, and which is based on high-resolution ChIP-seq data,
systematic identification of miRNA promoters, and quantitative sequencing of short
transcripts in multiple cell types. We find that the key ES cell transcription factors are
associated with promoters for most miRNAs that are preferentially expressed in ES cells
and with promoters for a set of silent miRNA genes. This silent set of miRNA genes is
co-occupied by Polycomb Group proteins in ES cells and expressed in a tissue-specific
fashion in differentiated cells. These data reveal how key ES cell transcription factors
promote the miRNA expression program that contributes to self-renewal and cellular
differentiation, and integrate miRNAs and their targets into an expanded model of the
regulatory circuitry controlling ES cell identity.
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Introduction
Embryonic stem (ES) cells hold significant potential for clinical therapies because of
their distinctive capacity to both self-renew and differentiate into a wide range of
specialized cell types. Understanding the transcriptional regulatory circuitry of ES cells
and early cellular differentiation is fundamental to understanding human development
and realizing the therapeutic potential of these cells. Transcription factors that control ES
cell pluripotency and self-renewal have been identified (Chambers and Smith, 2004;
Niwa, 2007; Silva and Smith, 2008) and a draft of the core regulatory circuitry by which
these factors exert their regulatory effects on protein-coding genes has been described
(Boyer et al., 2005; Loh et al., 2006; Lee et al., 2006; Boyer et al. 2006; Jiang et al.,
2008; Cole et al., 2008; Kim et al., 2008). MicroRNAs (miRNAs) are also likely to play
key roles in ES cell gene regulation (Kanellopoulou et al., 2005; Murchison et al., 2005;
Wang et al., 2007), but little is known about how miRNAs participate in the core
regulatory circuitry controlling self-renewal and pluripotency in ES cells.
Several lines of evidence indicate that miRNAs contribute to the control of early
development. miRNAs appear to regulate the expression of a significant percentage of all
genes in a wide array of mammalian cell types (Lewis et al., 2005; Lim et al., 2005; Krek
et al., 2005; Farh et al., 2005). A subset of miRNAs is preferentially expressed in ES
cells or embryonic tissue (Houbaviy et al., 2003; Suh et al., 2004; Houbaviy et al., 2005;
Mineno et al., 2006). Dicer-deficient mice fail to develop (Bernstein et al., 2003) and ES
cells deficient in miRNA processing enzymes show defects in differentiation, self-
renewal and perhaps viability (Kanellopoulou et al., 2005; Murchison et al., 2005; Wang
et al., 2007; Calabrese et al., 2008). Specific miRNAs have been shown to participate in
mammalian cellular differentiation and embryonic development (Stefani and Slack,
2008). However, how transcription factors and miRNAs function together in the
regulatory circuitry that controls early development has not yet been examined.
The major limitation in connecting miRNA genes to the core transcriptional
circuitry of ES cells has been sparse annotation of miRNA gene transcriptional start sites
and promoter regions. Mature miRNAs, which specify post-transcriptional gene
repression, arise from larger transcripts that are then processed (Bartel, 2004). Over 400
mature miRNAs have been confidently identified in the human genome (Landgraf et al.,
2007), but only a minority of the primary transcripts have been identified and annotated.
Prior attempts to connect ES cell transcriptional regulators to miRNA genes have
searched for transcription factor binding sites only close to the annotated mature miRNA
sequences (Boyer et al., 2005; Loh et al., 2006; Lee et al., 2006). Additionally, studies of
the core transcriptional circuitry of ES cells have compared transcription factor
occupancy to mRNA expression data, but have not systemically examined miRNA
expression in ES cells and differentiated cell types, limiting our knowledge of
transcriptional regulation of miRNA genes in these cells (Boyer et al., 2005; Loh et al.,
2006; Lee et al., 2006; Cole et al. 2008).
To incorporate miRNA gene regulation into the model of transcriptional
regulatory circuitry of ES cells, we began by generating new, high-resolution, genome-
wide maps of binding sites for key ES cell transcription factors using massive parallel
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sequencing of chromatin immunoprecipitation (ChIP-seq). These data reveal highly
overlapping occupancy of Oct4, Sox2, Nanog and Tcf3 at the transcriptional start sites of
miRNA transcripts, which we systematically mapped based on a method that uses
chromatin landmarks and transcript data. We then carried out quantitative sequencing of
short transcripts in ES cells, neural precursor cells (NPCs) and mouse embryonic
fibroblasts (MEFs), which revealed that Oct4, Sox2, Nanog and Tcf3 occupy the
promoters of most miRNAs that are preferentially or uniquely expressed in ES cells. Our
data also revealed that a subset of the Oct4/Sox2/Nanog/Tcf3 occupied miRNA genes are
silenced in ES cells by Polycomb Group proteins, but are expressed later in development
in specific lineages. High-resolution transcription factor location analysis, systematic
mapping of the primary miRNA transcriptional start sites in mouse and human, and
quantitative sequencing of miRNAs in three different cell types provide a valuable data
resource for studies of the gene expression program in ES and other cells and the
regulatory mechanisms that control cell fate. The data also produce an expanded model
of ES cell core transcriptional regulatory circuitry that now incorporates transcriptional
regulation of miRNAs, and post-transcriptional regulation mediated by miRNAs, into the
molecular understanding of pluripotency and early cellular differentiation.
155
Results
High-resolution genome-wide location analysis in ES cells with ChIP-seq
To connect miRNA genes to the core transcriptional circuitry of ES cells, we first
generated high-resolution genome-wide maps of Oct4, Sox2, Nanog, and Tcf3 occupancy
(Figure 1). ChIP-seq allowed us to map transcription factor binding sites and histone
modifications across the entire genome at high resolution (Barski et al., 2007; Johnson et
al., 2007; Mikkelsen et al., 2007; Robertson et al., 2007), and we optimized the protocol
to allow for robust analysis of transcription factor binding in murine ES cells
(Supplemental Material). Oct4, Sox2, Nanog and Tcf3 were found to co-occupy 14,230
sites in the genome (Figure 1A, Supplementary Figures S1 and S2, Supplementary Tables
S1-S3). Approximately one quarter of these occurred within 8kb of the transcription start
site of 3,289 annotated genes, another one quarter occurred within genes but more than
8kb from the start site, and almost half occurred in intergenic regions distal from start
sites (Supplementary Text). Binding of the four factors at sites surrounding the Sox2
gene (Figure 1 B) exemplifies two key features of the data: all four transcription factors
co-occupied the identified binding sites and the resolution was sufficient to determine the
DNA sequence associated with these binding events to a resolution of <25bp. Composite
analysis of all bound regions provided higher resolution and suggested how these factors
occupy their common DNA-sequence motif (Supplementary Figure S3, Supplementary
Table S4). Knowledge of these binding sites provided data necessary to map these key
transcription factors to the promoters of miRNA genes.
Identification of miRNA promoters
Imperfect knowledge of the start sites of primary miRNA transcripts has limited our
ability to identify the transcription factor binding events that control miRNA gene
expression in vertebrates. Previous strategies to identify the 5' ends of primary miRNAs
have been hampered because they relied on isolation of transient primary miRNA
transcript, required knowledge of the specific cell type in which each given miRNA is
transcribed, or focused only on potential start sites proximal to mature miRNAs (Fukao et
al., 2007; Mikkelsen et al., 2007; Zhou et al., 2007; Barrera et al., 2008). To
systematically identify transcriptional start sites for miRNA genes in the mouse and
human genomes, we took advantage of the recent observation that histone H3 is tri-
methylated at its lysine 4 residue (H3K4me3) at the transcriptional start sites of most
genes in the genome, even when genes are not productively transcribed, and knowledge
that this covalent modification is restricted to sites of transcription initiation (Barski et
al., 2007; Guenther et al., 2007). We used the genomic coordinates of the H3K4me3
enriched loci derived from multiple cell types (Supplementary Table S5, Barski et al.,
2007; Guenther et al., 2007; Mikkelsen et al., 2007) to create a library of candidate
transcription start sites in both human and mouse (Figure 2 and Supplementary Figure
S4).
High-confidence promoters were identified for over 80% of miRNAs in both
mouse and human (Figure 2, Supplementary Figure S4 and Supplementary Tables S6 and
S7). These promoters were associated with 185 murine primary microRNA transcripts
(pri-miRNAs) (specifying 336 mature miRNAs), and 294 human pri-miRNAs
(specifying 441 mature miRNAs) (Supplementary Table S6 and S7). To identify
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promoters for miRNA genes, the association of candidate transcriptional start sites with
regions encoding mature miRNAs was scored based on proximity to annotated mature
miRNA sequences (Landgraf et al., 2007), available EST data, and conservation between
species (Figure 2A and Supplementary Figure S5 and Supplementary Text). Four lines of
evidence indicate that this approach identified genuine transcriptional start sites for
miRNA genes. Existing EST data provided evidence that the predicted transcripts do in
fact originate at the identified start sites and continue through the annotated loci of
mature miRNAs (Figure 2B and Supplementary Figures S5). In addition to the chromatin
signature of promoters, a high fraction of these regions contained CpG islands, a DNA
sequence element often associated with promoters (Figure 2B and Supplementary Table
S6 and S7). Third, in some instances where evidence of primary miRNA transcripts,
which may be present only transiently before processing, were not available in published
databases at the identified transcriptional start sites, chromatin marks associated with
transcriptional elongation including nucleosomes methylated at H3 lysine 36
(H3K36me3) and H3 lysine 79 (H3K79me2), provided evidence that such transcripts are
actively produced (Figure 2C and Mikkelsen et al., 2007). Finally, most miRNA
promoters showed evidence of H3K4me3 enrichment in multiple tissues, as observed at
the promoters of most protein-coding genes (Barski et al., 2007; Guenther et al., 2007;
Heintzman et al., 2007) (Figure 2D).
Occupancy of miRNA promoters by core ES cell transcription factors
The binding sites of the ES cell transcription factors Oct4, Sox2, Nanog and Tcf3 were
next mapped to these high-confidence miRNA promoters (Figure 3). In murine ES cells,
Oct4, Sox2, Nanog, and Tcf3 co-occupied the promoters for 55 distinct miRNA
transcription units, which included three clusters of miRNAs that are expressed as large
polycistrons, thus suggesting that these regulators have the potential to directly control
the transcription of 81 distinct mature miRNAs (Figure 3A and Supplementary Tables
S6). This set of miRNAs occupied by Oct4/Sox2/Nanog/Tcf3 represents roughly 20
percent of annotated mammalian miRNAs, similar to the -~20 percent of protein-coding
genes that are bound at their promoters by these key transcription factors (Supplementary
Table S2).
To determine if transcription factor occupancy of miRNA promoters is conserved
across species, we performed genome-wide location analysis for Oct4 in human ES cells
using microarray-based analysis. We found extensive conservation of the set of miRNA
genes that were occupied at their promoters by Oct4, as exemplified by the mir-302
cluster (Figure 3A and 3B and Supplementary Tables S7 and S8). Transcription factor
occupancy does not necessarily mean that the adjacent gene is regulated by that factor;
conserved transcription factor occupancy, however, has been shown to occur
preferentially at genes that are regulated by that factor (Odom et al., 2007). Thus, our
data identify a set of miRNA genes that are bound at their promoters by key ES cell
transcription factors in mouse and human cells (Figure 3C), suggesting that core ES cell
transcription factor regulation of these particular miRNA transcripts has functional
significance.
Regulation of Oct4 bound miRNA transcripts during differentiation
Oct4 and Nanog are rapidly silenced as ES cells begin to differentiate (Chambers and
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Figure 1 High-resolution genome-wide mapping of core ES cell transcription factors with
ChIP-seq.
(A) Summary of binding data for Oct4, Sox2, Nanog and Tcf3. 14,230 sites are co-bound
genome wide and mapped to either promoter proximal (TSS +/- 8kb, dark green) (27% of
binding sites), genic (>8kb from TSS, middle green) (30% of binding sites), or intergenic
(light green) (43% of binding sites). The promoter proximal binding sites are associated
with 3,289 genes.
(B) (upper) Binding of Oct4 (blue), Sox2 (purple), Nanog (orange) and Tcf3 (red) across
37.5kb of mouse chromosome 3 surrounding the Sox2 gene (black below the graph,
arrow indicates transcription start site). Short sequences uniquely and perfectly mapping
to the genome were extended to 200bp (maximum fragment length) and scored in 25bp
bins. The score of the bins were then normalized to the total number of reads mapped.
Highly enriched regions are highlighted by a dotted box. Oct4/Sox2 DNA binding motifs
(Loh et al., 2006) were mapped across the genome and are shown as grey boxes below
the graph. Height of the box reflects the quality of the motif. (lower) Detailed analysis of
three enriched regions (Chromosome 3: 4,837,600-34,838,300, 34,845,300-34,846,000,
and 34,859,900-34,860,500) at the Sox2 gene indicated with boxes above. The 5' most
base from ChIP-seq were separated by strand and binned into 25bp regions. Sense (darker
tone) and anti-sense (light tone) of each of the four factors tested are directed towards the
binding site, which in each case occurs at a high-confidence Oct/Sox2 DNA binding
motif indicated below.
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Figure 2 Identification of miRNA promoters.
(A) Description of algorithm for miRNA promoter identification. A library of candidate
transcriptional start sites was generated with histone H3 lysine 4 tri-methyl (H3K4me3)
location analysis data from multiple tissues (Barski et al., 2007; Guenther et al., 2007;
Mikkelsen et al., 2007). Candidates were scored to assess likelihood that they represent
true miRNA promoters. Based on scores, a list of mouse and human miRNA promoters
was assembled. Additional details can be found in Supplemental Text.
(B) Examples of identified miRNA promoter regions are shown. A map of H3K4me3
enrichment is displayed in regions neighbouring selected human and mouse miRNAs for
multiple cell types: human ES cells (hES), REH human pro-B cell line (B cell), primary
human hepatocytes (Liver), primary human T cells (T cell), mouse ES cells (mES),
neural precursor cells (NPCs) and mouse embryonic fibroblasts (MEFs). miRNA
promoter coordinates were confirmed by distance to mature miRNA genomic sequence,
conservation and EST data (shown as solid line where available). Predicted
transcriptional start site and direction of transcription are noted by an arrow, with mature
miRNA sequences indicated (red). CpG islands, commonly found at promoters, are
indicated (green). Dotted lines denote presumed transcripts.
(C) Confirmation of predicted transcription start sites for active miRNAs using
chromatin modifications. Normalized ChIP-seq counts for H3K4me3 (red), H3K79me2
(blue) and H3K36me3 (green) are shown for two miRNA genes where EST data was
unavailable. Predicted start site (arrow), CpG islands (green bar), presumed transcript
(dotted lines) and miRNA positions (red bar) are shown.
(D) Most human and mouse miRNA promoters show evidence of H3K4me3 enrichment
in multiple tissues.
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Figure 3 Oct4, Sox2, Nanog and Tcf3 occupancy of miRNA promoters.
(A) Oct4 (blue), Sox2 (purple), Nanog (orange) and TCF3 (red) binding is shown at four
murine miRNA genes as in Figure lA. H3K4me3 enrichment in ES cells is indicated by
shading across genomic region. Presumed transcripts are shown as dotted lines.
Coordinates for the mmu-mir-290-295 cluster are derived from NCBI build 37.
(B) Oct4 ChIP enrichment ratios (ChIP-enriched versus total genomic DNA) are shown
across human miRNA promoter region for the hsa-mir-302 cluster. H3K4me3 enrichment
in ES cells is indicated by shading across genomic region.
(C) Schematic of miRNAs with conserved binding by the core transcription factors in ES
cells. Transcription factors are represented by dark blue circles and miRNAs are
represented by purple hexagons. miRNAs from the miR-302 cluster and miR290-295
(mouse)/371-372(human) cluster are selectively expressed in ES cells (Houbaviy et al.,
2003).
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Smith, 2004; Niwa, 2007). If the Oct4/Sox2/Nanog/Tcf3 complex is required for
activation or repression of its target miRNAs, the targets should be differentially
expressed when ES cells are compared to a differentiated cell-type. To test this
hypothesis, Solexa sequencing of 18-30 nucleotide transcripts in ES cells, mouse
embryonic fibroblasts (MEFs), and neural precursors (NPCs), was performed to obtain
quantitative information on the abundance of miRNAs in pluripotent cells relative to two
differentiated cell types (Figure 4).
In each cell type examined, a small subset of mature miRNA transcripts
predominated (Figure 4A). Members of the mir-290-295 cluster, which encodes multiple
miRNAs with the same seed sequence, constituted approximately two thirds of all mature
miRNA transcripts in murine ES cells. Let-7 family members constituted roughly one
quarter and one half of miRNAs in MEFs and NPCs, respectively. The mir-290-295
cluster, which dominated the expression profile of ES cells, but was scarce in both MEFs
and NPCs, is occupied at its promoters by Oct4, Sox2, Nanog and Tcf3 (Figure 3A),
consistent with the hypothesis that these factors are important for maintaining the
expression of the mir-290-295 miRNA cluster in ES cells.
To determine if the behavior of the mir-290-295 cluster is typical of the
Oct4/Sox2/Nanog/Tcf3-occupied miRNAs, we further examined the expression of this
set of miRNAs in the three cell types. Figure 4B shows how the abundance of this group
of miRNAs changed in MEFs and NPCs relative to ES cells. Approximately half of the
miRNAs dropped more than an order of magnitude in abundance in MEFs and NPCs
relative to ES cells. A small subset of the Oct4/Sox2/Nanog/Tcf3 -occupied miRNAs,
which will be further discussed below, were expressed only at low levels in ES cells and
showed increased abundance in MEFs and NPCs.
Oct4/Sox2/Nanog/Tcf3-occupied miRNAs are, in general, preferentially
expressed in embryonic stem cells, as demonstrated by the analysis shown in Figure 4C.
Whereas most miRNAs are unchanged in expression in ES cells relative to MEFs or
NPCs, a significant portion of Oct4/Sox2/Nanog/Tcf3 occupied miRNAs are 100 fold
more abundant in ES cells than in MEFs (p<5 x 1015), and 1,000 fold more abundant in
ES cells than in NPCs (p<5 x 10-9). This group of Oct4/Sox2/Nanog/Tcf3 bound
miRNAs that is significantly more abundant in ES cells than in NPCs and MEFs, was
also found to be actively expressed in induced pluripotent stem (iPS) cells (generated as
described in Wernig et al., 2007), at levels comparable to that in ES cells, consistent with
the hypothesis that core ES cell transcription factors maintain the expression of these
miRNAs in pluripotent cells (Supplementary Figure S6).
Polycomb Group Proteins co-occupy tissue-specific miRNAs that are silenced in ES cells
We noted that the Oct4/Sox2/Nanog/Tcf3-bound miRNAs include the majority of
miRNAs that were preferentially expressed in ES cells, but the data also revealed a
second, smaller group of Oct4/Sox2/Nanog/Tcf3-bound miRNA genes that appeared to
be transcriptionally inactive in ES cells (Figure 4B). This is reminiscent of previous
observations with protein-coding genes in ES cells: Oct4 occupies a set of
transcriptionally active genes but also occupied, with Polycomb Group proteins, a set of
transcriptionally repressed genes that are poised for expression upon cellular
differentiation (Lee et al., 2006; Bernstein et al., 2006; Boyer et al., 2006). We reasoned
that Polycomb complexes might also co-occupy Oct4 bound promoters for miRNA genes
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that showed little or no evidence for expression, and thus contribute to their silencing.
Indeed, new ChIP-seq data for the Polycomb Goup protein Suzl2 in murine ES cells
supported this hypothesis (Figure 5A and Supplementary Tables S6, S7, S 10). As
expected, these promoters were also enriched for nucleosomes with histone H3K27me3,
a chromatin modification catalyzed by Polycomb Group proteins (Figure 5A and
Supplementary Table S6 and Mikkelsen et al., 2007). In keeping with the repressive
function of the Polycomb Group proteins reported at protein coding genes, miRNAs
occupied at their promoters by Suzl2 in ES cells were significantly less abundant in ES
cells compared to all other miRNAs (Figure 5B). Approximately one quarter of the
Oct4/Sox2/Nanog/Tcf3-occupied miRNAs belonged to the repressed set of miRNA genes
bound by Suzl2 in murine ES cells (Supplementary Tables S6 and S7).
To further examine the behavior of this set of miRNAs during embryonic cell-fate
commitment, we returned to our quantitative sequencing data of short transcripts in ES
cells, MEFs and NPCs (Figure 5C). Notably, miRNAs that were bound by Polycomb
Group proteins in ES cells are among the transcripts that are specifically induced in each
of these cell types. For example, transcript levels of miR-9, a miRNA previously
identified in neural cells and which promotes neural differentiation (Lagos-Quintana et
al., 2002; Krichevsky et al., 2006), are significantly elevated in NPCs relative to ES cells,
but this miRNA remains repressed in MEFs. Similarly, miR-218 and miR-34b/34c
expression is induced in MEFs, but remains at low levels in NPCs (Figure 5C).
Consistent with Polycomb-mediated repression of these lineage-specific miRNAs, the
repressive chromatin mark deposited by Polycomb Group proteins, H3K27me3, is
selectively lost at the promoters of the miRNAs in the cells in which they are induced
(Figure 5C and Mikkelsen et al., 2007).
The tissue-specific expression pattern of miRNAs repressed by Polycomb in ES
cells is consistent with these miRNAs serving as determinants of cell-fate decisions in a
manner analogous to the developmental regulators whose genes are repressed by
Polycomb in ES cells (Lee et al., 2006; Bernstein et al., 2006; Boyer et al., 2006). Such a
function in cell-fate determination would require that these miRNAs remain silenced in
pluripotent ES cells. Indeed, the miRNAs that are repressed in ES cells by Polycomb
Group proteins appear to be induced, later in development, in a highly restricted subset of
differentiated tissues specific to each miRNA (Supplementary Figure S7), unlike the
majority of miRNAs identified in mouse (Landgraf et al., 2007). The miRNAs with
promoters bound by Polycomb Group proteins in ES cells are significantly enriched
(p<0.005) among the set of the most tissue-specific mammalian miRNAs (Supplementary
Fig. S7 and Landgraf et al., 2007). This suggests a model whereby Polycomb Group
proteins repress a set of tissue-specific miRNA genes in ES cells, a subset of which are
co-occupied by Oct4, Sox2, Nanog and Tcf3 (Figure 5D).
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Figure 4 Regulation of Oct4/Sox2/Nanog/TCF3-bound miRNAs during differentiation.
(A) Pie charts showing relative contributions of miRNAs to the complete population of
miRNAs in mES cells (red) , MEFs (blue) and neural precursors (NPCs, green) based on
quantification of miRNAs from by small RNA sequencing. A full list of the miRNAs
identified can be found in Supplementary Table S6.
(B) Normalized frequency of detection of individual mature miRNAs whose primary
transcripts are occupied by Oct4, Sox2, Nanog and Tcf3 in mouse. Red line in center and
right panel show the level of detection in ES cells.
(C) Histogram of changes in frequency of detection. Changes for miRNAs whose
primary transcripts are occupied by Oct4, Sox2, Nanog and Tcf3 in mouse are shown as
bars (red for ES enriched, blue for MEF enriched and green for NPC enriched). The
background frequency for non-occupied miRNAs is shown as a grey line.
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Figure 5. Polycomb represses lineage-specific miRNAs in ES cells.
(A) Suzl2 (light green) and H3K27me3 (dark green, Mikkelsen et al., 2007) binding are
shown for two miRNA genes in murine ES cells. Predicted start sites (arrow), CpG
islands (green bar), presumed miRNA primary transcript (dotted line) and mature miRNA
(red bar) are shown.
(B) Expression analysis of miRNAs from mES cells based on quantitative small RNA
sequencing. Cumulative distributions for PcG bound miRNAs (green line) and all
miRNAs (grey line) are shown.
(C) Expression analysis of miRNAs bound by Suzl2 in mES cells. Relative counts are
shown for mES (red), NPCs (orange) and MEFs (yellow). miR-9 transcript levels were
selectively induced in NPCs, while miR-218 and miR-34c were induced in MEFs.
H3K27me3 (green line) was lost from the miR-9-1 and the miR-9-2 promoters in NPCs,
while the promoters retained H3K4me3 (blue line) (Mikkelsen et al., 2007). H3K27me3
was lost at the miR-218 and miR-34c promoters in MEFs.
(D) Schematic of a subset of miRNAs bound by Suzl2 in both mES and hES cells. Cells
known to selectively express these miRNAs based on computation predictions (Farh et
al., 2005) or experimental confirmation (Yi et al., 2006; Yi et al., 2008; Landgraf et
al.,2007) are indicated. Transcription factors are represented by dark blue circles, and
Suzl2 by a green circle. miRNA gene promoters are represented by purple hexagons.
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Discussion
Here we provide new high-resolution, genome-wide maps of core ES cell transcription
factors, identify promoter regions for most miRNA genes, and deduce the association of
the ES cell transcription factors with these miRNA genes. We also provide quantitative
sequence data of short RNAs in ES cells, NPCs and MEFs to examine changes in miRNA
transcription. The key transcriptional regulators in ES cells collectively occupied the
promoters of many of the miRNAs that were most abundant in ES cells, including those
that were down-regulated as ES cells differentiate. In addition, these factors also
occupied the promoters of a second, smaller set of miRNAs that were repressed in ES
cells and were selectively expressed in specific differentiated cell types. This second
group of miRNAs constitutes a subset of the miRNAs that were silenced by the
Polycomb group proteins in ES cells, which is also known to silence key lineage-specific,
protein-coding developmental regulators. Together these data reveal two key groups of
miRNAs that are direct targets of Oct4/Sox2/Nanog/Tcf3, one group of miRNAs that is
preferentially expressed in pluripotent cells and a second group that is silenced in ES
cells by the Polycomb group proteins, and is poised to contribute to cell fate-decisions
during mammalian development.
miRNA contribution to ES cell identity
Several miRNA ploycistrons, which encode the most abundant miRNAs in ES cells and
which are silenced during early cellular differentiation (Houbaviy et al., 2003; Suh et al.,
2004; Houbaviy et al., 2005), were occupied at their promoters by Oct4, Sox2, Nanog
and Tcf3. These include the mir-290-295 cluster, which contains multiple mature
miRNAs that share seed sequences with members of the murine mir-302 cluster, as well
as the human mir-371-373 and mir-302 clusters. miRNAs in the 17-92 cluster also share
a highly similar seed sequence. miRNAs in this family have been implicated in cell
proliferation (O'Donnell et al., 2005; He et al., 2005; Voorhoeve et al., 2006), consistent
with the impaired self-renewal phenotype observed in miRNA-deficient ES cells
(Kanellopoulou et al., 2005; Murchison et al., 2005; Wang et al., 2007; Calabrese et al.,
2008). The zebrafish homologue of this miRNA family, mir-430, contributes to the rapid
degradation of maternal transcripts in early zygotic development (Giraldez et al., 2006),
and mRNA expression data suggests that this miRNA family also promotes the clearance
of transcripts in early mammalian development (Farh et al., 2005).
In addition to promoting the rapid clearance of transcripts as cells transition from
one state to another during development, miRNAs also likely contribute to the control of
cell identity by fine-tuning the expression of genes. mir-430, the zebrafish homologue of
the mammalian mir-302 family, serves to precisely tune the levels of Nodal antagonists
Lefty I and Lefty 2 relative to Nodal, a subtle modulation of protein levels that has
pronounced effects on embryonic development (Choi et al., 2007). Recently, a list of
-250 murine ES cell mRNAs that appear to be under the control of miRNAs in the mir-
290-295 cluster was reported (Sinkkonen et al., 2008). This study reports that Leflyl and
Lefty2 are evolutionarily conserved targets of the mir-290-295 miRNA family. These
miRNAs also maintain the expression of de novo DNA methyltransferases 3a and 3b
(Dnmt3a and Dnmt3b), perhaps by dampening the expression of the transcriptional
repressor Rbl2, helping to poise ES cells for efficient methylation of Oct4 and other
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pluripotency genes during differentiation.
Knowledge of how the core transcriptional circuitry of ES cells connects to both
miRNAs and protein-coding genes, reveals recognizable network motifs downstream of
Oct4/Sox2/Nanog/Tcf3, involving both transcriptional and post-transcriptional
regulation, that further reveal how this circuitry controls ES cell identity (Figure 6).
Leftyl and Lefty2, both actively expressed in ES cells, are directly occupied at their
promoters by Oct4/Sox2/Nanog/Tcf3. Therefore, the core ES cell transcription factors
appear to promote the active expression of Leftyl and Lefty2, but also fine-tune the
expression of these important signaling proteins by activating a family miRNAs that
target the Leftyl and Lefty2 3'UTRs. This network motif whereby a regulator exerts both
positive and negative effects on its target, termed "incoherent feed-forward" regulation
(Alon, 2007), provides a mechanism to fine-tune the steady-state level or kinetics of a
target's activation (Figure 6A). Over a quarter of the proposed targets of the mir-290-295
miRNAs also are likely under the direct transcriptional control of Oct4/Sox2/Nanog/Tcf3
based on our binding maps, suggesting that these miRNAs could participate broadly in
tuning the effects of ES cell transcription factors (Figure 6A).
The miRNA expression program directly downstream of Oct4/Sox2/Nanog/Tcf3
could help poise ES cells for rapid and efficient differentiation, consistent with the
phenotype of miRNA-deficient cells (Kanellopoulou et al., 2005; Murchison et al., 2005;
Wang et al., 2007; Calabrese et al., 2008). Oct4/Sox2/Nanog/Tcf3 also likely contributes
to this poising by their occupancy of the Let-7g promoter. Mature Let-7 transcripts are
scarce in ES cells, but were among the most abundant miRNAs in both MEFs and NPCs
(Figure 3). Primary Let-7g transcript is abundant in ES cells, but its maturation is
blocked by Lin28 (Viswanathan et al., 2008 and data not shown). We now report that the
promoters of both Let-7g and Lin28 are occupied by Oct4/Sox2/Nanog/Tcf3, suggesting
that the core ES cell transcription factors promote the transcription of both primary Let-
7g and Lin28, which blocks the maturation of Let-7g. In this way Let-7 and Lin-28
appear to participate in an incoherent feed-forward circuit downstream of
Oct4/Sox2/Nanog/Tcf3 to contribute to rapid cellular differentiation (Figure 6B).
Notably, ectopic expression of Lin28 in human fibroblasts promotes the induction of
pluripotency (Yu et al., 2007), suggesting blocked maturation of pri-Let-7 transcripts
plays an important role in the pluripotent state. Additionally, Dnmt3a and Dnmt3b,
which are indirectly up-regulated by the mir-290-25 miRNAs (Sinkkonen et al., 2008),
are also occupied at their promoters by Oct4/Sox2/Nanog/Tcf3, providing examples of
"coherent" regulation of important target genes by ES cell transcription factors and the
ES cell miRNAs maintained by those transcription factors (Figure 6C).
Multi-layer Regulatory Circuitry of ES cell identity
The regulatory circuitry we present for miRNAs in ES cells can now be integrated into
the model of core regulatory circuitry of pluripotency we have proposed previously
(Boyer et al., 2005; Lee et al., 2006; Cole et al., 2008), as illustrated in Figure 7. Our
data reveal that Oct4, Sox2, Nanog and Tcf3 occupy the promoters of two key sets of
miRNAs, similar to the two sets of protein-coding genes regulated by these factors: one
set that is actively expressed in pluripotent ES cells and another that is silenced in these
cells by Polycomb Group proteins and whose later expression might serve to facilitate
establishment or maintenance of differentiated cell states.
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Figure 6. miRNA modulation of the gene regulatory network in ES cells.
(A) An incoherent feed-forward motif (Alon 2007) involving a miRNA repression of a
transcription factor target gene is illustrated (left). Transcription factors are represented
by dark blue circles, miRNAs in purple hexagons, protein-coding gene in pink rectangles
and proteins in orange ovals. Particular instances of this netowrks motif identified in ES
cells, where signaling molecules or transcriptional regulators directly downstream of
Oct4/Sox2/Nanog/Tcf3 are tuned or silenced by miRNAs maintained in ES cells by
Oct4/Sox2/Nanog/Tcf3, are illustrated (right).
(B) Another incoherent feed-forward motif (Alon 2007) where a protein, encoded by a
gene under the control of Oct4/Sox2/Nanog/Tcf3, inhibits the maturation of a primary
miRNA transcript maintained in ES cells by Oct4/Sox2/Nanog/Tcf3, is illustrated (left).
In ES cells, Lin28 blocks the maturation of primary Let-7g (Visiwanthan et al., 2008).
Lin28 and the Let-7g gene are occupied by Oct4/Sox2/Nanog/Tcf3. Also, noted by the
purple dashed line is the Targetscan prediction (Grimson et al., 2007), that mature Let-7g
would target Lin28 (right).
(C) A coherent feed-forward motif (Alon 2007) where a miRNA represses the expression
of transcriptional repressor, which indirectly activates the expression of a gene
maintained in ES cells by Oct4/Sox2/Nanog/Tcf3, is illustrated (left). This motif is found
in ES cells, where mir-290-295 miRNAs repress Rbl2 indirectly maintaining the
expression of Dnmt3a and Dnmt3a, which are also occupied at their promoters by
Oct4/Sox2/Nanog/Tcf3 (right).
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Figure 7. Multi-level regulatory network controlling ES cell identity.
Updated map of ES cell regulatory circuitry is shown. Interconnected auto-regulatory
loop is shown to the left. Active transcripts are shown at the top right, and PcG silenced
transcripts are shown at the bottom. Transcription factors are represented by dark blue
circles, and Suzl2 by a green circle. Gene promoters are represented by red rectangles,
gene products by orange circles, and miRNA promoters are represented by purple
hexagons.
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The expanded circuit diagram presented here integrates transcription factor
occupancy of miRNA genes and existing data on miRNA targets into our model of the
molecular control of the pluripotent state. These data suggest that miRNAs that are
activated in ES cells by Oct4/Sox2/Nanog/Tcf3, serve to modulate the direct effects of
these transcription factors, participating in incoherent feed-forward regulation to tune
levels of key genes, and modifying the gene expression program to help poise ES cells
for efficient differentiation. Core ES cell transcription factors and the miRNAs under
their control coordinately contribute transcriptional and post-transcriptional gene
regulation to the network that maintains ES cell identity.
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Concluding Remarks
The regulatory circuitry controlled by ES cell transcription factors, Oct4, Sox2, Nanog
and Tcf3, and the Polycomb Group proteins, which is required for the normal ES cell
state, has offered insights into the molecular control of ES cell pluripotency and self-
renewal and cellular reprogramming (Jaenisch and Young, 2008). We now provide high-
resolution genome-wide location analysis of these factors provided by ChIP-seq data, and
quantitative sequencing of short transcripts in multiple cell types, to connect miRNA
genes to the core circuitry of ES cells. This information should prove useful as
investigators continue to probe the role of miRNAs in pluripotency, cell-fate decisions,
and perhaps regenerative medicine.
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Experimental Procedures
A detailed description of all materials and methods used can be found in Supplementary
Information.
Cell Culture
V6.5 (C57BL/6-129) murine ES cells were grown under typical ES conditions (see
Supplementary Information) on irradiated mouse embryonic fibroblasts (MEFs). For
location analysis, cells were grown for one passage off of MEFs, on gelatinized tissue-
culture plates. To generate neural precursor cells, ES cells were differentiated along the
neural lineage using standard protocols (see Supplementary Information). V6.5 ES cells
were differentiated into neural progenitor cells (NPCs) through embryoid body formation
for 4 days and selection in ITSFn media for 5-7 days, and maintained in FGF2 and EGF2
(R&D Systems) (See Supplementary Information). Mouse embryonic fibroblasts were
prepared and cultured from DR-4 strain mice as previously described (See
Supplementary Information).
Antibodies and ChIP assays
Detailed descriptions of antibodies, antibody specificity and ChIP methods used in this
study are provided in Supplementary Information.
Crosslinked cells (~1 x 107 per IP) were lysed and sonicated using a Misonix 3000
sonicator to solubilize and shear crosslinked DNA to a 200bp-1000bp fragment size.
Batch sonicated whole cell extract was incubated 12-18 hours at 40C with 100 p1 of
Dynal Protein G magnetic beads (Dynal) that has been pre-bound to 10 jg of the
appropriate antibody. Immunoprecipitates were washed with RIPA buffer and the DNA
eluted in 1% SDS at 65 0 C for 1 hour. Chemical cross-links were reversed for 10 hours to
allow isolation of immunoenriched DNA fragments. Immunoprecipitated DNA and
control whole cell extract DNA were purified by treatment with RNAse A, proteinase K
and two consecutive phenol:chloroform:isoamyl alcohol extractions.
ChlP-seq
Crosslinked cells (1 x 107 per IP) were lysed and sonicated using a Misonix 3000 sonicator
to solubilize and shear crosslinked DNA to a 200bp-1000bp fragment size. Batch sonicated
whole cell extract was incubated 12-18 hours at 40C with 100 p1 of Dynal Protein G
magnetic beads (Dynal) that has been pre-bound to 10 pg of the appropriate antibody.
Immunoprecipitates were washed with RIPA buffer and the DNA eluted in 1% SDS at
65'C for 1 hour. Chemical cross-links were reversed for 10 hours to allow isolation of
immunoenriched DNA fragments. Immunoprecipitated DNA and control whole cell extract
DNA were purified by treatment with RNAse A, proteinase K and two consecutive
phenol:chloroform:isoamyl alcohol extractions.
Purified immunoprecipitated DNA were prepared for sequencing according to a
modified version of the Solexa Genomic DNA protocol. Fragmented DNA was end
repaired and subjected to 18 cycles of LM-PCR using oligos provided by Illumina.
Amplified fragments between 150 and 300bp (representing shear fragments between 50
and 200nt in length and ~100bp of primer sequence) were isolated by agarose gel
electrophoresis and purified. High quality samples were confirmed by the appearance of a
smooth smear of fragments from 100-1000bp with a peak distribution between 150 and
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300bp. 3ng of Linker-ligated DNA was applied to the flow-cell using the Solexa Cluster
Station fluidics device. Following bridge amplification the cluster density and morphology
were confirmed by microscopic analysis of flow-cells stained with a 1:5000 dilution of
SYBR Green I (Invitrogen). Samples were then subjected to 26 bases of sequencing
according to Illumina's standard protocols.
Images acquired from the Solexa sequencer were processed through the bundled
Solexa image extraction pipeline and aligned to both mouse NCBI build 36 and 37 using
ELAND. Only sequences uniquely matching the reference genome without mismatches
were used. Mapped reads were extended to 200bp and allocated into 25bp bins. Groups of
bins containing statistically significant enrichment for the epigenetic modification were
identified by comparison to a Poissonian background model as well as comparison to an
empirical distribution of reads obtained from whole cell extract DNA.
Quanititative short RNA sequencing
A method of cloning the 18-30nt transcripts previously described (Lau et al., 2001) was
modified to allow for Solexa (Illumina) sequencing (manuscript submitted). Single-
stranded cDNA libraries of short transcripts were generated using size selected RNA
from mouse embryonic stem cells, mouse neural precursors, and mouse embryonic
fibroblasts. RNA extraction was performed using Trizol, followed by RNeasy
purification (Qiagen).
5,pg of RNA was size selected and gel purified. 3' Adaptor
(pTCGTATGCCGTCTTCTGTTG [idT]) was ligated to RNA with T4 RNA ligase and
also, separately with RNA Ligase (Rnl2(1-249)k->Q). Ligation products were gel
purified and mixed. 5' adaptor (GUUCAGAGUUCUACAGUCCGACGAUC) was
ligated with 4 RNA Ligase.
RT-PCR (Superscript II, Invitrogen) was performed with 5' primer
(CAAGCAGAAGACGGCATA). Splicing of overlapping ends PCR (SOEPCR) was
performed (Phusion, NEB) with 5' primer and 3' PCR primer
(AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA), generating
cDNA with extended 3' adaptor sequence. PCR product (40 jl) was denatured (85°C, 10
min, formamide loading dye), and the differently sized strands were purified on a 90%
formamide, 8% acrylamide gel, yielding single-stranded DNA suitable Solexa
sequencing.
The single-stranded DNA samples were resuspended in 10mM Tris (EB buffer)/0. 1%
Tween and then used as indicated in the standard Solexa sequencing protocol (Illumina).
Each library was run on one lane of the Solexa sequencer.
Promoter array design and data extraction
The design of the oligonucleotide-based whole genome array set and data extraction
methods are described in Lee et al., 2006. The microarrays used for location analysis in
this study were manufactured by Agilent Technologies (http://www.agilent.com).
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Chapter 6
Concluding Remarks
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Concluding Remarks
The work presented in this thesis has piece by piece begun to dissect the network of
embryonic stem cells by first mapping the role of key transcription factors and then
incorporating inputs from chromatin modifiers, signaling pathways and miRNAs into the
network diagram. Together this work has greatly improved our understanding both of
how the ES cell state is regulated as well as general properties of vertebrate networks.
The approaches taken in these studies to examine the ES cell network can be applied to
and guide studies in other vertebrate cell types. These studies have also uncovered or
highlighted interesting topics that require further exploration. Here I discuss possible
future directions that stem from my thesis work and conclude with a brief description of
some recent work that highlights the importance of understanding vertebrate networks
and their manipulation.
Transcription Factors
While a handful of key ES cell transcription factors, including Oct4, Sox2 and Nanog,
have been incorporated into the map of the ES cell network, there are hundreds of other
transcription factors in ES cells that affect gene expression and should be added to the
network diagram. Several of these factors have been implicated as playing an important
role in ES cells (Hanna et al., 2002; Lim et al., 2007). In order to both understand the
role of these other transcription factors in the network and to understand how
transcription factors work in combination at target genes to specify expression levels it is
important to incorporate inputs from these other factors in the network map. Expanding
the network will allow us to identify network hubs, examine the combinatorial nature of
gene regulation in vertebrates and may uncover other important network themes.
Binding data of Oct4, Sox2, Nanog and Tcf3 revealed that they bind in extremely
close proximity to each other on DNA. This proximity of binding suggests the possibility
that these factors may be physically interacting with each other or even forming a
complex on chromatin. It would be interesting to perform biochemical studies to
examine the possible interactions between these factors and the functional significance of
these interactions.
Studies of vertebrate networks are still in the early stage of data generation but as
more data is collected it will be important to develop algorithms that make sense of and
interpret the data. For example, as we uncover the set of regulators controlling target
gene expression it may be possible to determine the logic created by the combination of
regulators at a promoter that controls gene expression. It will be interesting to examine
whether a 'transcription factor code' can be deduced that could predict transcription
levels simply from the set of transcription factors regulating a gene.
Chromatin Regulators
The discovery that Polycomb complexes silence developmental regulators controlling
other cell lineages seems to be a fundamental mechanism maintaining cell state.
However, as Polycomb complexes do not directly bind DNA it will be important to
identify how Polycomb proteins are recruited to the set of silent developmental regulators
in ES and other cells. One hypothesis is that non-coding RNAs direct Polycomb to this
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set of genes as some Polycomb proteins bind RNA (Bernstein et al., 2006; Zhang et al.,
2004).
During differentiation the repression of the subset of developmental regulators
necessary for the particular cell lineage being adopted must be relieved without removing
repression of other developmental regulators. The removal of Polycomb complexes from
these regulators being activated must be a key mechanisms allowing and directing
differentiation. Understanding how Polycomb is selectively removed from a particular
subset of developmental regulators is therefore an important question that should be
explored in future studies.
Studies of chromatin marks revealed that a large number of genes in ES and other
cell types have stalled transcription. Given this, it is clear that transcription elongation is
a highly regulated process that is likely to play a key role in controlling proper gene
expression. It will be important to further explore both the mechanisms regulating
transcription elongation as well as the role that this type of regulation plays in the
transcriptional regulatory network controlling cell state.
Signaling Pathways
Although input from the Wnt pathway into the ES cell network has begun to be mapped
through its terminal component Tcf3, its role in the network that is mediated by the other
three Tcf proteins must also be explored. It is not clear how much of Wnt signaling is
mediated by Tcf3 versus the other Tcf proteins, which are also expressed in ES cells.
Although these proteins can function redundantly they are also known in some instances
to have independent roles (Liu et al., 2005). It would be very interesting to examine the
role of the other Tcf proteins in the ES cell network and to examine their relative use in
mediating Wnt signaling. It would be particularly interesting to profile the role of Tcf4
as this factor is up-regulated upon differentiation and so may mediate the role of Wnt in
the process of differentiation.
While the role of the Wnt pathway in maintaining the ES cell state has begun to
be teased apart there are several other pathways known to play an important role in
maintaining ES cells whose inputs into the network have not yet been examined
(Valdimarsdottir and Mummery, 2005; Xu et al., 2005). It will be interesting to
determine whether these other pathways also control the ES cell state by directly
connecting to the core regulators and their target genes as seems to be the case for the
Wnt pathway. It is also known that the effects of signaling pathways can be affected by
the status of other pathways and so incorporating inputs from multiple pathways may
lead to a better understanding for how they act in a combinatorial manner to determine
cell state.
Currently, the only signaling pathway whose input into the network has been
studied is the Wnt pathway, which is believed to help maintain the ES cell network.
There are several signaling pathways, however, which are known to be involved in the
process of ES cell differentiation (Lowell et al., 2006; Ying et al., 2003). It would be
very interesting to examine how these pathways initiate changes in the network to direct
differentiation down particular lineages.
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Non-coding RNAs
Chapter 5 describes an initial study of non-coding RNAs in ES cells that
examines the regulation of miRNA genes. The set of genes regulated by these miRNA
genes, however, is largely unknown. In order to fully incorporate these miRNA genes
into the ES cell network it is necessary to identify their target genes. This is perhaps
especially important for the set of miRNA genes that are uniquely expressed in ES cells
and so are likely to play an important role in the ES cell network.
While miRNA genes have begun to be incorporated into the map of the ES cell
network, there are other classes of non-coding RNAs that play a role in regulating gene
expression whose role in the ES cell network is entirely unknown. The incorporation of
other types of non-coding RNAs into the network would incorporate additional layers of
regulation and deepen our understanding of how multiple levels of regulation act together
to specify gene expression.
Medical Applications
A chief motivation for the study and mapping of vertebrate regulatory networks is the
belief that a better understanding can guide efforts in reprogramming networks and cell
state. Scientists have recently demonstrated the ability to reprogram fibroblast cells into
ES cells by forced expression of several ectopic genes (Jaenisch and Young, 2008; Okita
et al., 2007; Park et al., 2008; Takahashi and Yamanaka, 2006; Takahashi et al., 2007;
Wernig et al., 2007; Yu et al., 2007). This technique has been applied to medical
treatments in model organisms. For example, scientists have taken skin cells from mice
with sickle cell anemia or Parkinson's disease, reprogrammed these cells to ES cells,
differentiated these cells to a useful cell type, injected them into diseased mice and been
able to alleviate the disease symptoms (Hanna et al., 2007; Wernig et al., 2008). These
studies demonstrate the enormous medical promise offered by reprogramming cell states.
In order to understand the process of cellular reprogramming it will be necessary
to study transcriptional regulatory networks as they transition from one cell state to
another. The study of dynamic network changes is experimentally quite challenging,
however these studies should nonetheless be attempted as they are important both to
understanding the creation of cells to be used for medical treatments and to understanding
the dynamic nature of networks.
Current reprogramming techniques rely on the expression of ectopic genes to
'jump start' the core network of the desired cell type. This genetic manipulation in order
to reprogram cells limits their use in medical treatments as genetic perturbations can lead
to increased risk of diseases such as cancer. During development cells do not undergo
genetic changes but instead rely on signaling pathways to induce network modifications.
Through better understanding how cells use signaling pathways to initialize network
changes scientists may be able to leverage this knowledge to manipulate cell networks
without the use of ectopic genes. For this reason it will be important for future studies to
aggressively pursue the study of signaling pathways and natural network manipulations.
While our understanding of the ES cell network and its manipulation is quickly
developing there are many other medically relevant cell types and networks that need to
be examined. In order to develop methods to manipulate a patient's cells into the needed
cell type it will likely be important to understand the network governing the desired cell
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type. Additionally, many diseases are caused by dysregulation of a cell's network and so
by understanding the errors in the network scientists may be able to develop methods to
correct these errors. It is therefore imperative to begin dissecting the networks of other
medically relevant cell types.
Summary
The work presented in this thesis together begin to form a coherent picture of the
regulatory network governing the embryonic stem cell state. Transcriptional regulatory
networks are quite complex, especially in higher organisms, and involve many layers of
regulation that we are only beginning to understand. Each study presented here attacked
the network from a distinct angle but nonetheless function together to create a unified
picture of the control of ES cells and of vertebrate networks in general. As these studies
ventured into the relatively new field of vertebrate regulatory networks they both
uncovered many important themes and highlighted the necessity of numerous future
studies. Given the developmental and medical relevance of the field it seems clear that it
will receive much attention, progress quickly, and yield many important insights.
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Appendix A
Genome-wide Map of Nucleosome Acetylation and Methylation in Yeast
Published as: Dmitry K. Pokholok, Christopher T. Harbison, Stuart Levine, Megan Cole,
Nancy M. Hannett, Tong Ihn Lee, George W. Bell, Kimberly Walker, P. Alex Rolfe,
Elizabeth Herbolsheimer, Julia Zeitlinger, Fran Lewitter, David K. Gifford, and Richard
A. Young. (2005). "Genome-wide Map of Nucleosome Acetylation and Methylation in
Yeast." Cell 122: 517-527.
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My contribution to this project
This project was led by Dmitri Pokholok and Chris Harbison. I worked with Stuart
Levine and Elizabeth Herbolsheimer to develop an error model and gene calling
algorithm for use with genome-wide binding data. I also played a large part in
determining the proper experimental and computational normalizations for the histone
mark ChIPs.
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Summary
Eukaryotic genomes are packaged into nucleosomes whose position and chemical
modification state can profoundly influence regulation of gene expression. We profiled
nucleosome modifications across the yeast genome using chromatin immunoprecipitation
coupled with DNA microarrays to produce high-resolution genome-wide maps of histone
acetylation and methylation. These maps take into account changes in nucleosome
occupancy at actively transcribed genes and, in doing so, revise previous assessments of
the modifications associated with gene expression. Both acetylation and methylation of
histones are associated with transcriptional activity, but the former occurs predominantly
at the beginning of genes, whereas the latter can occur throughout transcribed regions.
Most notably, specific methylation events are associated with the beginning, middle, and
end of actively transcribed genes. These maps provide the foundation for further
understanding the roles of chromatin in gene expression and genome maintenance.
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Introduction
The genomes of eukaryotes are packaged into chromatin, the fundamental unit of which
is the nucleosome. Nucleosomes consist of approximately 146 base pairs of DNA
wrapped around a histone octamer (Luger et al., 1997). The histone components of
nucleosomes and additional chromatin proteins can interact to form higherorder
chromosomal structures. Nucleosomes are thus critical to the organization and
maintenance of genetic material, and their position and modification state can profoundly
influence genetic activities such as regulation of gene expression (Kouzarides, 2002;
Narlikar et al., 2002).
Several recent studies have explored the relative occupancy and modification state
of nucleosomes across the yeast genome by using chromatin immunoprecipitation of
histones and DNA-microarray analysis, a technique known as "genome-wide location
analysis" or "ChIP-chip" (Bernstein et al., 2002, 2004; Kurdistani et al., 2004; Lee et al.,
2004; Robyr et al., 2002; Santos- Rosa et al., 2002). The results of these studies, which
used DNA microarrays that probed a single site in the intergenic or transcribed portions
of the genome, suggested that the intergenic regions of S. cerevisiae are less densely
occupied by nucleosomes than transcribed regions (Lee et al., 2004) and that nucleosome
density in both regions inversely correlates with transcription rates (Bernstein et al.,
2004; Lee et al., 2004). Similar studies have explored the relationship between
transcription and genome occupancy by chromatin regulators (Humphrey et al., 2004;
Kurdistani et al., 2002; Lieb et al., 2001; Ng et al., 2002b, 2003b; Robert et al., 2004;
Robyr et al., 2002) or transcription and modification of nucleosomes (Kurdistani et al.,
2004; Robyr et al., 2002; Roh et al., 2004). Some conclusions from these studies are
difficult to reconcile with one another; for example, the histone acetyltransferases Gcn5
and Esal appear to be recruited to genes upon transcriptional activation (Robert et al.,
2004), but acetylation of the amino acid residues they target in histones does not appear
to be strongly associated with transcriptional activity (Kurdistani et al., 2004).
To more accurately define nucleosomal occupancy and modification and their
relationships to transcription, we have investigated genome-wide chromatin structure at
considerably higher resolution than that afforded by the experimental designs that have
been used thus far. Such designs have typically used DNA microarrays with a single
feature to capture signals from each intergenic or transcribed region (Bernstein et al.,
2004; Kurdistani et al., 2004; Lee et al., 2004). We describe here profiling of protein-
DNA occupancy at high resolution and accuracy using improved protocols and DNA
microarrays that tile the yeast genome. The results we obtain with this approach provide a
more complete picture of nucleosome occupancy and the nature of modifications
associated with transcriptional activity, resolve discrepancies in previous reports, and
allow us to produce the first high-resolution maps of histone acetylation and methylation
in the yeast genome.
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Results and Discussion
High-Resolution Genome-wide ChIP-Chip
To increase the resolution and accuracy of genomewide location analysis, we designed a
DNA microarray that contains over 40,000 probes for the yeast genome and developed
hybridization methods that maximized signal-to-noise ratios on this array (see
Experimental Procedures). To test whether these modifications improved the resolution
and accuracy of genome-wide binding analysis, we explored the genome-wide occupancy
of Gcn4, a transcriptional regulator of amino acid-biosynthetic genes with a well-
characterized DNA binding specificity (Hope and Struhl, 1985; Oliphant et al., 1989),
crystal structure (Ellenberger et al., 1992; O'Shea et al., 1991), and previously identified
target genes (Arndt and Fink, 1986; Natarajan et al., 2001). The binding data for
individual target genes are shown in Figure IA and in Figure SI in the Supplemental
Data available with this article online. For those regions for which there is strong
evidence for Gcn4 binding, we found that the peak of Gcn4 binding occurred directly
over that binding site.
To test the accuracy of the new method, we identified a test set of 84 genes most
likely to be targeted by Gcn4 in vivo (Figure lB, Table S1, Experimental Procedures) and
a set of 945 genes least likely to be targeted by Gcn4; the selection criteria for these sets
of genes is described in Experimental Procedures. Based on these positive and negative
Gcn4 targets, analysis of Gcn4 binding with the new method suggests a falsepositive rate
of less than 1% and a false-negative rate of ~25%, corresponding with a total of 210
genes whose promoters are bound within the optimal p-value threshold of 6 x 10-6
(Experimental Procedures). These results demonstrate that the new array and protocol
modifications provide substantially higher resolution and accuracy than our previous
method using self-printed arrays (Harbison et al., 2004; Lee et al., 2002).
Global Nucleosome Occupancy
The improved accuracy and resolution of this ChIP-Chip method was used to investigate
nucleosome occupancy and modification throughout the yeast genome. When we
examined histone occupancy with antibodies against core histone H3 or histone H4, using
genomic DNA as the reference channel, we found a relatively high density of
nucleosomes over transcribed regions and a lower density over intergenic regions
(Figures IC and ID). Figure IC shows a stereotypical example of histone occupancy at a
portion of chromosome XV. Figure 1D presents composite profiles of histone H3 and H4
for 5324 genes aligned according to the location of translation initiation and termination
sites. There was an -20% reduction in histone occupancy in intergenic sequences relative
to genic sequences for the average gene. These results are consistent with previous
observations (Lee et al., 2004) and suggest that the majority of yeast genes have higher
nucleosome density over transcribed regions relative to intergenic regions.
We were surprised to find that differential enrichment of intergenic and genic
regions also occurred in control experiments lacking antibody (compare Figure 2A and
Figure lD). Results similar to those in Figure 2A were obtained in control experiments
when ChIPs were performed with antibodies directed against nonhistone proteins (data
not shown). Others have noted that different relative levels of intergenic and genic DNA
are recovered using various extraction strategies (Nagy et al., 2003), but control data of
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Figure 1. Nucleosome Occupancy across the Yeast Genome with High-Resolution
Genome-wide Location Analysis
(A) Occupancy of the HIS] promoter by Gcn4. The genomic positions of probe regions
are arrayed along the x axis, with the ratio of enrichment of Gcn4 for probes along the y
axis. ORFs are depicted as gray rectangles, and arrows indicate the direction of
transcription. Red boxes represent sequence matches to the Gcn4 binding specificity
within promoter regions.
(B) Composite profile of Gcn4 binding at the set of 84 high-confidence Gcn4 target
genes. Promoter and downstream regions were aligned with each other according to the
position of a sequence match to the Gcn4 binding specificity. Aligned probes were then
assigned to 50 bp segment bins, and an average of the corresponding enrichment ratio
was calculated. Standard error of the mean is shown in gray. Genetic elements are
depicted as in Figure lA, except that dashed lines represent sites including both ORFs
and intergenic regions.
(C) Nucleosome occupancy at the promoter of CPA], a gene encoding an amino acid
biosynthetic enzyme. The genomic positions of probe regions are arrayed along the x
axis, with the ratio of enrichment of histone H3 (blue) or H4 (red) for probes along the y
axis. ORFs are depicted as gray rectangles, and arrows indicate the direction of
transcription.
(D) A composite profile of histone occupancy at 5324 genes. The ends of ORFs were
defined at fixed points according to the position of translational start and stop sites. The
length of the ORF was then subdivided into 40 regions of equal length, and probes were
assigned according to their nearest corresponding relative position. Probes in promoter
regions were similarly assigned following subdivision into 20 regions. The average
histone H3 (blue) or H4 (red) enrichment for each subdivided bin is plotted.
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Figure 2. Comparisons of Histone Profiles
(A) A composite profile of enrichment in a control experiment. The profile is created as
in Figure 1D, except that enrichment is measured from a mock immunoprecipitation, in
which no antibody has been included (Experimental Procedures).
(B) A composite profile of histone occupancy normalized to a control. The profile is
created as in Figure ID, except that enrichment from H3 immunoprecipitation is
normalized to enrichment from mock immunoprecipitations.
(C) A composite profile of histone occupancy according to transcriptional activity. All
genes for which data were available (Holstege et al., 1998) were divided into five classes
according to their transcriptional rate. Composite data were computed for H3 enrichment
as in Figure ID.
(D) A composite profile of normalized histone occupancy according to transcriptional
activity. The composite profile is created as in Figure 2C, except that enrichment from
H3 immunoprecipitation is normalized to enrichment from mock immunoprecipitations.
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this type have not yet been used to normalize the results of histone ChIP studies
(Bernstein et al., 2004, 2005; Kurdistani et al., 2004; Lee et al., 2004). When these
control experiments were used to normalize the histone H3 data, we found that there were
not substantial differences in the relative levels of intergenic versus genic DNA at the
average gene (Figure 2B). Nonetheless, approximately 40% of yeast promoters do have
lower levels of histones than their downstream transcribed regions, even after the
normalization by control experiments (Figure S2), and we show below that these are
associated with transcribed genes.
To examine the relationship between gene expression and nucleosome occupancy,
we assigned genes into five different classes depending on their transcriptional rate
(Holstege et al., 1998) and created a composite histone H3 profile for each class (Figures
2C and 2D). The composite histone profile in Figure 2C was generated by using whole
genomic DNA in the reference channel, and that in Figure 2D was generated by
normalizing to a no-antibody control ChIP. The results in both profiles confirm that
nucleosome occupancy at both promoter and transcribed regions inversely correlates with
gene activity, in agreement with previous gene-specific and genome-wide studies
(Bernstein et al., 2004; Boeger et al., 2003; Lee et al., 2004; Reinke and Horz, 2003). The
results shown in Figure 2D also suggest that nucleosome occupancy is reduced
maximally at the promoters of active genes. In contrast, the promoters of transcriptionally
inactive genes are as densely populated with nucleosomes as genic regions.
If gene activation leads to reduced nucleosome occupancy, then dynamic
activation of specific genes should cause reduced histone levels at these newly
transcribed genes. To test this notion, we performed ChIP-Chip with histone antibodies
on cells before and after exposure to oxidative stress (Causton et al., 2001). At genes
known to be activated by oxidative stress (e.g., HSP30 and HSP82), nucleosome
occupancy dropped substantially (Figure S3). These results confirm that gene activation
leads to reduced nucleosome density in both promoter and transcribed regions, with the
greatest effect occurring at the promoter.
Histone Acetylation
The histone acetylases Gcn5 and Esal are generally recruited to the promoter regions of
active genes (Robert et al., 2004), and thus we would expect that the amino acid residues
that are substrates of these HATs would be preferentially acetylated at active genes. A
recent genome-wide study, however, reported little correlation between transcriptional
activity and acetylation of the histone H3 and H4 amino acid residues targeted by Gcn5
and Esal (Kurdistani et al., 2004). To understand the source of these discrepancies, we
used the new methods to investigate selected histone modifications genome-wide.
Histone H3 lysine 9 acetylation (H3K9ac) and histone H3 lysine 14 acetylation
(H3K14ac) are among the modifications catalyzed by Gcn5 (Kuo et al., 1996; Utley et
al., 1998; Zhang et al., 1998). We used ChIP-Chip to measure the levels of H3K9ac
relative to the levels of core histone H3 genome-wide. The results show that acetylation
of histone H3 at lysine 9 peaks at the predicted transcriptional start sites of active genes
(Figure 3A) and that this modification correlates with transcription rates genome-wide
(Figure 3B). We also found that acetylation of histone H3 at lysine 14 peaks over the start
sites of active genes (Figure 3C) and correlates with transcription rates genome-wide
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(Figure 3D). We conclude that there is a positive association between Gcn5, the
modifications known to be catalyzed by Gcn5, and transcriptional activity (Figure 3 and
Figure S4A).
Four lysine residues of histone H4 are acetylated by Esal, an acetyltransferase
associated with the NuA4 complex (Allard et al., 1999; Clarke et al., 1999; Vogelauer et
al., 2000). We measured the levels of hyperacetylated histone H4 relative to core histone
genome-wide using ChIP-Chip with an antibody that recognizes histone H4 acetylated at
lysines 5, 8, 12, and 16 (H4K5ac8acl2acl6ac). The results showed that H4
hyperacetylation peaks over the start sites of active genes (Figure 3E) and correlates with
transcription rates (Figure 3F), although the association is not as strong as that observed
for H3K9ac and H3Kl4ac. Our analysis cannot exclude the possibility that acetylation of
individual lysine residues in the N-terminal tail of histone H4 might correlate differently
with transcriptional activity. Nonetheless, our data reveal a positive, albeit modest,
correlation between Esal occupancy, the modifications known to be catalyzed by this
enzyme, and transcriptional activity (Figure 3 and Figure S4B).
To ascertain whether dynamic gene activation leads to the expected increase in
histone acetylation at sites catalyzed by Gcn5 and Esal, we performed ChIP-Chip with
the relevant histone antibody on cells before and after exposure to oxidative stress. The
results confirm that gene activation leads to increased histone acetylation at sites
catalyzed by Gcn5 and Esal in the promoter and transcribed regions of activated genes
(Figure S5).
In general, we find that histones with the acetylated residues studied here are
enriched predominantly at promoter regions and transcriptional start sites of active genes
and that enrichment drops substantially across the ORFs (Figure 3 and Figure S5). This is
consistent with the model that transcriptional activators generally recruit Gcn5 and Esal
to promoters of genes upon their activation (Robert et al., 2004) and with the idea that the
two HATs acetylate local nucleosomes when recruited to these genes. Our conclusion
that there is a strong correlation between transcriptional activity and acetylation of the
histone H3 and H4 amino acid residues targeted by Gcn5 and Esal is in contrast to that of
Kurdistani et al. (2004). This discrepancy is most likely due to differences in the material
used in the control channel in the ChIP-Chip procedure. The experiments described here
compare ChIP with a histone-modification antibody to a control ChIP with a core histone
antibody. The experiments reported in Kurdistani et al. (2004) used whole genomic DNA
in the reference channel. We found we could replicate the results in Kurdistani et al.
(2004) if we used whole genomic DNA as a reference in ChIP-Chip experiments (Figure
S6), but for reasons described above, this method of normalization is inappropriate.
Histone Methylation
Methylation of histones in S. cerevisiae is carried out by three known histone
methyltransferases, which are capable of covalently modifying specific lysine residues in
histone H3 with up to three methyl groups (Peterson and Laniel, 2004). Since
characterization of specific methylation marks has been studied primarily at the level of
individual genes (Bannister et al., 2005; Bernstein et al., 2002; Krogan et al., 2003b; Ng
et al., 2003a; Xiao et al., 2003), we sought to systematically profile mono-, di-, and
trimethylated residues at K4, K36, and K79 of histone H3 in nucleosomes associated with
genomic DNA.
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Figure 3. Nucleosome Acetylation Generally Correlates with Transcriptional Activity
(A) Acetylation of H3K9 at a locus on chromosome XII. Enrichment is depicted as in
Figure 1. The number beneath each gene represents the transcriptional frequency of the
corresponding ORF (Holstege et al., 1998) in mRNA/hr.
(B) Composite profile of acetylation of H3K9 across the average gene. Composite
profiles of acetylation according to transcriptional-frequency class are shown as in Figure
2.
(C) Acetylation of H3K14 at a locus on chromosome XII. Enrichment is depicted as in
Figure 1. The number beneath each gene represents the transcriptional frequency of the
corresponding ORF (Holstege et al., 1998) in mRNA/hr.
(D) Composite profile of acetylation of H3K14 across the average gene. Composite
profiles of acetylation according to transcriptional frequency class are shown as in Figure
2.
(E) Hyperacetylation of H4 at a locus on chromosome XII. Enrichment is depicted as in
Figure 1. The number beneath each gene represents the transcriptional frequency of the
corresponding ORF (Holstege et al., 1998) in mRNA/hr.
(F) Composite profile of hyperacetylation of H4 across the average gene. Composite
profiles of acetylation according to transcriptional frequency class are shown as in Figure
2.
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The histone methyltransferase Setl has previously been shown to be recruited to
the 5' end of actively transcribed genes where it is responsible for histone H3K4
methylation (Bernstein et al., 2002; Briggs et al., 2001; Krogan et al., 2003a; Ng et al.,
2003b; Santos-Rosa et al., 2002). We measured histone H3K4 trimethylation (H3K4me3)
using ChIP-Chip and found that the results confirm previous studies (Santos-Rosa et al.,
2002) and provide a higher-resolution picture of H3K4 trimethylation across the yeast
genome (Figures 4A and 4B). Peaks of histone H3K4 trimethylation occurred at
the beginning of actively transcribed genes, and there was a positive correlation between
this modification and transcription rates (Figures 4A and 4B).
We also investigated the profiles of mono- and dimethylated histone H3K4-
containing nucleosomes and found that they exhibit a pattern distinct from that observed
for trimethylated histone H3K4 (Figure S7). While trimethylated H3K4 peaks at the
beginning of the transcribed portions of genes, dimethylated H3K4 (H3K4me2) is most
enriched in the middle of genes, and monomethylated H3K4 (H3K4me) is found
predominantly at the end of genes.
We measured genome-wide the relative levels of H3K36 trimethylation, which is
catalyzed by Set2, a factor associated with the later stages of transcriptional elongation
(Strahl et al., 2002). In contrast to the pattern observed with H3K4 trimethylated histones,
we found that trimethylated H3K36 (H3K36me3) was enriched throughout the coding
region, peaking near the 3# ends of transcription units (Figures 4C and 4D). H3K36
trimethylation also correlated with transcriptional activity. These results are consistent
with the model that Set2 is recruited by the transcription elongation apparatus and that it
methylates local nucleosomes during active transcription.
The Dotl histone methyltransferase modifies histone H3 lysine 79 (H3K79),
which occurs within the core domain of histone H3 (Feng et al., 2002; Ng et al., 2002a,
2003a). Methylation of this residue is estimated to occur in -90% of all histones and is
associated with telomeric silencing control in yeast (Ng et al., 2003a; van Leeuwen et al.,
2002), but global ChIP profiles of dimethylated H3K79 in Drosophila (Schubeler et al.,
2004) have linked this modification to active transcription. We investigated the genomic
profile of H3K79 trimethylation in yeast (H3K79me3) and found that histones with this
modification are enriched within the transcribed regions of genes (Figures 4E and 4F).
Most genes appeared to have nucleosomes modified at H3K79; there was little
correlation between the relative levels of H3K79 trimethylation at genes and
transcriptional activity (Figure 4F).
Global Map of Histone Marks
We recently mapped the locations of conserved transcription-factor binding sites
throughout the yeast genome (Harbison et al., 2004). We used the results described here
to generate a complementary genome-wide map of nucleosome occupancy and histone
modifications that includes results for eight sets of histone modifications (H3K9ac,
H3K14ac, H4K5ac8acl2acl6ac, H3K4mel, H3K4me2, H3K4me3, H3K36me3, and
H3K79me3). A portion of this map is shown in Figure 5, and a browsable form of the
complete yeast-genome chromatin map is available at the authors' website
(http://web.wi.mit.edu/young/nucleosome).
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Concluding Remarks
It is well established that nucleosomes play fundamentally important roles in the
organization and maintenance of the genome. Nucleosome modifications have been
shown to be associated with transcriptional regulation at well-studied genes, and models
have emerged that connect regulation of gene expression to histone modification by
specific chromatin regulators (Cosma et al., 1999; Gregory et al., 1999; Kuo et al., 1998;
Reinke and Horz, 2003). We have carried out a systematic genome- wide analysis of
nucleosome acetylation and methylation at sufficient resolution to determine whether
models that connect regulation of gene expression to histone modification (Deckert and
Struhl, 2001; Reid et al., 2000; Reinke et al., 2001; Suka et al., 2002) apply to gene
regulation throughout the yeast genome.
The results described here, taken together with recent discoveries, are consistent
with the following general model connecting gene expression to histone modification.
Transcriptional activation by DNA binding regulators generally involves recruitment of
Gcn5 and Esal to promoters, where these HATs acetylate specific residues on histones
H3 and H4 at local nucleosomes (Figure 3) (Bhaumik and Green, 2001; Cosma et al.,
1999; Larschan and Winston, 2001; Reid et al., 2000). We were able to find few
exceptions to this general rule, where only one or the other HAT acetylates its target
residues at the promoters of actively transcribed genes (data not shown). Active
transcription is characteristically accompanied by histone H3K4 trimethylation by Setl at
the beginning of genes (Figure 4B) and by H3K4 dimethylation and monomethylation at
nucleosomes positioned further downstream in the transcription unit (Figure S7) (Krogan
et al., 2003a; Ng et al., 2003b). As the transcription apparatus proceeds down the
transcription unit, increasing levels of histone H3K36 trimethylation are observed at most
active genes, catalyzed by Set2 (Figure 4D) (Krogan et al., 2003b; Strahl et al., 2002).
Histone H3K79me3, which is catalyzed by Dotl (Feng et al., 2002; Ng et al., 2003a; van
Leeuwen et al., 2002), is enriched within genes, but, unlike the other modifications
studied here, this enrichment is not clearly associated with active transcription (Figure
4F). Correlations between transcriptional activity and histone occupancy or modification
at intergenic and transcribed regions are summarized in Table S2.
The genome-wide maps of histone occupancy and modification described here
should provide investigators with information useful for further exploring the histone
code and its implications for gene regulation and chromosome organization and
maintenance. We expect that the approaches used here to map histone occupancy and
modification in yeast can also be used to gain insights into the linkage between gene
expression and histone modification across the genome in higher eukaryotes.
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Figure 4. Nucleosome Methylation Generally Correlates with Transcriptional Activity
(A) Trimethylation of H3K4 at a locus on chromosome XII. Enrichment is depicted as in
Figure 1. The number beneath each gene represents the transcriptional frequency of the
corresponding ORF (Holstege et al., 1998) in mRNA/hr.
(B) Composite profile of trimethylation of H3K4 across the average gene. Composite
profiles of methylation according to transcriptional frequency class are shown as in
Figure 2.
(C) Trimethylation of H3K36 at a locus on chromosome XII. Enrichment is depicted as
in Figure 1. The number beneath each gene represents the transcriptional frequency of the
corresponding ORF (Holstege et al., 1998) in mRNA/hr.
(D) Composite profile of trimethylation of H3K36 across the average gene. Composite
profiles of methylation according to transcriptional frequency class are shown as in
Figure 2.
(E) Trimethylation of H3K79 at a locus on chromosome XII. Enrichment is depicted as in
Figure 1. The number beneath each gene represents the transcriptional frequency of the
corresponding ORF (Holstege et al., 1998) in mRNA/hr.
(F) Composite profile of trimethylation of H3K79 across the average gene. Composite
profiles of methylation according to transcriptional frequency class are shown as in
Figure 2.
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Figure 5. A High-Resolution Genome-wide Map of Nucleosome States
A map for a region on chromosome IV is depicted as in Figure 1. Conserved binding sites
for transcriptional regulators (Harbison et al., 2004) are depicted as colored boxes.
Numbers beneath genes represent transcriptional activity (mRNA/hr). Enrichment values
from acetylated H3K14, trimethylated H3K4, and histone H3 are depicted in red, green,
and black, respectively.
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Experimental Procedures
A detailed protocol of the ChIP-chip procedure, the microarray data described herein, and
a description of the error model used for data analysis are available at the authors'
website (http://web.wi.mit.edu/young/nucleosome).
Array Design
The Agilent DNA microarray used here has 44,290 features consisting of 60-mer
oligonulceotide probes. The array covers 12 Mb of the yeast genome (85%), excluding
highly repetitive regions, with an average probe density of 266 bp. Intergenic regions are
represented by 14,256 probes, and ORFs are represented by 27,185 probes. The
remaining 2,849 features included blank spots and controls.
Epitope Tagging., Antibodies, and Strains
Transcriptional and chromatin regulators were tagged at the C terminus with a 9-copy
myc epitope. The sequence encoding the myc epitope was introduced into the
endogenous gene immediately upstream of the stop codon. Specific oligonucleotides
were used to generate PCR products from plasmids described by Cosma et al. (1999).
The resulting PCR products were transformed into a W303 yeast to generate the tagged
strains by one-step genomic integration. Clones were selected for growth on the
appropriate selective media plates, and the insertion was confirmed by PCR. The
expression of the epitope-tagged protein was confirmed by Western blotting using an
anti-Myc (9El 1). The antibodies used in this study are listed in Table 1.
Table 1. AntiboDtd Used in This Study
Specificity Supplier Catalag
Anti-Histone H3 Abcam abi 71
Anti-Histono H4 Abcam ab10156
Anti-H3Kac Upstate Bkitechnology 06-942
Anti-H3K14ac Upstate Biktechology 06-911
Anti-H4ac Upstate diotechnology 06-866
Anti-H3K4me3 Abcam ab8580
Anti-H3K4me2 Abcam ab7766
Anti-H3K4mel Abcram ab885
Anti-H3K36me3 Abcam abOO50
Anti-H3KT7me3 Abcam ab2621
Anti-myc Taconic BioteIchnogy 9E01
Rabbit IgG Upstate Biotechnology 12-370
Chromatin Immunoprecipitation and Genome-wide ChIP-Chip
Chromatin immunoprecipitation and genome-wide location analysis were performed as
described previously (Ren et al., 2000), except that the crosslinking time was reduced to
30 min at room temperature, the order of Proteinase K and RNase treatment was
reversed, and high-resolution oligonucleotide arrays (Agilent Technologies) were used
for hybridizations. Briefly, yeast cells were grown in at least two independent cultures in
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rich medium. Response to hydrogen peroxide was induced by adding hydrogen peroxide
to the cell cultures grown at mid-log phase in YPD medium at 300 C to final concentration
of 0.4 mM for 20 min. Cultures were treated with formaldehyde (1%) for 30 min, and
cells were collected by centrifugation, washed with ice-cold TBS, and disrupted by
vortexing in lysis buffer in the presence of glass beads. The chromatin was sonicated to
yield an average DNA fragment of 500 bp. The DNA fragments crosslinked to the
proteins were enriched by immunoprecipitation with specific antibodies. After reversal of
the crosslinks and purification, the immunoprecipitated and input DNA was labeled by
ligation-mediated PCR with Cy5 and Cy3 fluorescent dyes, respectively. Both pools of
labeled DNA were hybridized to a single DNA microarray (described above). Images of
Cy5 and Cy3 fluorescence intensities were generated by scanning array using GenePix
5000 scanner and were analyzed with GenePix Pro 5.1 software. Experiments were
carried out at least in duplicate.
We and other groups have noted that there can be modest differences in the
relative levels of intergenic and genic yeast DNA that are recovered during phenol
extraction (Nagy et al., 2003). Experimental analysis indicates that this is not due to
differences in our ability to detect intergenic and genic DNA on the DNA microarrays.
Our experiments also indicate that this observation is not due to artifacts due to
differential labeling of DNA. Others have speculated that differential recovery is due to
contaminating nucleases that might preferentially digest intergenic DNA (Nagy et al.,
2003). It is also possible that there are intrinsic differences in susceptibility to shearing by
sonication in intergenic and genic DNA.
Mock-Immunoprecipitation Normalization
Control immunoprecipitations were performed as above with two exceptions. In one case,
an antibody with no specificity to histones (rabbit IgG) was substituted for the H3- or H4-
specific antibody. In the second case, no antibody was added during the overnight
incubation with magnetic beads. For histone H3 and H4 (data not shown), data were
normalized relative to the "no antibody" control. Distributions of relative occupancy at
ORF and intergenic regions by histone H3 are depicted in Figure S8. Following
normalization by this method, the standard deviation is 0.38, and we used two-sampled t
tests to determine the likelihood of differences occurring by chance in both the original
and controlled experiments (Figure S8).
Data Analysis
Genome-wide location data were subjected to quality-control filters and median
normalized, and the weighted average ratio of immunoprecipitated to control DNA was
determined for each spot across all replicates. A confidence value (p value) for single
probes and an averaged confidence value for neighboring probes were calculated.
A binding cutoff for Gcn4 was determined by comparing maximum IP/WCE
ratios to a high-likelihood positive list and a highlikelihood negative list using ROC
curve analysis. A positive list of 84 genes (Table SI) was selected on the basis of
previous highconfidence binding data (p % 0.001) (Harbison et al., 2004), the presence of
a perfect or near perfect Gcn4 consensus binding site (TGASTCA) in the region of -400
bp to +50 bp, and a greater than 2-fold change in steady-state mRNA levels dependent on
Gcn4 when shifted to amino acid starvation medium (Natarajan et al., 2001). The
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negative list of 945 genes not transcribed from divergent intergenic regions was selected
by weak binding (p R 0.1), absence of a motif near the presumed start site, and a less than
60% change in steady-state mRNA levels in response to shift to amino acid starvation.
Each gene was scored based on the minimum p value found in the region -250 bp to +50
bp from the UAS using the higher of the single and averaged confidence score. Optimal
parameters were determined by maximizing the absolute difference in identified genes in
both the positive list and the negative list using the Statistics-ROC package for Perl.
Nucleosome-depleted promoters were defined as intergenic regions upstream of
protein-coding genes for which unmodified histone H3 or H4 enrichment met the
following criterion: the enrichment of any probe within the intergenic region was less
than the average ratio of enrichment at two neighboring ORFs.
Throughout the text, histone H3 occupancy is often referred to as nucleosome
occupancy. There are two reasons to believe that the results with H3 likely reflect
nucleosome occupancy and not nucleosomes that are missing H3 specifically. First, we
obtained similar results in independent experiments with H3 and H4. Second, previous in
vitro studies suggest that it is H2A-H2B dimmers (and not H3 or H4) that preferentially
dissociate from nucleosomes during transcription (Kireeva et al., 2002).
Supplemental Data
Supplemental Data include two tables and eight figures and can be found with this article
online at http://www.cell.com/cgi/content/full/122/4/517/DC1/.
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Supplementary Methods and Discussion
Growth Conditions and Quality Control for Human Embryonic Stem Cells
Human embryonic stem (ES) cells were obtained from WiCell (Madison, WI; NIH Code
WA09) and grown as described. Cell culture conditions and harvesting have been
described previously (Boyer et al., 2005; Lee et al., 2006; Guenther et al., 2007). Quality
control for the H9 cells included immunohistochemical analysis of pluripotency markers,
alkaline phosphatase activity, teratoma formation, and formation of embryoid bodies and
has been previously published as supplemental material(Boyer et al., 2005; Lee et al.,
2006)
Growth Conditions for Murine Embryonic Stem Cells
V6.5 (C57BL/6-129) murine ES cells were grown under typical ES cell culture
conditions on irradiated mouse embryonic fibroblasts (MEFs) as previously described
(Boyer et al., 2006). Briefly, cells were grown on gelatinized tissue culture plates in
DMEM-KO (Gibco/Invitrogen) supplemented with 15% fetal bovine serum
(characterized from Hyclone), 1000 U/ml leukemia inhibitory factor (LIF) (Chemicon;
ESGRO ESG 1106), non-essential amino acids, L-glutamine, Penicillin/Streptomycin
andB-mercaptoethanol. Immunostaining was used to confirm expression of pluripotency
markers, SSEA 1 (Developmental Studies Hybridoma Bank) and Oct4 (Santa Cruz, SC-
5279). For location analysis, cells were grown for one passage off of MEFs, on
gelatinized tissue-culture plates.
Antibodies
Oct4-bound genomic DNA was enriched from whole cell lysate using an epitope specific
goat polyclonal antibody purchased from Santa Cruz (sc-8628) and compared to a
reference whole cell extract (Boyer et al., 2005). A summary of regions occupied with
high confidence for this antibody identified by ChIP-seq in mES cells are listed in Table
S3 and by ChIP-chip on genome-wide tiling arrays in hES cells are on Table S8. Oct4
ChIP-seq data can be visualized on the UCSC browser by uploading supplemental file
mES_regulator_ChIPseq.mm8.WIG.gz
Sox2-bound genomic DNA was enriched from whole cell lysate using an affinity
purified goat polyclonal antibody purchased from R&D Systems (AF2018) and compared
to a reference whole cell extract (Boyer et al., 2005). A summary of regions occupied
with high confidence for this antibody identified by ChIP-seq in mES cells are listed in
Table S3. Sox2 ChIP-seq data can be visualized on the UCSC browser by uploading
supplemental file mESregulator_ChIPseq.mm8.WIG.gz
Nanog-bound genomic DNA was enriched from whole cell lysate using an
affinity purified rabbit polyclonal antibody purchased from Bethyl Labs (b11662) and
compared to a reference whole cell extract (Boyer et al., 2005).. A summary of regions
bound with high confidence for this antibody are listed in Table S3. Nanog ChIP-seq data
can be visualized on the UCSC browser by uploading supplemental file
mES_regulator_ChIPseq.mm8.WIG.gz
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Tcf3-bound genomic DNA was enriched from whole cell lysate using an epitope
specific goat polyclonal antibody purchased from Santa Cruz (sc-8635) and compared to
a reference whole cell extract (Cole et al., 2008). A summary of regions occupied with
high confidence for this antibody identified by ChIP-seq in mES cells are listed in Table
S3. Tcf3 ChIP-seq data can be visualized on the UCSC browser by uploading
supplemental file mESregulatorChlPseq.mm8.WIG.gz
Suzl2-bound genomic DNA was enriched from whole cell lysate using an affinity
purified rabbit polyclonal antibody purchased from Abcam (AB 12073) and compared to a
reference whole cell extract (Lee et al., 2006). A summary of regions bound with high
confidence for this antibody are listed in Table S10. Suzl2 ChIP-seq data can be
visualized on the UCSC browser by uploading supplemental file
mES_chomatin_ChlPseq.mm8.WIG.gz
H3K4me3-modified nucleosomes were enriched from whole cell lysate using an
epitope-specific rabbit polyclonal antibody purchased from Abcam (AB8580) (Santos-
Rosa et al., 2002; Guenther et al., 2007). Samples were analyzed using ChIP-seq.
Comparison of this data with ChIP-seq published previously (Mikkelsen et al., 2007)
showed near identify in profile and bound regions (Table S5). H3K4me3 ChlP-seq data
can be visualized on the UCSC browser by uploading supplemental file
mES_chomatin_ChlPseq.mm8.WIG.gz
H3K79me2-modified nucleosomes were isolated from mES whole cell lysate
using Abcam antibody AB3594 (Guenther et al., 2007). Chromatin immunoprecipitations
against H3K36me3 were compared to reference WCE DNA obtained from mES cells.
Samples were analyzed using ChIP-seq and were used for visual validation of predicted
miRNA promoter association with mature miRNA sequences only (Figure 2).
H3K79me2 ChIP-seq data can be visualized on the UCSC browser by uploading
supplemental file mES_chomatin_ChlPseq.mm8.WIG.gz
H3K36me3-modified nucleosomes were isolated from mES whole cell lysate
using rabbit polyclonal antibody purchased from Abcam (AB9050) (Guenther et al.,
2007). Chromatin immunoprecipitations against H3K36me3 were compared to reference
WCE DNA obtained from mES cells. Samples were analyzed using ChIP-seq and were
used for visual validation of predicted miRNA promoter association with mature miRNA
sequences only (Figure 2). H3K36me3 ChIP-seq data can be visualized on the UCSC
browser by uploading supplemental file mES_chomatin_ChlPseq.mm8.WIG.gz
Chromatin Immunoprecipitation
Protocols describing all materials and methods have been previously described (Lee et al.
2007) and can be downloaded from http://web.wi.mit.edu/young/hES_PRC.
Briefly, we performed independent immunoprecipitations for each analysis.
Embryonic stem cells were grown to a final count of 5x 107 - x108 cells for each location
analysis experiment. Cells were chemically crosslinked by the addition of one-tenth
volume of fresh 11% formaldehyde solution for 15 minutes at room temperature. Cells
were rinsed twice with lxPBS and harvested using a silicon scraper and flash frozen in
liquid nitrogen. Cells were stored at -80°C prior to use.
Cells were resuspended, lysed in lysis buffers and sonicated to solubilize and
shear crosslinked DNA. Sonication conditions vary depending on cells, culture
conditions, crosslinking and equipment. We used a Misonix Sonicator 3000 and
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sonicated at approximately 28 watts for 10 x 30 second pulses (90 second pause between
pulses). For ChIP of Oct4, Nanog, Tcf3 and Suzl2 in murine ES cells, SDS was added to
lysate after sonication to a final concentration of 0.1%. Samples were kept on ice at all
times.
The resulting whole cell extract was incubated overnight at 4°C with 100 pl of
Dynal Protein G magnetic beads that had been preincubated with approximately 10 pg of
the appropriate antibody. Beads were washed 4-5 times with RIPA buffer and 1 time with
TE containing 50 mM NaCl. For ChIP of Oct4, Nanog, Tcf3 and Suzl2 in murine ES
cells, the following 4 washes for 4 minutes each were used instead of RIPA buffer: 1X
low salt (20mM Tris pH 8.1, 150mM NaCI, 2mM EDTA, 1% Triton X-100, 0.1% SDS),
IX high salt (20mM Tris pH 8.1, 500mM NaCl, 2mM EDTA, 1% Triton X-100, 0.1%
SDS), 1X LiCl (10mM Tris pH 8.1, 250mM LiC1, 1mM EDTA, 1% deoxycholate, 1%
NP-40), and 1X TE+ 50mM NaC1. Bound complexes were eluted from the beads by
heating at 650C with occasional vortexing and crosslinking was reversed by overnight
incubation at 650 C. Whole cell extract DNA (reserved from the sonication step) was also
treated for crosslink reversal.
ChIP-Seq Sample Preperation and Analysis
All protocols for Illumina/Solexa sequence preparation, sequencing and quality control
are provided by Illumina (http://www.illumina.com/pages.ilmn?ID=203). A brief
summary of the technique and minor protocol modifications are described below.
Sample Preparation
Purified immunoprecipitated (ChIP) DNA were prepared for sequencing according to a
modified version of the Illumina/Solexa Genomic DNA protocol. Fragmented DNA was
prepared for ligation of Solexa linkers by repairing the ends and adding a single adenine
nucleotide overhang to allow for directional ligation. A 1:100 dilution of the Adaptor
Oligo Mix (Illumina) was used in the ligation step. A subsequent PCR step with limited
(18) amplification cycles added additional linker sequence to the fragments to prepare
them for annealing to the Genome Analyzer flow-cell. After amplification, a narrow
range of fragment sizes was selected by separation on a 2% agarose gel and excision of a
band between 150-300 bp (representing shear fragments between 50 and 200nt in length
and -100bp of primer sequence). The DNA was purified from the agarose and diluted to
10 nM for loading on the flow cell.
Polony generation on Solexa Flow-Cells
The DNA library (2-4 pM) was applied to the flow-cell (8 samples per flow-cell) using
the Cluster Station device from Illumina. The concentration of library applied to the flow-
cell was calibrated such that polonies generated in the bridge amplification step originate
from single strands of DNA. Multiple rounds of amplification reagents were flowed
across the cell in the bridge amplification step to generate polonies of approximately
1,000 strands in 1pm diameter spots. Double stranded polonies were visually checked for
density and morphology by staining with a 1:5000 dilution of SYBR Green I (Invitrogen)
and visualizing with a microscope under fluorescent illumination. Validated flow-cells
were stored at 40C until sequencing.
Sequencing
Flow-cells were removed from storage and subjected to linearization and annealing of
sequencing primer on the Cluster Station. Primed flow-cells were loaded into the
228
Illumina Genome Analyzer 1G. After the first base was incorporated in the Sequencing-
by-Synthesis reaction the process was paused for a key quality control checkpoint. A
small section of each lane was imaged and the average intensity value for all four bases
was compared to minimum thresholds. Flow-cells with low first base intensities were re-
primed and if signal was not recovered the flow-cell was aborted. Flow-cells with signal
intensities meeting the minimum thresholds were resumed and sequenced for 26 cycles.
Solexa Data Analysis
Images acquired from the Illumina/Solexa sequencer were processed through the bundled
Solexa image extraction pipeline which identified polony positions, performed base-calling
and generated QC statistics. Sequences were aligned using the bundled ELAND software
using murine genome NCBI Build 36 and 37 (UCSC mm8, mm9) as the reference genome.
Alignments to build 37 were used for analysis of the mmu-mir-290 cluster only as that
cluster is not represented on build 36. Only sequences perfectly and uniquely mapping to the
genome were used. A summary of the number of reads used is shown in Table S 1.
The analysis methods used were derived from previously published methods
(Johnson et al., 2007, Mikkelsen et al., 2007). Sequences from all lanes for each
chromatin IP were combined, extended 200bp (maximum fragment length accounting for
-~100bp of primer sequence), and allocated into 25 bp bins. Genomic bins containing
statistically significant ChlP-seq enrichment were identified by comparison to a
Poissonian background model, using a p-value threshold of 109-. A list of the numbers of
counts in a genomic bins required for each sample to meet this threshold are provided in
Table SI . Addtionally, we used and empirical background model obtained from
identical Solexa sequencing of DNA from whole cell extract (WCE) from matched cell
samples (> 5x normalized enrichment across the entire region, see below). A summary of
the bound regions and their relation to gene targets can be found in Tables S2, S3, S5 and
S10.
The p-value threshold was selected to minimize the expected false-positive rate.
Assuming background reads are spread randomly throughout the genome, the probability
of observing a given number of counts can be modelled as a Poisson process where the
expectation can be calculated as the number of mapped reads times the number of bins
per read (8) divided by the total number of bins available (we assumed 50% as a very
conservative estimate). With the genome divided into ~10' bins of 25 bp, a probability of
p<10 9- represents the likelihood that ~1 experiment in 10 will randomly enrich one bin in
the genome.
The Poisson background model assumes a random distribution of binding events,
however we have observed significant deviations from this expectation in ChlP-seq
datasets. These non-random events can be detected as sites of enrichment using control
IPs and create a significant number of false positive events for actual ChlP-seq
experiments. To remove these regions, we compared genomic bins and regions that meet
the statistical threshold for enrichment to an empirical distribution of reads obtained from
Solexa sequencing of DNA from whole cell extract (WCE) from matched cell samples.
We required that enriched regions have five-fold greater ChlP-seq density in the specific
IP sample as compared with the non-specific WCE sample, normalized for the total
number of reads. This served to filter out genomic regions that are biased to having a
greater than expected background density of ChIP-seq reads. We observed that ~200-500
regions in the genome showed non-specific enrichment in these experiments.
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Identifications of regions enriched for Oct4/Sox2/Nanog/Tcf3
The identification of enriched regions in ChIP-chip and ChlP-seq experiments is typically
done using threshold for making a binary determination of enriched or not enriched.
Unfortunately, there is not actually a clear delineation between truly bound and and
unbound regions. Instead, enrichment is a continuum and the threshold is set to minimize
false positives (high-confidence sites). This typically requires that thresholds be set at a
level that allows a high false-negative rate (-30% for ChIP-chip, Lee et al). When
multiple factors are compared, focusing only on the intersection of the different data sets
compounds this effect, leading to higher false negative rates and the loss of many critical
target genes.
Oct4, Sox2, Nanog and Tcf3 co-occupy promoters throughout the genome (Cole,
Figure 1) and cluster analysis of enriched sites reveals apparent co-enrichment for all 4
factors at >90% of sites (Frampton & Young, unpublished data). However, the overlap
for any two factors at the cut-off for high-confidence enrichment is only about two thirds
(Figure S1, Tables S2 and S3). Therefore many of these sites must have enrichment that
is below the high-confidence threshold for at least some of the participating factors.
Variability in the enrichment observed for each factor at different binding sites is
common in the data (Figures ib, 3, and S2).
To determine a threshold of binding for multiple factors, we used two
complementary methods to examine high-confidence targets of the four regulators. First,
the classes of genes enriched by different numbers of factors at high-confidence were
compared to the known classes of targets based on gene ontology (Figure Slb,
http://gostat.wehi.edu.au/cgi-bin/goStat.pl, Beissbarth and Speed, 2004). The highest
confidence targets (those with high levels of immuno-enrichment observed for all for
factors) preferentially encoded factors involved in DNA binding, regulation of
transcription and development as has been previously shown (Boyer et al., 2005). These
gene ontology categories continued to be overrepresented among high-confidence targets
of either 3 of the 4 factors or 2 of 4 the factors, albeit at lower levels, but were barely
enriched among high confidence targets of only one factor.
As a second test, we examined how different numbers of overlapping high-
confidence targets affected the overlap with our previous genome-wide studies using
ChIP-chip. Because not not all egions of the genome are tiled with equal density on the
microarrays used for ChIP-chip, we first determined the minimum probe density required
to confirm binding detected by ChlP-seq (Figure S2). At most genes with high probe
density, the ChlP-seq and ChIP-chip data were very highly correlated. However, regions
of the genome with microarray coverage of less than three probes per kilobase were
generally unreliable in detecting these enrichment. These regions, which had low probe
coverage on the microarrays, represent approximately 1/3 of all sites co-enriched for the
four factors by ChlP-seq. In regions where probe density was greater than three probe
per kilobase the fraction of ChIP-seq sites confirmed by ChIP-chip experiments increased
with additional factors co-binding with a large fall off below 2 factors (data not shown).
Based on these two analyses, we elected to choose targets occupied at high-confidence by
2 or more of the 4 factors tested for further analysis in this manuscript. (Figures 1 a and
Sla [red line]).
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While a majority of the miRNA promoters identified as occupied by
Oct4/Sox2/Nanog/Tcf3 are not occupied by all four factors at high-confidence, it is
interesting to note that all of the miRNA genes that share highly similar seeds to miR-302
are occupied at high confidence by all four factors (miR-302 cluster, miR-290 cluster and
miR-106a cluster), similar to the promoters of core transcriptional regulators of ES cells.
By comparison, promoters also occupied by Suzl2 almost never showed high-confidence
binding for all four factors (Table S4, see mmu-miR-9-2 in Figure 3). Similar effects
were observed for protein-coding genes in mES cells (Lee et al., 2006). Whether this is
caused by reduced epitope availability in PcG bound regions or reflects reduced protein
binding is unclear.
DNA Motif Discovery and High-resolution Binding-Site Analysis
DNA motif discovery was performed on the genomic regions that were enriched for Oct4
at high-confidence. In order to obtain maximum resolution, a modified version of the
ChIP-seq read mapping algorithm was used. Genomic bins were reduced in size from 25
bp to 10 bp. Furthermore, a read extension that placed greater weight towards the middle
of the 200 bp extension was used. This model placed 1/3 count in the 8 bins from 0-40
and 160-200 bp, 2/3 counts in the 8 bins from 40-80 and 120-160 bp and I count in the 4
bins from 80-120 bp. This allowed increased precision for determination of the peak of
ChIP-seq density in each Oct4 bound region. 100bp surrounding the 500 Oct4 bound
regions with the greatest peak ChIP-seq density were submitted to the motif disocvery
tool MEME (Bailey and Elkan, 1995; Bailey, 2006) to search for over-represented DNA
motifs. A single sixteen basepair motif was discovered by the MEME algorithm (Table
S4, Figure S2i). This motif was significantly (p<10'00) over-represented in the Oct4
bound input sequences and occurred in 445 of the 500 hundred basepair sequences.
As a default, MEME uses the individual nucleotide frequencies within input
sequences to model expected motif frequencies. This simple model might result
discovery of motifs which are enriched because of non-random di-, tri-, etc. nucleotide
frequencies. Consequently, three different sets of control sequences of identical length
were used to ensure the specificity of the motif discovery results. First, the sequences
immediately flanking each input sequence were used as control sequences. Second,
randomly selected sequences having the same distribution of distances from transcription
start sites as the Oct4 input sequences were used as control sequences. Third, sequences
from completely random genomic regions were used as control sequences. Each of these
sets of control seqeunces were also examined using MEME. For each of these controls,
the motif discovered from actual Oct4 bound sequences was not identified in the control
sequences.
The motif discovery process was repeated using different numbers and lengths of
sequences, but the same motif was discovered for a wide array of input sequences.
Furthermore, when motif discovery was repeated with the top 500 Sox2, Nanog, and Tcf3
occupied regions, the same motif was identified. Overall, the motif occurs within 100 bp
of the peak of ChlP-seq density at more than 90% of the top regions enriched in each
experiment, while occuring in the same span at 24-28% of control regions and within 25
bp of the ChlP-seq peak at more than 80% of regions versus 9-11% of control regions.
We next attempted to determine the precise sites on the genome bound by Oct4,
Sox2, Nanog, and Tcf3 at basepair resolution using composite analysis of the bound
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regions for each factor. In particular, we examined if the different factors tended to
associate with specific sequences within the assymetric DNA motif identified at a high
fraction of the sites occupied by Oct4, Sox2, Nanog, and Tcf3. A set of ~-2,000 of the
highest confidence bound regions was determined for each factor based on a count
threshold approximately two fold higher than the threshold for high-confidence regions
shown in Table S1 (Poissoin: p < 10-9). Regions without a motif within 50bp of the peak
of ChIP-seq enrichment, typically -~10% of regions, were removed from this analysis.
The distance from the first base of the central motif in each bound region to the 5' end of
all reads within 250bp was tabulated, keeping reads mapping to the same strand as the
motif separate from reads mapping to the oppositie strand. The difference in ChlP-seq
read frequency between reads mapping to the same strand as the motif and the reads
mapping to the oppositite strand was calculated at every basepair within the 500 bp
window Figure S3. We made the assumption that the precise peak of the ChlP-seq
distribution was the point at which this strand bias was equal to zero.
To determine the precise position where the strand bias was equal to zero, we
created a simplified model of the strand bias for each transcription factor. We chose a
function with 4 parameters (A,B, C, and M), one of which (M) was the point at which the
curve crosses the x-axis.
Curve fitting was performed using a least squares model by GNUplot
(http://www.gnuplot.info/) using an approximated set of initial conditions (A = -1000, B
= 100, C = 2, M = 10). The variablity in M was detemined by monte carlo simulation
(n=25) using a random set of half of the ChlP-seq reads in each dataset and is shown in
Figure S3.
Identification of miRNA promoters in human and mouse
To better understand the regulation of miRNAs, we sought to identify the sites of
transcription initiation for all miRNAs in both human and mouse, at least to low
resolution (-lkb). Most methods used to identify promoters require active transcription
of the miRNA and isolation of rare primary miRNA transcripts. We decided to use an
approach based on in vivo chromatin signature of promoters. This approach has two
principle advantages. First, the required data has been published by a variety of
laboratories and is readily accessible and second, it does not require the active
transcription of the miRNA primary transcript.
Recent results using genome-wide location analysis of H3K4me3 indicate that
between 60 and 80% of all protein-coding genes in any cell population have promoters
enriched in methylated nucleosomes, even where the gene is not detected by typical
transcription profiling (Guenther et al., 2007) Importantly, over 90% of the H3K4me3
enriched regions in these cells map to known or predicted promoters, suggesting that
H3K4me3 can be used as a proxy for sites of active initiation. Our strategy to identify
miRNA promoters, therefore, uses H3K4me3 enriched sites from as many sources as
possible as a collection of promoters. In human, H3K4me3 sites were identified in ES
cells (H9), hepatocytes, a pro-B cell line (REH cells) (Guenther et al., 2007) and T
cells(Barski et al., 2007). Mouse H3K4me3 sites were identified from ES cells (V6.5),
neural precursors, and embryonic fibroblasts (Mikkelsen et al., 2007). In total, we
identified 34,793 high-confidence H3K4me3 enriched regions in human and 34,096 high-
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confidence regions enriched in mouse, collectively present at ~75% of all protein-coding
genes.
The list of miRNAs identified in the miRNA atlas (Landgraf et al., 2007)were
used as the basis for our identification. The total list consists of 496 miRNAs in human,
382 miRNAs in mouse. ~65% of the murine miRNAs can be found in both species.
For each of these miRNAs, possible start sites were derived from both all H3K4me3
enriched regions within 250kb upstream of the miRNA as well as all known start sites for
any miRNAs that were identified as being within known transcripts from RefSeq(Pruitt et
al., 2005) Mammalian Gene Collection (MGC) (Gerhard et al., 2004) Ensembl (Hubbard
et al., 2005), or University of California Santa Cruz (UCSC) Known Genes
(genome.ucsc.edu)(Kent et al., 2002)for which EntrezGene
(http://www.ncbi.nlm.nih.gov/entrez/) gene IDs had been generated. Where an annotated
start site was found to overlap an H3K4me3 enriched region, the known start was used in
place of the enriched region.
A scoring system was derived empirically to select the most likely start sites for
each miRNA. Each possible site was given a bonus if it was either the start of a known
transcript that spanned the miRNA or of an EST that spanned the miRNA. Scores were
reduced if the H3K4me3 enriched region was assignable instead to a transcript or EST
that did not overlap the miRNA. Additional positive scores were given to enriched sites
within 5kb of the miRNA, while additional negative scores were given based on the
number of intervening H3K4me3 sites between the test region and the miRNA. Finally,
each enriched region was tested for conservation between human and mouse using the
UCSC liftover program (Hinrichs et al., 2006). If two test regions overlapped, they were
considered to be conserved (21%). In the cases where human and mouse disagreed on the
quality of a site, if the site had an EST or gene overlapping the miRNA, that site was
given a high score in both species. Alternatively, if one species had a non-overlapping
site, that site was considered to be an unlikely promoter in both species. Finally, for
miRNAs where a likely promoter was identified in only one species, we manually
checked the homologous region of the other genome to search for regions enriched for
H3K4me3-modified nucleosomes that may have fallen below the high-confidence
threshold. Start sites were considered to be likely if the total score was > 0 (Figure S4 and
S5). In total, we identified likely start sites for ~85% of all miRNAs in both species
(Tables S6 and S7). Predicted miRNA genes can be visualised on the UCSC browser by
uploading the supplemental files mouse_miRNA_track.mm8.bed and
human_miRNA_track.hgl7.bed
Several lines of evidence suggest the high quality of these predictions. First,
previous studies have found that miRNAs within 50kb of each other are likely to be co-
regulated(Lagos-Quintana et al., 2001; Lau et al., 2001). While the nature of these
clusters was not included in our analysis, nearly all miRNAs within a cluster end up
identifying the same promoter region (see Figures 2, 3, 5 and S3). The only exceptions to
this are found in the large clusters of repeat derived miRNAs found in chromosome 12 of
mouse and chromosome 14 in human where a single H3K4me3 enriched region splits the
clusters. Second, consistent with the frequent association of CpG islands with the
transcriptional start sites for protein-coding genes, -50% of the miRNA promoters
identified here overlap CpG islands (Tables S6 and S7). Finally, for miRNAs that were
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active in ES cells, histone modifications associated with elongation were able to
"connect" the mature miRNAs to the predicted transcription start site (Figure 2).
To further ascertain the accuracy of our promoter predictions, we compared our
predicted start sites to those identified in recent studies. Predictions were tested against
mmu-mir-34b / mmu-mir-34c (Corney et al., 2007),hsa-mir-34a (Chang et al., 2007)
mmu-mir-101 a, mmu-mir-202, mmu-mir-22, mmu-mir-124a-1, mmu-mir-433 (Fukao et
al., 2007), and hsa-mir-17/18a/19a/20a/19b-1/92a-1 (O'Donnell et al., 2005). Additional
miRNA promoters in these manuscripts were not predicted strongly by the above
algorithm. For these 14 miRNAs, H3K4me3 sites were identified within lkb of all but
two of the sites. mmu-mir-202 was predicted about 20kb upstream of the annotated start
site, but may reflect an H3K4me3 site absent from the tissues sampled. mmu-mir-433 is
in the middle of a large cluster of miRNAs on mouse chromosome 12. The annotated
TSS lies within the cluster between mir-433 and mir-431 suggesting the promoter may be
incorrect. Overall, the accuracy of the promoter predictions is believed to be ~75% (6/8).
Additional H3K4me3 data sets and EST data should allow for improved accuracy in
predicting and validating these initiation sites.
ChIP-chip Sample Preperation and Analysis
Immunoprecipitated DNA and whole cell extract DNA were purified by treatment with
RNAse A, proteinase K and multiple phenol:chloroform:isoamyl alcohol extractions.
Purified DNA was blunted and ligated to linker and amplified using a two-stage PCR
protocol. Amplified DNA was labelled and purified using Bioprime random primer
labeling kits (Invitrogen): immunoenriched DNA was labeled with Cy5 fluorophore,
whole cell extract DNA was labelled with Cy3 fluorophore.
Labelled DNA was mixed (-5 pg each of immunoenriched and whole cell extract
DNA) and hybridized to arrays in Agilent hybridization chambers for up to 40 hours at
400 C. Arrays were then washed and scanned.
Slides were scanned using an Agilent DNA microarray scanner BA. PMT
settings were set manually to normalize bulk signal in the Cy3 and Cy5 channel. For
efficient batch processing of scans, we used Genepix (version 6.0) software. Scans were
automatically aligned and then manually examined for abnormal features. Intensity data
were then extracted in batch.
44k Human Whole Genome Array
The human promoter array was purchased from Agilent Technology (www.agilent.com).
The array consists of 115 slides each containing -44,000 60mer oligos designed to cover
the non-repeat portion of the human genome. The design of these arrays are discussed in
detail elsewhere (Lee et al., 2006).
Data Normalization and Analysis
We used GenePix software (Axon) to obtain background-subtracted intensity values for
each fluorophore for every feature on the whole genome arrays. Among the Agilent
controls is a set of negative control spots that contain 60-mer sequences that do not cross-
hybridize to human genomic DNA. We calculated the median intensity of these negative
control spots in each channel and then subtracted this number from the intensities of all
other features.
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To correct for different amounts of each sample of DNA hybridized to the chip,
the negative control-subtracted median intensity value of control oligonucleotides from
the Cy3-enriched DNA channel was then divided by the median of the control
oligonucleotides from the Cy5-enriched DNA channel. This yielded a normalization
factor that was applied to each intensity in the Cy5 DNA channel.
Next, we calculated the log of the ratio of intensity in the Cy3-enriched channel to
intensity in the Cy5 channel for each probe and used a whole chip error model20 to
calculate confidence values for each spot on each array (single probe p-value). This error
model functions by converting the intensity information in both channels to an X score
which is dependent on both the absolute value of intensities and background noise in each
channel using an f-score calculated as described16 for promoter regions or using a score of
0.3 for tiled arrays. When available, replicate data were combined, using the X scores
and ratios of individual replicates to weight each replicate's contribution to a combined X
score and ratio. The X scores for the combined replicate are assumed to be normally
distributed which allows for calculation of a p-value for the enrichment ratio seen at each
feature. P-values were also calculated based on a second model assuming that, for any
range of signal intensities, IP:control ratios below 1 represent noise (as the
immunoprecipitation should only result in enrichment of specific signals) and the
distribution of noise among ratios above 1 is the reflection of the distribution of noise
among ratios below 1.
High Confidence Enrichment
To automatically determine bound regions in the datasets, we developed an algorithm to
incorporate information from neighboring probes. For each 60-mer, we calculated the
average X score of the 60-mer and its two immediate neighbours. If a feature was
flagged as abnormal during scanning, we assumed it gave a neutral contribution to the
average X score. Similarly, if an adjacent feature was beyond a reasonable distance from
the probe (1000 bp), we assumed it gave a neutral contribution to the average X score.
The distance threshold of 1000 bp was determined based on the maximum size of
labelled DNA fragments put into the hybridization. Since the maximum fragment size
was approximately 550 bp, we reasoned that probes separated by 1000 or more bp would
not be able to contribute reliable information about a binding event halfway between
them.
This set of averaged values gave us a new distribution that was subsequently used
to calculate p-values of average X (probe set p-values). If the probe set p-value was less
than 0.001, the three probes were marked as potentially bound.
As most probes were spaced within the resolution limit of chromatin
immunoprecipitation, we next required that multiple probes in the probe set provide
evidence of a binding event. Candidate bound probe sets were required to pass one of
two additional filters: two of the three probes in a probe set must each have single probe
p-values < 0.005 or the centre probe in the probe set has a single probe p-value < 0.001
and one of the flanking probes has a single point p-value < 0.1. These two filters cover
situations where a binding event occurs midway between two probes and each weakly
detects the event or where a binding event occurs very close to one probe and is very
weakly detected by a neighboring probe. Individual probe sets that passed these criteria
and were spaced closely together were collapsed into bound regions if the centre probes
of the probe sets were within 1000 bp of each other.
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Comparing Enriched Regions to Known Genes and miRNAs
Enriched regions were compared relative to transcript start and stop coordinates of known
genes compiled from four different databases: RefSeq (Pruitt et al., 2005), Mammalian
Gene Collection (MGC) (Gerhard et al., 2004), Ensembl (Hubbard et al., 2005), and
University of California Santa Cruz (UCSC) Known Genes (genome.ucsc.edu) (Kent et
al., 2002). All human coordinate information was downloaded in January 2005 from the
UCSC Genome Browser (hgl7, NCBI build 35). Mouse data was downloaded in June of
2007 (mm8, NCBI build 36).
To convert bound transcription start sites to more useful gene names, we used
conversion tables downloaded from UCSC and Ensembl to automatically assign
EntrezGene (http://www.ncbi.nlm.nih.gov/entrez/) gene IDs and symbols to the RefSeq,
MGC, Ensembl, UCSC Known Gene. Comparisons of Oct4, Sox2, Nanog, Tcf3,
H3K4me3 and Suzl2 to annotated regions of the genomes can be found in Tables S3, S5,
S8 and S10
For miRNAs start sites, two separate windows were used to evaluate overlaps. For
chromatin marks and non-sequence specific proteins, miRNA promoters were considered
bound if they were within 1kb of an enriched sequence. For sequence specific factors
such as Oct4, we used a more relaxed region of 8kb surrounding the promoter, consistent
with previous work we have published (Boyer et al., 2005). A full list of the high
confidence start sites bound to promoters can be found in Tables S6 and S7.
Growth Conditions for Neural Precursors, mouse embryonic fibroblasts, and induced
pluripotent stem cells.
To generate neural precursor cells, ES cells were differentiated along the neural lineage
using standard protocols. V6.5 ES cells were differentiated into neural progenitor cells
(NPCs) through embryoid body formation for 4 days and selection in ITSFn media for 5-
7 days, and maintained in FGF2 and EGF2 (R&D Systems) (Okabe et al., 1996).
Mouse embryonic fibroblasts were prepared from DR-4 strain mice as previously
described (Tucker et al., 1997). Cells were cultured in Dulbecco's modified Eagle
medium supplemented with 10% cosmic calf serum, 0-mercaptoethanol, non-essential
amino acids, L-glutamine and penicillin/streptomycin.
Analysis of Mature miRNA Frequency by Solexa Sequencing
Polony generation on Solexa Flow-Cells
The DNA library (2-4 pM) was applied to the flow-cell (8 samples per flow-cell) using
the Cluster Station device from Illumina. The concentration of library applied to the flow-
cell was calibrated such that polonies generated in the bridge amplification step originate
from single strands of DNA. Multiple rounds of amplification reagents were flowed
across the cell in the bridge amplification step to generate polonies of approximately
1,000 strands in ly/m diameter spots. Double stranded polonies were visually checked for
density and morphology by staining with a 1:5000 dilution of SYBR Green I (Invitrogen)
and visualizing with a microscope under fluorescent illumination. Validated flow-cells
were stored at 40C until sequencing.
Sequencing and Analysis
Flow-cells were removed from storage and subjected to linearization and annealing of
sequencing primer on the Cluster Station. Primed flow-cells were loaded into the
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Illumina Genome Analyzer 1G. After the first base was incorporated in the Sequencing-
by-Synthesis reaction the process was paused for a key quality control checkpoint. A
small section of each lane was imaged and the average intensity value for all four bases
was compared to minimum thresholds. Flow-cells with low first base intensities were re-
primed and if signal was not recovered the flow-cell was aborted. Flow-cells with signal
intensities meeting the minimum thresholds were resumed and sequenced for 36 cycles.
Images acquired from the Illumina/Solexa sequencer were processed through the bundled
Solexa image extraction pipeline which identified polony positions, performed base-
calling and generated QC statistics. Sequences were then assigned to a miRNA if they
perfectly matched at least the first 20bp of the mature miRNA sequences downloaded
from targetScan (http://www.targetscan.org/). Mature miRNA frequencies were then
normalized to each other by determining the expected frequency in mapped reads/million.
A full list of the miRNAs detected can be found in Table S9
miRNA Microarray Expression Analysis
Mouse embryonic fibroblasts and neural precursor cells were cultured as described
above. Murine induced pluripotent (iPS) cells, derived as previously described (Wernig
et al., 2007), were cultured under the same conditions as murine embryonic stem cells
(described above). RNA was extracted with RNeasy (Qiagen) reagents. 5 ug total RNA
from treated and control samples were labeled with Hy3TM and Hy5 TM fluorescent label,
using the miRCURYTM LNA Array labeling kit (Exiqon, Denmark) following the
procedure described by the manufacturer. The labeled samples were mixed pair-wise and
hybridized to the miRNA arrays printed using miRCURYTM LNA oligoset version 8.1
(Exiqon, Denmark). Each miRNA was printed in duplicate, on codelink slides (GE),
using GeneMachines Omnigrid 100. The hybridization was performed at 60C overnight
using the Agilent Hybridization system - SurHyb, after which the slides were washed
using the miRCURYTM LNA washing buffer kit (Exiqon, Denmark) following the
procedure described by the manufacturer. The slides were then scanned using Axon
4000B scanner and the image analysis was performed using Genepix Pro 6.0.
Median minus background signal intensities for all microarray probes were
tabulated and quantile normalized. Within each sample, each probe was given a signal
value of the average signal of the probe of that rank, across the full dataset. Intensities
were then floored at one unit and log normalized. Control probes were removed from
further analysis. Statistically significant differential expression was calculated using the
online NIA Array Analysis Tool (http://lgsun.grc.nia.nih.gov/ANOVA/).
Probes were tested for differential expression using the following settings:
Threshold z-value to remove outliers: 10000
Error Model: Max(Average,Bayesian)
Error variance averaging window: 100
Proportion of highest error variances to be removed: 0.01
Bayesian degrees offreedom: 5
FDR threshold: 0.10
Of 1008 probes, 230 were determined to be differentially expressed between 3 MEF and
2 ES samples. Expression data for the iPS samples were not used for identifying
differentially expressed miRNAs.
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For clustering and heat map display, expression data were Z-score normalized.
Centroid linkage, Spearman rank correlation distance, hierarchical clustering of genes
and arrays was performed using Gene Cluster 3.0 (http://bonsai.ims.u-
tokyo.ac.jp/~mdehoon/software/cluster/software.htm#ctv). Heatmaps were generated
using Java Treeview (http://jtreeview.sourceforge.net/) with color saturation at 0.6
standard deviations. Complete miRNA microarray expression data, differentially
expression results, and clustergram data are provided (Supplementary Tables S99).
Tissue-Specificity of miRNAs
To determine the global tissue-specificity for miRNAs we used data from the recent
publication of the miRNA atlas4. Specificity scores were taken from Table S34 Node 0
from Landgraf et al. (2007). Of the 45 distinct mature miRNAs with specificity scores >1
that are not bound only by Oct4/Sox2/Nanog/Tcf3, 16 were identified as Suzl2 targets.
These 16 represent over 40% of the distinct mature miRNAs whose promoters are
occupied by Suzl2 (p < 5x10-4 for specificity scores > 1.3)
Identification of Oct4/Sox2/Nanog/Tcf3 occupied feed forward loops
To identify feed forward loops we examined the recent data set identifying functional
targets of the miR-290 cluster (Sinkkonen et al., 2008). In their study, Sinkkonen et al.
identified miR-290 targets by both looking at mRNAs that increase in level in a Dicer -/-
cell line and overlap that data set with mRNAs that decrease in expression when miR-290
is added back to the cells. Because the promoter of the miR-290 gene is occupied by
Oct4/Sox2/Nanog/Tcf3, any targets of the miRNA cluster that are also occupied by the 4
factors would represent feed forward targets. Of the 245 miR-290 cluster targets
identified in the intersect of the two data sets, promoters for 64 are occupied by
Oct4/Sox2/Nanog/Tcf3. This is approximately 50% more interactions then would be
expected by random (binomial p-value < 1x 104).
Interestingly, only a small minority of these genes are also occupied by significant
quantities of the PRC2 subunit Suzl2. Of the 64 targets whose promoters are occupied by
Oct4/Sox2/Nanog/Tcf3, only 5 are occupied by domains of Suzl2 binding >500bp (larger
region sizes have been correlated with gene silencing, Lee et al., 2006). This may be
because PcG bound proteins are not functional targets of mir-290 in mES cells or because
these proteins are not expressed following Dicer deletion, they are excluded from the
target list, but may be targets at other stages of development. In the later case, the
miRNAs may serve as a redundant silencing mechanism for ES cells to help prevent even
low levels of expression of the developmental regulators bound by PcG complexes.
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Figure S . Promoters for known genes occupied by Oct4/Sox2/Nanog/Tcf3 in mES cells.
(A) Overlap of genes whose promoters are within 8kb of sites enriched for Oct4, Sox2,
Nanog, or Tcf3. Not shown are the Nanog:Oct4 overlap (289) and Sox2:Tcf3 overlap
(26). Red line deliniates genes considered occupied by Oct4/Sox2/Nanog/Tcf3.
(B) Enrichment for selected GO-terms previously reported to be associated with
Oct4/Sox2/Nanog binding (Boyer et al., 2005) was tested on the sets of genes occupied at
high-confidence for 1 to 4 of the tested DNA binding factors. Hypergeometric p-value is
shown for genes annotated for DNA binding (blue), Regulation of Transcription (green)
and Development (red).
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Figure S2. Comparison of ChIP-seq and ChIP-chip genome wide data for Oct4, Nanog
and Tcf3.
(A) Binding of Oct4 (blue), Nanog (orange) and Tcf3 (red) across 17kb surrounding the
Wnt8a and Nodal genes (black below the graph, arrow indicates transcription start site) as
in figure lb. (upper) Binding derived from ChIP-seq data plotted as reads per million.
(lower) Binding derived from ChIP-chip enrichment ratios (Cole et. al., 2008)
(B) Poor probe density prevents detection of -~1/3 of ChIP-seq binding events on Agilent
genome-wide tiling arrays. Top panel shows the fraction of regions that are occupied by
Oct4/Sox2/Nanog/Tcf3 at high-confidence in mES cells as identified by ChIP-seq that
are enriched for Oct4 (blue), Nanog (orange) and Tcf3 (red) on Agilent genome-wide
microarrays (Cole et al., 2008). Numbers on the x-axis define the boundaries used to
classify probe densities for the histogram. Bottom panel illustrates a histogram of the
microarray probe densities of the enriched regions identified.
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Figure S3. High resolution analysis of Oct4/Sox2/Nanog/Tcf3 binding based on Meta-
analysis.
(A-D) Short sequence reads for a. Oct4, b. Sox2, c. Nanog, d. Tcf3 mapping within
250bp of 2000 highly enriched regions where the peak of binding was found within 50bp
of a high quality Oct4/Sox2 motif were collected. Composite profiles were created at
base pair resolution for forward and reverse strand reads centered on the Oct4/Sox2 motif
(aligned at +1). The difference between the number of positive and negative strand reads
are shown for each base pair (circles). The best fit line is shown for each factor (see
Supplemental Text).
(E-H) Zoomed in region of a-d showing 20bp surrounding the Oct4/Sox2 motif. Dashed
line indicates the position where the best fit line crosses the X-axis. For reference, the
motif is shown below each graph.
(I) Summary of meta-analysis for Oct4, Sox2, Nanog and Tcf3. Arrows indicate the
nucleotide where each transcription factor switches from a positive strand bias to a
negative strand bias. The octomer and HMG box motifs are indicated.
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Figure S4
Figure S4. Algorithm for Identification of miRNA promoters.
(A) Flowchart describing the method used to identify the promoters for primary miRNA
transcripts in human and mouse. For a full description, see supplemental text.
(B) Two examples of identification of miRNA promoters. Top, Initial identification of
possible start sites based on H3K4me3 enriched regions from four cell types"'2
Enrichment of H3K4me3-modified nucleosomes is shown as shades of gray. Red bar
represents the position of the mature miRNA. Black bars below the graph are regions
enriched for H3K4me3. Initial scores are shown below the black bars. The region on the
far right was excluded from the analysis (score = X) since it is downstream of the mature
miRNA. Middle, Identification of candidate start sites <5kb upstream of the mature
miRNA (yellow shaded area). Bottom, identification of candidate start sites that either
initiate overlapping (left) or non-overlapping (right) transcripts. EST and transcript data
is shown. Scores associated with identified genes are shown bold.
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Figure S5
Figure S5. Summary of miRNA promoter classification.
(A) Promoters assigned to mature miRNAs were classified by the dominant feature of
their scoring. Green: miRNAs that were found to have overlapping ESTs or genes
confirming their promoters. Orange: miRNAs that were found to have a candidate start
site within 5kb of the mature miRNA. Gray: miRNAs with either no candidates within
250kb of the mature miRNA or where all candidates had a score less then zero (see Fig.
S4b, right). Yellow: miRNAs for which the closest candidate start site was selected solely
on the basis of its proximity.
(B) The basis of miRNA promoter identification, including Gene or EST evidence
(green), distance of <5 kilobases to mature miRNA (orange), nearest possible promoter to
miRNA (yellow), tended to be conserved between human and mouse
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Figure S6. miRNA genes occupied by the core transcriptional regulators in ES cells are
expressed in induced Pluripotent Stem (iPS) cells.
miRNAs were purified from MEFs (lanes 1-3), mES cells (lane 4,5) and iPS cells (lane6)
and hybridized to LNA miRNA arrays. Differentially expressed probes enriched in either
mEFs or mES cells are shown (FDR < 10%, see supplemental text, iPS cells were not
used to determinedifferential expression). miRNA probes were Z-score normalized, and
cell types were clustered hierarchically (top). Probes associated with active miRNAs
occupied at their promoters by Oct4/Sox2/Nanog/Tcf3 are listed to the right.
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Figure S7. PcG occupied miRNAs are generally expressed in a tissue specific manner.
Mature miRNAs derived from genes occupied by Suzl2 and H3K27me3-modified
nucleosomes were compared to the list of tissue specific miRNAs derived from the
miRNA expression atlas (Landgraf et al., 2007). Vertical axis represents tissue-specificity
and miRNAs with specificity score _1 are shown. miRNAs bound by
Oct4/Sox2/Nanog/Tcf3 and expressed in mES cells are not shown (largely ES cell
specific miRNAs). Among the tissue specific miRNAs there is significant enrichment (p
< 0.005 by hypergeometric distribution) for miRNAs occupied by Suzl2 (green).
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